| 1 |
Gong M, Wang K, Sun H, Wang K, Zhou Y, Cong Y, Deng X, Mao Y. Threshold of 25(OH)D and consequently adjusted parathyroid hormone reference intervals: data mining for relationship between vitamin D and parathyroid hormone. J Endocrinol Invest 2023. [PMID: 36920734 DOI: 10.1007/s40618-023-02057-9] [Reference Citation Analysis]
|
| 2 |
Habli M, Belal D, Sharma A, Halawa A. Infertility, pregnancy and breastfeeding in kidney transplantation recipients: Key issues. World J Meta-Anal 2023; 11(3): 55-67 [DOI: 10.13105/wjma.v11.i3.55] [Reference Citation Analysis]
|
| 3 |
Fong JMN, Chia EC, Zhang M, Malakar RD. Recalcitrant hypercalcemia in a dialysis patient: Case report, literature review, and proposed management algorithm. Semin Dial 2023;36:170-4. [PMID: 36597278 DOI: 10.1111/sdi.13137] [Reference Citation Analysis]
|
| 4 |
Liu L, Lu H, Zou G, Wang H, Li J, Yang Y, Zhang J, Wang X, Li W, Zhuo L. Efficacy and safety of low-dose rituximab as induction therapy for antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement: a Chinese case series. BMC Nephrol 2023;24:28. [PMID: 36755215 DOI: 10.1186/s12882-023-03075-8] [Reference Citation Analysis]
|
| 5 |
Kuo YC, Wang SY, Hung YL, Hsu CC, Kou HW, Chen MY, Tsai CY, Chang CH, Wang YC, Hsu JT, Yeh TS, Lee WC, Yeh CN. Risk factors of recurrent secondary hyperparathyroidism after adequate primary surgical treatment. Front Endocrinol (Lausanne) 2023;14:1063837. [PMID: 36817581 DOI: 10.3389/fendo.2023.1063837] [Reference Citation Analysis]
|
| 6 |
Belfort-DeAguiar R, Lomonaco R, Cusi K. Approach to the Patient With Nonalcoholic Fatty Liver Disease. J Clin Endocrinol Metab 2023;108:483-95. [PMID: 36305273 DOI: 10.1210/clinem/dgac624] [Reference Citation Analysis]
|
| 7 |
Cavalier E. Determination of parathyroid hormone: from radioimmunoassay to LCMS/MS. Clin Chem Lab Med 2023. [PMID: 36640443 DOI: 10.1515/cclm-2022-0942] [Reference Citation Analysis]
|
| 8 |
Yan Y, Gong H, Hu J, Wu D, Zheng Z, Wang L, Lei C. Perioperative parameters-based prediction model for acute kidney injury in Chinese population following valvular surgery. Front Cardiovasc Med 2023;10:1094997. [PMID: 36960471 DOI: 10.3389/fcvm.2023.1094997] [Reference Citation Analysis]
|
| 9 |
Fassio A, Andreola S, Gatti D, Bianco B, Gatti M, Gambaro G, Rossini M, Viapiana O, Negrelli R, Adami G. Radiofrequency echographic multi-spectrometry and DXA for the evaluation of bone mineral density in a peritoneal dialysis setting. Aging Clin Exp Res 2023;35:185-92. [PMID: 36329361 DOI: 10.1007/s40520-022-02286-7] [Reference Citation Analysis]
|
| 10 |
Brandenburg VM. Vitamin D und sekundärer Hyperparathyreoidismus (sHPT) bei CKD im Spiegel der Zeit. Dialyse aktuell 2022;26:448-452. [DOI: 10.1055/a-1941-9118] [Reference Citation Analysis]
|
| 11 |
Bilen N, Gokalp MA, Yilmaz L, Aytekin A, Baskonus I. Analysis of intraoperative laboratory measurements and imaging techniques such as Tc-99 m-MIBI SPECT/CT, 18F-fluorocholine PET/CT and ultrasound in patients operated with prediagnosis of parathyroid adenoma. Ir J Med Sci 2022. [DOI: 10.1007/s11845-022-03215-3] [Reference Citation Analysis]
|
| 12 |
Faienza MF, Pontrelli P, Brunetti G. Type 2 diabetes and bone fragility in children and adults. World J Diabetes 2022; 13(11): 900-911 [DOI: 10.4239/wjd.v13.i11.900] [Reference Citation Analysis]
|
| 13 |
Xiong Y, He T, Liu WV, Zhang Y, Hu S, Wen D, Wang Y, Zhang P, He F, Li X. Quantitative assessment of lumbar spine bone marrow in patients with different severity of CKD by IDEAL-IQ magnetic resonance sequence. Front Endocrinol 2022;13:980576. [DOI: 10.3389/fendo.2022.980576] [Reference Citation Analysis]
|
| 14 |
Buyukdemirci S, Oguz EG, Cimen SG, Sahin H, Cimen S, Ayli MD. Vitamin D deficiency may predispose patients to increased risk of kidney transplant rejection. World J Transplant 2022; 12(9): 299-309 [DOI: 10.5500/wjt.v12.i9.299] [Reference Citation Analysis]
|
| 15 |
Bello AK, Okpechi IG, Osman MA, Cho Y, Cullis B, Htay H, Jha V, Makusidi MA, Mcculloch M, Shah N, Wainstein M, Johnson DW. Epidemiology of peritoneal dialysis outcomes. Nat Rev Nephrol. [DOI: 10.1038/s41581-022-00623-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 16 |
Monciino P, Magagnoli L, Fasulo E, Frittoli M, Leotta C, Pham HN, Stucchi A, Ciceri P, Galassi A, Cozzolino M. Efficacy and Safety of Etelcalcetide in Hemodialysis Patients with Moderate to Severe Secondary Hyperparathyroidism. Kidney and Dialysis 2022;2:482-494. [DOI: 10.3390/kidneydial2030044] [Reference Citation Analysis]
|
| 17 |
Rowe PS, McCarthy EM, Yu AL, Stubbs JR. Correction of Vascular Calcification and Hyperphosphatemia in CKD Rats Treated with ASARM Peptide. Kidney360 2022;3:1683-98. [PMID: 36514737 DOI: 10.34067/KID.0002782022] [Reference Citation Analysis]
|
| 18 |
Kim S, Kim H, Kang D, Ko J, Kim J, Kim K, Kim B, Cho J, Song M, Chung W. Hepatic and Renal Safety of Concurrent Use of Conventional and Herbal Medications for Musculoskeletal Disorders: A Retrospective Observational Study. J Korean Med Rehabil 2022;32:131-140. [DOI: 10.18325/jkmr.2022.32.3.131] [Reference Citation Analysis]
|
| 19 |
Gupta K, Kumar C, Puri G. The Panorama of Hyperparathyroidism. Indian Journal of Endocrine Surgery and Research 2022;17:40-51. [DOI: 10.5005/jp-journals-10088-11184] [Reference Citation Analysis]
|
| 20 |
Brown-Tortorici AR, Narasaki Y, You AS, Norris KC, Streja E, Peralta RA, Guerrero Y, Daza A, Arora R, Lo R, Nakata T, Nguyen DV, Kalantar-Zadeh K, Rhee CM. The Interplay between Dietary Phosphorous, Protein Intake, and Mortality in a Prospective Hemodialysis Cohort. Nutrients 2022;14:3070. [PMID: 35893923 DOI: 10.3390/nu14153070] [Reference Citation Analysis]
|
| 21 |
Brandenburg V, Ketteler M. Vitamin D and Secondary Hyperparathyroidism in Chronic Kidney Disease: A Critical Appraisal of the Past, Present, and the Future. Nutrients 2022;14:3009. [DOI: 10.3390/nu14153009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 22 |
Zhu A, Whitlock RH, Ferguson TW, Nour-Mohammadi M, Komenda P, Rigatto C, Collister D, Bohm C, Reaven NL, Funk SE, Tangri N. Metabolic Acidosis is Associated With Acute Kidney Injury in Patients With CKD. Kidney Int Rep 2022;7:2219-29. [PMID: 36217527 DOI: 10.1016/j.ekir.2022.07.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Okasha KM, Aboufreikha MH, Elrefaey W, Ashmawy MM, Mourad H, Elsebaey MA, Elnaggar MH, Mashaal RG, Metwally S, Mashal SSA, Shalaby NA, Elhoseny SA, Alkassas A, Elbarbary M, Shoeib O, Ali DA, Baiomy N, Alnabawy SM. Association of Serum Osteoprotegerin Level With Myocardial Injury and Cardiovascular Calcification in Chronic Kidney Disease Patients. Front Med 2022;9:814970. [DOI: 10.3389/fmed.2022.814970] [Reference Citation Analysis]
|
| 24 |
Grzejszczak P, Wilimborek J, Bednarkiewicz J, Makówka A, Kurnatowska I. Vitamin D Metabolites, Body Composition, and Nutritional Status in Patients in the Long Term After Kidney Transplantation. Ann Transplant 2022;27:e936009. [PMID: 35726175 DOI: 10.12659/AOT.936009] [Reference Citation Analysis]
|
| 25 |
Alrais M, Thomas D, Abdolmonem H, Zachariah S, Jagdale R, Baker D. On the Relationship Between Cardiovascular Risk Marker Calcium Phosphate Product and Health-Related Quality of Life in Hemodialysis Patients. Nephro-Urol Mon 2022;In Press. [DOI: 10.5812/numonthly-121520] [Reference Citation Analysis]
|
| 26 |
Gaweda AE, Lederer ED, Brier ME. Use of Artificial Intelligence to Identify New Mechanisms and Approaches to Therapy of Bone Disorders Associated With Chronic Kidney Disease. Front Med (Lausanne) 2022;9:807994. [PMID: 35402468 DOI: 10.3389/fmed.2022.807994] [Reference Citation Analysis]
|
| 27 |
Van den Branden A, Verhulst A, D’haese PC, Opdebeeck B. New Therapeutics Targeting Arterial Media Calcification: Friend or Foe for Bone Mineralization? Metabolites 2022;12:327. [DOI: 10.3390/metabo12040327] [Reference Citation Analysis]
|
| 28 |
Kim G, Ju S, Park K. A Case of Full Mouth Rehabilitation with Immediate Placement and Bilateral Sinus Graft in a Patient with End-stage Renal Disease and Diabetes. J Implantol Appl Sci 2022;26:39-50. [DOI: 10.32542/implantology.2022004] [Reference Citation Analysis]
|
| 29 |
Ureña Torres PA, Souberbielle JC, Solal MC. Bone Fragility in Chronic Kidney Disease Stage 3 to 5: The Use of Vitamin D Supplementation. Metabolites 2022;12:266. [DOI: 10.3390/metabo12030266] [Reference Citation Analysis]
|
| 30 |
Hobson P, Kumwenda M, Shrikanth S, Nair H, Wong S. Risk and incidence of cognitive impairment in patients with chronic kidney disease and diabetes: the results from a longitudinal study in a community cohort of patients and an age and gender-matched control cohort in North Wales, UK. BMJ Open 2022;12:e053008. [PMID: 35277401 DOI: 10.1136/bmjopen-2021-053008] [Reference Citation Analysis]
|
| 31 |
Molinari P, Alfieri CM, Mattinzoli D, Campise M, Cervesato A, Malvica S, Favi E, Messa P, Castellano G. Bone and Mineral Disorder in Renal Transplant Patients: Overview of Pathology, Clinical, and Therapeutic Aspects. Front Med 2022;9:821884. [DOI: 10.3389/fmed.2022.821884] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 32 |
Soohoo M, Obi Y, Rivara MB, Adams SV, Lau WL, Rhee CM, Kovesdy CP, Kalantar-Zadeh K, Arah OA, Mehrotra R, Streja E. Comparative Effectiveness of Dialysis Modality on Laboratory Parameters of Mineral Metabolism. Am J Nephrol 2022;53:157-68. [PMID: 35226895 DOI: 10.1159/000521508] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 33 |
Kim Y, Lee E, Lee MJ, Park B, Park I. Characteristics of fracture in patients who firstly starts kidney replacement therapy in Korea: a retrospective population-based study. Sci Rep 2022;12:3107. [PMID: 35210536 DOI: 10.1038/s41598-022-07178-4] [Reference Citation Analysis]
|
| 34 |
Bello AK, Okpechi IG, Osman MA, Cho Y, Htay H, Jha V, Wainstein M, Johnson DW. Epidemiology of haemodialysis outcomes. Nat Rev Nephrol 2022. [PMID: 35194215 DOI: 10.1038/s41581-022-00542-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 35 |
Silva AP, Viegas CSB, Guilherme P, Tavares N, Dias C, Rato F, Santos N, Faísca M, de Almeida E, Neves PL, Simes DC. Gla-Rich Protein, Magnesium and Phosphate Associate with Mitral and Aortic Valves Calcification in Diabetic Patients with Moderate CKD. Diagnostics 2022;12:496. [DOI: 10.3390/diagnostics12020496] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 36 |
Chen C, Lo W, Hu P, Chan H, Shen W, Wu M, Wu M. Efficacy of Osteoporosis Medications for Patients With Chronic Kidney Disease: An Updated Systematic Review and Network Meta-Analysis. Front Pharmacol 2022;13:822178. [DOI: 10.3389/fphar.2022.822178] [Reference Citation Analysis]
|
| 37 |
Jehn U, Kortenhorn A, Schütte-Nütgen K, Thölking G, Westphal F, Strauss M, Wennmann DO, Pavenstädt H, Suwelack B, Görlich D, Reuter S. The Influence of Parathyroidectomy on Osteoporotic Fractures in Kidney Transplant Recipients: Results from a Retrospective Single-Center Trial. J Clin Med 2022;11:654. [PMID: 35160109 DOI: 10.3390/jcm11030654] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 38 |
Poiana C, Dusceac R, Niculescu DA. Utility of Trabecular Bone Score (TBS) in Bone Quality and Fracture Risk Assessment in Patients on Maintenance Dialysis. Front Med 2022;8:782837. [DOI: 10.3389/fmed.2021.782837] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 39 |
Maemoto M, Hirata Y, Hosoe S, Ouchi J, Narushima K, Akizawa E, Tsuji Y, Takada H, Yanagisawa A, Shuto S. Discovery of Gut-Restricted Small-Molecule Inhibitors of Intestinal Sodium-Dependent Phosphate Transport Protein 2b (NaPi2b) for the Treatment of Hyperphosphatemia. J Med Chem 2022. [PMID: 35034442 DOI: 10.1021/acs.jmedchem.1c01474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 40 |
Battaglia Y, Bellasi A, Bortoluzzi A, Tondolo F, Esposito P, Provenzano M, Russo D, Andreucci M, Cianciolo G, Storari A. Bone Mineral Density Changes in Long-Term Kidney Transplant Recipients: A Real-Life Cohort Study of Native Vitamin D Supplementation. Nutrients 2022;14. [PMID: 35057505 DOI: 10.3390/nu14020323] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 41 |
Boutin L, Legrand M, Sadoune M, Mebazaa A, Gayat E, Chadjichristos CE, Dépret F. Elevated plasma Galectin-3 is associated with major adverse kidney events and death after ICU admission. Crit Care 2022;26:13. [PMID: 34991653 DOI: 10.1186/s13054-021-03878-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 42 |
Aregger F, Enghard P. Akute Nierenschädigung. Nephrologe 2022;17:59-69. [DOI: 10.1007/s11560-021-00553-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 43 |
Fishbane SN, Nigwekar S. Phosphate Absorption and Hyperphosphatemia Management in Kidney Disease: A Physiology-Based Review. Kidney Med 2021;3:1057-64. [PMID: 34939015 DOI: 10.1016/j.xkme.2021.07.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 44 |
Jung JY, Yoo KD, Kang E, Kang HG, Kim SH, Kim H, Kim HJ, Park TJ, Suh SH, Jeong JC, Choi JY, Hwang YH, Choi M, Kim YL, Oh KH; Clinical Practice Guideline Work Group. Executive Summary of the Korean Society of Nephrology 2021 Clinical Practice Guideline for Optimal Hemodialysis Treatment. Kidney Res Clin Pract 2021;40:578-95. [PMID: 34922430 DOI: 10.23876/j.krcp.21.700] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 45 |
Cagliani JA, Marinelli L, Cho Y, Miyara SJ, Ruhemann A, Loyola A, Molmenti E, Smith C, Coppa G, Barrera R. Fenoldopam Increases Urine Output in Oliguric Critically Ill Surgical Patients. Cureus 2021. [DOI: 10.7759/cureus.20445] [Reference Citation Analysis]
|
| 46 |
Abdallah E, Sherif N, Mosbah O, Metwally A, Abd Elazim I, Mahmoud O, Farouk M, Mamdouh S, El-shishtawy S, Mohamed A. The Relationship between Serum Sclerostin Levels and Bone Mineral Disorders and Vascular Calcification in Hemodialysis Patients. Open Access Maced J Med Sci 2021;9:1664-1671. [DOI: 10.3889/oamjms.2021.7578] [Reference Citation Analysis]
|
| 47 |
Kim JS, Hwang HS. Vascular Calcification in Chronic Kidney Disease: Distinct Features of Pathogenesis and Clinical Implication. Korean Circ J 2021;51:961-82. [PMID: 34854578 DOI: 10.4070/kcj.2021.0995] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 48 |
Han S, Son M, Choi B, Park C, Shin DH, Jung JH, Lee MJ, Shin GT, Kim H, Park RW, Park I. Characterization of Medication Trends for Chronic Kidney Disease: Mineral and Bone Disorder Treatment Using Electronic Health Record-Based Common Data Model. Biomed Res Int 2021;2021:5504873. [PMID: 34853790 DOI: 10.1155/2021/5504873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 49 |
Bernardor J, Alioli C, Meaux MN, Peyruchaud O, Machuca-Gayet I, Bacchetta J. Peripheral Blood Mononuclear Cells (PBMCs) to Dissect the Underlying Mechanisms of Bone Disease in Chronic Kidney Disease and Rare Renal Diseases. Curr Osteoporos Rep 2021. [PMID: 34773213 DOI: 10.1007/s11914-021-00707-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 50 |
Liu H, Wang R. Associations between the serum magnesium and all-cause or cardiovascular mortality in chronic kidney disease and end-stage renal disease patients: A meta-analysis. Medicine (Baltimore) 2021;100:e27486. [PMID: 34766558 DOI: 10.1097/MD.0000000000027486] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 51 |
Neto R, Pereira L, Magalhães J, Quelhas-Santos J, Martins S, Carvalho C, Frazão JM. Sclerostin and DKK1 circulating levels associate with low bone turnover in patients with chronic kidney disease Stages 3 and 4. Clin Kidney J 2021;14:2401-8. [PMID: 34754436 DOI: 10.1093/ckj/sfab081] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 52 |
Byrne F, Gillman B, Palmer B, Kiely M, Eustace J, Kearney P, Davidson F, Shiely F. The effect of dietary phosphorus load and food matrix on postprandial serum phosphate in hemodialysis patients: a pilot study. HRB Open Res 2021;4:119. [DOI: 10.12688/hrbopenres.13382.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 53 |
Qin Z, Li H, Xu Y, Li J, Su B, Liao R. Higher Blood Lead Level Is Associated With Increased Likelihood of Abdominal Aortic Calcification. Front Cardiovasc Med 2021;8:747498. [PMID: 34722678 DOI: 10.3389/fcvm.2021.747498] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 54 |
Hasan LM, Shaheen DAH, El Kannishy GAH, Sayed-Ahmed NAH, Abd El Wahab AM. Is health-related quality of life associated with adequacy of hemodialysis in chronic kidney disease patients? BMC Nephrol 2021;22:334. [PMID: 34620098 DOI: 10.1186/s12882-021-02539-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 55 |
Bover J, Gunnarsson J, Csomor P, Kaiser E, Cianciolo G, Lauppe R. Impact of nutritional vitamin D supplementation on parathyroid hormone and 25-hydroxyvitamin D levels in non-dialysis chronic kidney disease: a meta-analysis. Clin Kidney J 2021;14:2177-86. [PMID: 34603696 DOI: 10.1093/ckj/sfab035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 56 |
Kosheleva NA, Magdeeva NA. Comorbidity in real clinical practice - the patient with gout, cardiovascular disease and kidney damage. jour 2021;2:112-117. [DOI: 10.21886/2712-8156-2021-2-3-112-117] [Reference Citation Analysis]
|
| 57 |
Pirklbauer M, Bushinsky DA, Kotanko P, Schappacher-Tilp G. Personalized Prediction of Short- and Long-Term PTH Changes in Maintenance Hemodialysis Patients. Front Med (Lausanne) 2021;8:704970. [PMID: 34595186 DOI: 10.3389/fmed.2021.704970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 58 |
Raikou VD. Serum phosphate and chronic kidney and cardiovascular disease: Phosphorus potential implications in general population. World J Nephrol 2021;10:76-87. [PMID: 34631478 DOI: 10.5527/wjn.v10.i5.76] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 59 |
Akizawa T, Sato Y, Ikejiri K, Kanda H, Fukagawa M. Effect of Tenapanor on Phosphate Binder Pill Burden in Hemodialysis Patients. Kidney Int Rep 2021;6:2371-80. [PMID: 34514198 DOI: 10.1016/j.ekir.2021.06.030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 60 |
Qin Z, Chang K, Liao R, Jiang L, Yang Q, Su B. Greater Dietary Inflammatory Potential Is Associated With Higher Likelihood of Abdominal Aortic Calcification. Front Cardiovasc Med 2021;8:720834. [PMID: 34485417 DOI: 10.3389/fcvm.2021.720834] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 61 |
Ma J, Mao Z, Yao Y, Lu Y, Wang H, Yang Y, Yang J, Wang W, Teng L. Coexistence of papillary thyroid carcinoma in secondary hyperparathyroidism. BMC Surg 2021;21:335. [PMID: 34488715 DOI: 10.1186/s12893-021-01330-z] [Reference Citation Analysis]
|
| 62 |
Hatano M, Kitajima I, Yamamoto S, Nakamura M, Isawa K, Hirota Y, Hoshino J, Sawa N, Ubara Y. Case report: Osteomalacia due to bisphosphonate treatment in a patient on hemodialysis. BMC Nephrol 2021;22:298. [PMID: 34479496 DOI: 10.1186/s12882-021-02509-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 63 |
Yoshida K, Yonaha T, Yamanouchi M, Sumi H, Taki Y, Otobe Y, Miyashita M, Hachisuka R, Han W, Shibagaki Y, Tominaga N. Welfare receipt and the risk of vitamin D deficiency in Japanese patients on maintenance hemodialysis: a cross-sectional, retrospective study. Ren Replace Ther 2021;7:45. [PMID: 34466274 DOI: 10.1186/s41100-021-00364-6] [Reference Citation Analysis]
|
| 64 |
Jafari M, Anwar S, Kour K, Sanjoy S, Goyal K, Prasad B. T Scores, FRAX, Frailty Phenotype, Falls, and Its Relationship to Fractures in Patients on Maintenance Hemodialysis. Can J Kidney Health Dis 2021;8:20543581211041184. [PMID: 34457317 DOI: 10.1177/20543581211041184] [Reference Citation Analysis]
|
| 65 |
Tominaga N, Yonaha T, Yamanouchi M, Sumi H, Taki Y, Shibagaki Y, Shiizaki K, Yano S. Bone responsiveness to parathyroid hormone is negatively associated with parathyroid hormone-lowering drug use in patients undergoing hemodialysis: a cross-sectional study. BMC Nephrol 2021;22:275. [PMID: 34372813 DOI: 10.1186/s12882-021-02482-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 66 |
González-casaus ML, Fernández-calle P, Buño Soto A. Should clinical laboratories adapt to the reality of chronic kidney disease in the determination of parathyroid hormone? Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 2021;2:342-351. [DOI: 10.1515/almed-2021-0046] [Reference Citation Analysis]
|
| 67 |
Komaba H, Zhao J, Yamamoto S, Nomura T, Fuller DS, McCullough KP, Evenepoel P, Christensson A, Zhao X, Alrukhaimi M, Al-Ali F, Young EW, Robinson BM, Fukagawa M. Secondary hyperparathyroidism, weight loss, and longer term mortality in haemodialysis patients: results from the DOPPS. J Cachexia Sarcopenia Muscle 2021;12:855-65. [PMID: 34060245 DOI: 10.1002/jcsm.12722] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 68 |
Park S, Cho NJ, Heo NH, Rhee EJ, Gil H, Lee EY. Vascular Calcification as a Novel Risk Factor for Kidney Function Deterioration in the Nonelderly. J Am Heart Assoc 2021;10:e019300. [PMID: 34151587 DOI: 10.1161/JAHA.120.019300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 69 |
Jørgensen HS, Behets G, Viaene L, Bammens B, Claes K, Meijers B, Naesens M, Sprangers B, Kuypers D, D'Haese PC, Evenepoel P. Static histomorphometry allows for a diagnosis of bone turnover in renal osteodystrophy in the absence of tetracycline labels. Bone 2021;152:116066. [PMID: 34147707 DOI: 10.1016/j.bone.2021.116066] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 70 |
Rysz J, Franczyk B, Rokicki R, Gluba-Brzózka A. The Influence of Dietary Interventions on Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Nutrients 2021;13:2065. [PMID: 34208727 DOI: 10.3390/nu13062065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 71 |
Figueres L, Beck-Cormier S, Beck L, Marks J. The Complexities of Organ Crosstalk in Phosphate Homeostasis: Time to Put Phosphate Sensing Back in the Limelight. Int J Mol Sci 2021;22:5701. [PMID: 34071837 DOI: 10.3390/ijms22115701] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 72 |
Bataille S, Pedinielli N, Carreno E, Prezelin-Reydit M, Chauveau P, Jean G, Robert T, Bobot M, Seret G, Jouve E, Lavainne F, Serveaux M, Vrigneaud L, Gentile S. VITADIAL "Does correction of 25 OH-VITAmin D with cholecalciferol supplementation increase muscle strength in hemoDIALysis patients?": study protocol for a randomized controlled trial. Trials 2021;22:364. [PMID: 34034786 DOI: 10.1186/s13063-021-05302-9] [Reference Citation Analysis]
|
| 73 |
Sprague SM, Martin KJ, Coyne DW. Phosphate Balance and CKD-Mineral Bone Disease. Kidney Int Rep 2021;6:2049-58. [PMID: 34386654 DOI: 10.1016/j.ekir.2021.05.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 74 |
Aquilani R, Maestri R, Dossena M, La Rovere MT, Buonocore D, Boschi F, Verri M. Altered Amino Acid Metabolism in Patients with Cardiorenal Syndrome Type 2: Is It a Problem for Protein and Exercise Prescriptions? Nutrients 2021;13:1632. [PMID: 34067952 DOI: 10.3390/nu13051632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 75 |
Pimentel A, Bover J, Elder G, Cohen-Solal M, Ureña-Torres PA. The Use of Imaging Techniques in Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD)-A Systematic Review. Diagnostics (Basel) 2021;11:772. [PMID: 33925796 DOI: 10.3390/diagnostics11050772] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 76 |
Christodoulou M, Aspray TJ, Schoenmakers I. Vitamin D Supplementation for Patients with Chronic Kidney Disease: A Systematic Review and Meta-analyses of Trials Investigating the Response to Supplementation and an Overview of Guidelines. Calcif Tissue Int 2021;109:157-78. [PMID: 33895867 DOI: 10.1007/s00223-021-00844-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 77 |
Dube P, DeRiso A, Patel M, Battepati D, Khatib-Shahidi B, Sharma H, Gupta R, Malhotra D, Dworkin L, Haller S, Kennedy D. Vascular Calcification in Chronic Kidney Disease: Diversity in the Vessel Wall. Biomedicines 2021;9:404. [PMID: 33917965 DOI: 10.3390/biomedicines9040404] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 78 |
Cailleaux PE, Ostertag A, Metzger M, Stengel B, Boucquemont J, Houillier P, Flamant M, Ureña-Torres P, Cohen-Solal M; NephroTest Study group. Longitudinal Bone Loss Occurs at the Radius in CKD. Kidney Int Rep 2021;6:1525-36. [PMID: 34169193 DOI: 10.1016/j.ekir.2021.03.874] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 79 |
Zhou X, Guo Y, Luo Y. The optimal range of serum intact parathyroid hormone for a lower risk of mortality in the incident hemodialysis patients. Ren Fail 2021;43:599-605. [PMID: 33781171 DOI: 10.1080/0886022X.2021.1903927] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 80 |
Wang T, Li Y, Wu H, Chen H, Zhang Y, Zhou H, Li H. Optimal blood pressure for the minimum all-cause mortality in Chinese ESRD patients on maintenance hemodialysis. Biosci Rep. 2020;40:BSR20200858. [PMID: 32756870 DOI: 10.1042/bsr20200858] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 81 |
Eddington H, Chinnadurai R, Alderson H, Ibrahim ST, Chrysochou C, Green D, Erekosima I, Hutchison A, Bubtana A, Hegarty J, Kalra PA. A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism. BMC Nephrol 2021;22:106. [PMID: 33757437 DOI: 10.1186/s12882-021-02312-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 82 |
Jia F, Wang S, Jing Y, Zhao H, Rong P, Zhang H, Lu W, Xue Y, Sun G. Osteocalcin and Abdominal Aortic Calcification in Hemodialysis Patients: An Observational Cross-Sectional Study. Front Endocrinol (Lausanne) 2021;12:620350. [PMID: 33815281 DOI: 10.3389/fendo.2021.620350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 83 |
Xu H, Peng W, Yang Z, Zhang Y, Xia C, Li Z, Xu R, Guo Y. The association of secondary hyperparathyroidism and myocardial damages in hemodialysis end-stage renal disease patients: assessed by cardiovascular magnetic resonance native T1 mapping. J Cardiovasc Magn Reson 2021;23:23. [PMID: 33691727 DOI: 10.1186/s12968-021-00713-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 84 |
Berner C, Marculescu R, Frommlet F, Kurnikowski A, Schairer B, Aigner C, Bieglmayer C, Hecking M. Parathyroid Hormone Concentrations in Maintenance Hemodialysis: Longitudinal Evaluation of Intact and Biointact Assays. Kidney Med 2021;3:343-352.e1. [PMID: 34136780 DOI: 10.1016/j.xkme.2020.12.015] [Reference Citation Analysis]
|
| 85 |
Gregório PC, Bucharles S, Cunha RSD, Braga T, Almeida AC, Henneberg R, Stinghen AEM, Barreto FC. In vitro anti-inflammatory effects of vitamin D supplementation may be blurred in hemodialysis patients. Clinics (Sao Paulo) 2021;76:e1821. [PMID: 33624705 DOI: 10.6061/clinics/2021/e1821] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 86 |
Jiang L, Yin Q, Yang M, Li M, Pan M, Han Y, Zhao Z, Wang Z, Zhu L, Wei Q, Tu Y, Gao M, Liu H, Zhang X, Liu BC, Wang B. Fibroblast Growth Factor 21 Predicts and Promotes Vascular Calcification in Haemodialysis Patients. Kidney Dis (Basel) 2021;7:227-40. [PMID: 34179118 DOI: 10.1159/000512750] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
| 87 |
Weissheimer R, Bucharles SGE, Truyts CAM, Jorgetti V, Figueiredo AE, Barrett P, Olandoski M, Pecoits-Filho R, Moraes TP. High prevalence of biochemical disturbances of chronic kidney disease - mineral and bone disorders (CKD-MBD) in a nation-wide peritoneal dialysis cohort: are guideline goals too hard to achieve? J Bras Nefrol 2021;43:173-81. [PMID: 33538758 DOI: 10.1590/2175-8239-JBN-2020-0147] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 88 |
Apetrii M, Covic A. Targeting NaPi-IIb for Hyperphosphatemia in Chronic Kidney Disease Patients - The Dead End? Kidney Int Rep 2021;6:557-8. [PMID: 33735330 DOI: 10.1016/j.ekir.2021.01.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 89 |
Lee S, Doktorchik C, Martin EA, D'Souza AG, Eastwood C, Shaheen AA, Naugler C, Lee J, Quan H. Electronic Medical Record-Based Case Phenotyping for the Charlson Conditions: Scoping Review. JMIR Med Inform 2021;9:e23934. [PMID: 33522976 DOI: 10.2196/23934] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 90 |
Silveira AA, Brescia MDG, Nascimento CPD Jr, Arap SS, Montenegro FLM. Delayed sampling of intraoperative parathormone may be unnecessary during parathyroidectomy in kidney-transplanted and dialysis patients. J Bras Nefrol 2021;43:228-35. [PMID: 33475675 DOI: 10.1590/2175-8239-JBN-2020-0108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 91 |
Xie L, Hu X, Li W, Ouyang Z. A retrospective study of end-stage kidney disease patients on maintenance hemodialysis with renal osteodystrophy-associated fragility fractures. BMC Nephrol 2021;22:23. [PMID: 33430788 DOI: 10.1186/s12882-020-02224-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 92 |
Lipińska-Opałka A, Tomaszewska A, Kubiak JZ, Kalicki B. Vitamin D and Immunological Patterns of Allergic Diseases in Children. Nutrients 2021;13:E177. [PMID: 33435598 DOI: 10.3390/nu13010177] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 93 |
Lundin MT, Bressendorff I, Kristensen B, Jørgensen NR, Butt R, Hansen D. Randomized Trial of Acute Changes in Plasma Phosphate After Phosphorus-Standardized Meals in Peritoneal Dialysis. Kidney Int Rep 2021;6:304-12. [PMID: 33615055 DOI: 10.1016/j.ekir.2020.11.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 94 |
Hansrivijit P, Gadhiya KP, Gangireddy M, Goldman JD. Risk Factors, Clinical Characteristics, and Prognosis of Acute Kidney Injury in Hospitalized COVID-19 Patients: A Retrospective Cohort Study. Medicines (Basel) 2021;8:4. [PMID: 33430296 DOI: 10.3390/medicines8010004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 95 |
Tabibzadeh N, Karaboyas A, Robinson BM, Csomor PA, Spiegel DM, Evenepoel P, Jacobson SH, Ureña-Torres PA, Fukagawa M, Al Salmi I, Liang X, Pisoni RL, Young EW. The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation. Nephrol Dial Transplant 2021;36:160-9. [PMID: 33068419 DOI: 10.1093/ndt/gfaa195] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 96 |
Lam NN, Sarabu N, Habbous S, Garg AX. Rationale and Landscape of Living Kidney Donation in Contemporary Practice. Living Kidney Donation 2021. [DOI: 10.1007/978-3-030-53618-3_1] [Reference Citation Analysis]
|
| 97 |
Haffner D, Mahan JD. Growth and Pubertal Development in Children and Adolescents Receiving Chronic Dialysis. Pediatric Dialysis 2021. [DOI: 10.1007/978-3-030-66861-7_28] [Reference Citation Analysis]
|
| 98 |
Granata A, Salvatore M, Spiezie S. Parathyroid. Imaging in Nephrology 2021. [DOI: 10.1007/978-3-030-60794-4_23] [Reference Citation Analysis]
|
| 99 |
Jansz TT, Özyilmaz A, van Reekum FE, Boereboom FTJ, de Jong PA, Verhaar MC, van Jaarsveld BC. Progression of coronary artery calcification in conventional hemodialysis, nocturnal hemodialysis, and kidney transplantation. PLoS One 2020;15:e0244639. [PMID: 33378347 DOI: 10.1371/journal.pone.0244639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 100 |
Vidal A, Ríos R, Pineda C, López I, Raya AI, Aguilera-Tejero E, Rodríguez M. Caloric Intake in Renal Patients: Repercussions on Mineral Metabolism. Nutrients 2020;13:E18. [PMID: 33374582 DOI: 10.3390/nu13010018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 101 |
Onfiani, Carubbi, Pellegrini. Evaluating renal function and defining protein requirements in patients affected by anorexia nervosa: a case report. IJEDO 2020. [DOI: 10.32044/ijedo.2020.08] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 102 |
Minisola S, Colangelo L, Pepe J, Diacinti D, Cipriani C, Rao SD. Osteomalacia and Vitamin D Status: A Clinical Update 2020. JBMR Plus 2021;5:e10447. [PMID: 33553992 DOI: 10.1002/jbm4.10447] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 103 |
Cirillo M, Bilancio G, Cavallo P, Giordano F, Iesce G, Costanzo S, De Curtis A, Di Castelnuovo A, Iacoviello L. Reduced Kidney Function and Relative Hypocalciuria-Observational, Cross-Sectional, Population-Based Data. J Clin Med 2020;9:E4133. [PMID: 33371520 DOI: 10.3390/jcm9124133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 104 |
Owens E, Tan KS, Ellis R, Del Vecchio S, Humphries T, Lennan E, Vesey D, Healy H, Hoy W, Gobe G. Development of a Biomarker Panel to Distinguish Risk of Progressive Chronic Kidney Disease. Biomedicines 2020;8:E606. [PMID: 33327377 DOI: 10.3390/biomedicines8120606] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 105 |
Yavropoulou MP, Vaios V, Makras P, Georgianos P, Batas A, Tsalikakis D, Tzallas A, Ntritsos G, Roumeliotis S, Eleftheriadis T, Liakopoulos V. Expression of Circulating MicroRNAs Linked to Bone Metabolism in Chronic Kidney Disease-Mineral and Bone Disorder. Biomedicines 2020;8:E601. [PMID: 33322822 DOI: 10.3390/biomedicines8120601] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 106 |
Vahdat S. Vitamin D and Kidney Diseases: A Narrative Review. Int J Prev Med 2020;11:195. [PMID: 33815719 DOI: 10.4103/ijpvm.IJPVM_54_19] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 107 |
Ramos R, Chazot C, Ferreira A, Di Benedetto A, Gurevich K, Feuersenger A, Wolf M, Arens HJ, Walpen S, Stuard S. The real-world effectiveness of sucroferric oxyhydroxide in European hemodialysis patients: a 1-year retrospective database analysis. BMC Nephrol 2020;21:530. [PMID: 33287733 DOI: 10.1186/s12882-020-02188-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 108 |
Greene B, Kim SJ, McCarthy EP, Pasternak JD. Effects of Social Disparities on Management and Surgical Outcomes for Patients with Secondary Hyperparathyroidism. World J Surg 2020;44:537-43. [PMID: 31570954 DOI: 10.1007/s00268-019-05207-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 109 |
Harrak H, René E, Alsalemi N, Elftouh N, Lafrance J. Osteoporotic fracture rates in chronic hemodialysis and effect of heparin exposure: a retrospective cohort study. BMC Nephrol 2020;21:261. [DOI: 10.1186/s12882-020-01916-4] [Reference Citation Analysis]
|
| 110 |
da Silva Canhos MM, de Oliveira RC, Modelli de Andrade LG, Caramori JCT, Barretti P, Martin LC. Association between vitamin D levels and mortality in hemodialysis patients: a cohort study. Ren Fail 2020;42:225-33. [PMID: 32126885 DOI: 10.1080/0886022X.2020.1735415] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 111 |
Floege J, Funk F, Ketteler M, Rastogi A, Walpen S, Covic AC, Sprague SM. Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammation. Nephrol Dial Transplant 2020;35:946-54. [PMID: 32259248 DOI: 10.1093/ndt/gfaa030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 112 |
Pimentel A, Ureña-Torres P, Bover J, Luis Fernandez-Martín J, Cohen-Solal M. Bone Fragility Fractures in CKD Patients. Calcif Tissue Int 2021;108:539-50. [PMID: 33219822 DOI: 10.1007/s00223-020-00779-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 113 |
Huang JF, Zheng XQ, Sun XL, Zhou X, Liu J, Li YM, Wang XY, Zhang XL, Wu AM. Association between Bone Mineral Density and Severity of Chronic Kidney Disease. Int J Endocrinol 2020;2020:8852690. [PMID: 33193760 DOI: 10.1155/2020/8852690] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 114 |
Chen S, Sheng K, Shen Y, Jiang H, Lei X, Qu L, Xu C, Chen J, Zhang P. Impact of parathyroidectomy on left ventricular function in end stage renal disease patients. BMC Nephrol 2020;21:479. [PMID: 33187492 DOI: 10.1186/s12882-020-02139-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 115 |
Ma H, Ouyang C, Huang Y, Xing C, Cheng C, Liu W, Yuan D, Zeng M, Yu X, Ren H, Yuan Y, Zhang L, Xu F, Cui Y, Ren W, Huang H, Qian H, Fan B, Wang N. Comparison of microwave ablation treatments in patients with renal secondary and primary hyperparathyroidism. Ren Fail 2020;42:66-76. [PMID: 31928297 DOI: 10.1080/0886022X.2019.1707097] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 116 |
Tsai PH, Chung CH, Chien WC, Chu P. Effects of calcium-containing phosphate binders on cardiovascular events and mortality in predialysis CKD stage 5 patients. PLoS One 2020;15:e0241435. [PMID: 33125428 DOI: 10.1371/journal.pone.0241435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 117 |
Levine MA, Luke PP, Sener A. Canadian survey on the rates of use of intraoperative diuretics and justification for their use during renal allograft reperfusion. Can J Surg 2020;63:E483-8. [PMID: 33107815 [PMID: 33107815 DOI: 10.1503/cjs.016019] [Reference Citation Analysis]
|
| 118 |
Wiederkehr M. Brown tumor complicating end-stage kidney disease. Clin Nephrol Case Stud 2020;8:72-9. [PMID: 33062583 DOI: 10.5414/CNCS110195] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 119 |
Winder MB, Mason DL, Rangaswami J, Asif A, Vachharajani TJ, Mathew RO. Racial differences in the relationship between high-normal 25-hydroxy vitamin d and parathyroid hormone levels in early stage chronic kidney disease. J Bras Nefrol 2021;43:34-40. [PMID: 33022030 DOI: 10.1590/2175-8239-JBN-2020-0138] [Reference Citation Analysis]
|
| 120 |
Baker T, Naylor H, MacNeil B, MacKinnon M. Evaluation of a Pharmacist-Dietician-Led Patient-Centered Approach to Managing CKD-MBD: A Mixed-Method Study. Pharmacy (Basel) 2020;8:E171. [PMID: 32938006 DOI: 10.3390/pharmacy8030171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 121 |
Morishita M, Maruyama Y, Nakao M, Matsuo N, Tanno Y, Ohkido I, Ikeda M, Yokoo T. Factors affecting the relationship between ionized and corrected calcium levels in peritoneal dialysis patients: a retrospective cross-sectional study. BMC Nephrol 2020;21:370. [PMID: 32847525 DOI: 10.1186/s12882-020-02033-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 122 |
Tokumaru T, Toyama T, Hara A, Kitagawa K, Yamamura Y, Nakagawa S, Oshima M, Miyagawa T, Sato K, Ogura H, Kitajima S, Iwata Y, Sakai N, Shimizu M, Furuichi K, Hashiba A, Wada T. Association between Unhealthy Dietary Habits and Proteinuria Onset in a Japanese General Population: A Retrospective Cohort Study. Nutrients 2020;12:E2511. [PMID: 32825196 DOI: 10.3390/nu12092511] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 123 |
Chao JY, Li CY, Wang MC, Kao Yang YH. The use of activated vitamin D and risks of hospitalization for infection and amputation in incident hemodialysis patients in Taiwan: a nationwide population-based cohort study. BMC Nephrol 2020;21:331. [PMID: 32762673 DOI: 10.1186/s12882-020-01988-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 124 |
Holden RM, Mustafa RA, Alexander RT, Battistella M, Bevilacqua MU, Knoll G, Mac-Way F, Reslerova M, Wald R, Acott PD, Feltmate P, Grill A, Jindal KK, Karsanji M, Kiberd BA, Mahdavi S, McCarron K, Molnar AO, Pinsk M, Rodd C, Soroka SD, Vinson AJ, Zimmerman D, Clase CM. Canadian Society of Nephrology Commentary on the Kidney Disease Improving Global Outcomes 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder. Can J Kidney Health Dis 2020;7:2054358120944271. [PMID: 32821415 DOI: 10.1177/2054358120944271] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 125 |
Zhang R, Zhang Z, Huang P, Li Z, Hu R, Zhang J, Qiu W, Hu P. Diagnostic performance of ultrasonography, dual-phase 99mTc-MIBI scintigraphy, early and delayed 99mTc-MIBI SPECT/CT in preoperative parathyroid gland localization in secondary hyperparathyroidism. BMC Med Imaging 2020;20:91. [PMID: 32746794 DOI: 10.1186/s12880-020-00490-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 126 |
Viegas C, Araújo N, Marreiros C, Simes D. The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): challenging old concepts with new facts. Aging (Albany NY) 2019;11:4274-99. [PMID: 31241466 DOI: 10.18632/aging.102046] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 127 |
Yun HJ, Ryoo SR, Kim JE, Choi YJ, Park I, Shin GT, Kim H, Jeong JC. Trabecular bone score may indicate chronic kidney disease-mineral and bone disorder (CKD-MBD) phenotypes in hemodialysis patients: a prospective observational study. BMC Nephrol 2020;21:299. [PMID: 32711466 DOI: 10.1186/s12882-020-01944-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 128 |
Pirklbauer M, Fuchs L, Heiss R, Ratschiller T, Mayer G. Intradialytic Calcium Kinetics and Cardiovascular Disease in Chronic Hemodialysis Patients. Blood Purif 2020;49:723-32. [PMID: 32712610 DOI: 10.1159/000508060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 129 |
Baptista AL, Padilha K, Malagrino PA, Venturini G, Zeri AC, Dos Reis LM, Martins JS, Jorgetti V, Pereira AC, Titan SM, Moyses RM. Potential Biomarkers of the Turnover, Mineralization, and Volume Classification: Results Using NMR Metabolomics in Hemodialysis Patients. JBMR Plus 2020;4:e10372. [PMID: 32666023 DOI: 10.1002/jbm4.10372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 130 |
Vetchinnikova ON, Ivanova MY. Prevalence and risk factors of post-kidney transplant hyperparathyroidism: a single-center study. RJTAO 2020;22:63-71. [DOI: 10.15825/1995-1191-2020-2-63-71] [Reference Citation Analysis]
|
| 131 |
Hiemstra TF, Smith JC, Lim K, Xu D, Kulkarni S, Bradley JA, Paapstel K, Schoenmakers I, Bradley JR, Tomlinson L, McEniery CM, Wilkinson IB. Effect of kidney donation on bone mineral metabolism. PLoS One 2020;15:e0235082. [PMID: 32634148 DOI: 10.1371/journal.pone.0235082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 132 |
Lambert O, Couchoud C, Metzger M, Choukroun G, Jacquelinet C, Mercadal L. Effects of the dialysate calcium concentrations and mineral bone disease treatments on mortality in The French Renal Epidemiology and Information Network (REIN) registry. PLoS One 2020;15:e0235135. [PMID: 32628733 DOI: 10.1371/journal.pone.0235135] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 133 |
Medina-Liabres KRP, Kim BM, Kim S. Biopsy-proven acute phosphate nephropathy: A case report. World J Clin Cases 2020; 8(12): 2585-2589 [PMID: 32607335 DOI: 10.12998/wjcc.v8.i12.2585] [Reference Citation Analysis]
|
| 134 |
Covic AC, Sprague SM, Rastogi A, Ketteler M, Walpen S, Perrin A, Floege J. Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study. Nephron 2020;144:428-39. [PMID: 32585670 DOI: 10.1159/000507258] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 135 |
Anis KH, Pober D, Rosas SE. Vitamin D Analogues and Coronary Calcification in CKD Stages 3 and 4: A Randomized Controlled Trial of Calcitriol Versus Paricalcitol. Kidney Med 2020;2:450-8. [PMID: 32775985 DOI: 10.1016/j.xkme.2020.05.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 136 |
Yang S, Niu Q, Gan L, Zhang X, Tu L, Zuo L. Effect of long-term use of unfractionated or low-molecular-weight heparin on bone mineral density in maintenance hemodialysis patients. Hemodial Int 2020;24:374-82. [PMID: 32520445 DOI: 10.1111/hdi.12854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 137 |
El-Kholey MMAE, Ibrahim GES, Elshahat OI, El-Kannishy G. Impact of Subtotal Parathyroidectomy on Clinical Parameters and Quality of Life in Hemodialysis Patients with Secondary Hyperparathyroidism. Endocrinol Metab (Seoul) 2019;34:367-73. [PMID: 31884736 DOI: 10.3803/EnM.2019.34.4.367] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 138 |
Papastergiou J, Donnelly M, Li W, Sindelar RD, van den Bemt B. Community Pharmacy-Based eGFR Screening for Early Detection of CKD in High Risk Patients. Can J Kidney Health Dis 2020;7:2054358120922617. [PMID: 32523707 DOI: 10.1177/2054358120922617] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 139 |
Oh YJ, Kim H, Kim AJ, Ro H, Chang JH, Lee HH, Chung W, Jun HS, Jung JY. Reduction of Secreted Frizzled-Related Protein 5 Drives Vascular Calcification through Wnt3a-Mediated Rho/ROCK/JNK Signaling in Chronic Kidney Disease. Int J Mol Sci 2020;21:E3539. [PMID: 32429518 DOI: 10.3390/ijms21103539] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 140 |
Matsumoto AK, Maes M, Michelin AP, Soares AE, Semeão LO, Godeny P, Venturini D, Barbosa DS, Delfino VDA. Vitamin D deficiency is not associated with increased oxidative stress in chronic kidney disease pre-dialysis patients. J Bras Nefrol 2020;42:420-8. [PMID: 32406474 DOI: 10.1590/2175-8239-JBN-2019-0156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 141 |
Shigematsu T, Asada S, Endo Y, Kawata T, Fukagawa M, Akizawa T. Efficacy and Safety of Evocalcet Evaluated by Dialysate Calcium Concentration in Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis. Int J Nephrol Renovasc Dis 2020;13:97-106. [PMID: 32494184 DOI: 10.2147/IJNRD.S243210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 142 |
Atmis B, Cevizli D, Melek E, Erdogan KE, Gonlusen G, Surmelioglu O, Bayazit AK. Proptosis in a child with chronic kidney disease: Answers. Pediatr Nephrol 2020;35:789-91. [PMID: 31823042 DOI: 10.1007/s00467-019-04423-3] [Reference Citation Analysis]
|
| 143 |
Fu S, Yu H, Li Y, Lv F, Deng J, Zhang F, Luan F, Zhao Y, Yao Y. Multiple Measures of Mineral Metabolism Were Associated With Renal Function in Chinese Centenarians: A Cross-Sectional Study. Front Med (Lausanne) 2020;7:120. [PMID: 32351965 DOI: 10.3389/fmed.2020.00120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 144 |
Coyne DW, Ficociello LH, Parameswaran V, Rosen MM, Mullon C, Kossmann RJ, Sprague SM. Sucroferric Oxyhydroxide in Maintenance Hemodialysis: A Retrospective, Comparative Cohort Study. Kidney Med 2020;2:307-16. [PMID: 32734250 DOI: 10.1016/j.xkme.2020.01.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 145 |
Nickolas TL, Chen N, McMahon DJ, Dempster D, Zhou H, Dominguez J 2nd, Aponte MA, Sung J, Evenepoel P, D'Haese PC, Mac-Way F, Moyses R, Moe S. A microRNA Approach to Discriminate Cortical Low Bone Turnover in Renal Osteodystrophy. JBMR Plus 2020;4:e10353. [PMID: 32490328 DOI: 10.1002/jbm4.10353] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 146 |
Löfdahl E, Haggård C, Rådegran G. Bone Mineral Density in Relation to Chronic Kidney Disease After Heart Transplantation: A Retrospective Single-center Study at Skåne University Hospital in Lund 1988-2016. Transplant Direct 2020;6:e537. [PMID: 32195328 DOI: 10.1097/TXD.0000000000000981] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 147 |
Gembillo G, Cernaro V, Siligato R, Curreri F, Catalano A, Santoro D. Protective Role of Vitamin D in Renal Tubulopathies. Metabolites 2020;10:E115. [PMID: 32204545 DOI: 10.3390/metabo10030115] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 148 |
Ketteler M, Sprague SM, Covic AC, Rastogi A, Spinowitz B, Rakov V, Walpen S, Floege J. Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients. Nephrol Dial Transplant 2019;34:1163-70. [PMID: 29846719 DOI: 10.1093/ndt/gfy127] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 149 |
Yamaguchi S, Hamano T, Doi Y, Oka T, Kajimoto S, Kubota K, Yasuda S, Shimada K, Matsumoto A, Hashimoto N, Sakaguchi Y, Matsui I, Isaka Y. Hidden Hypocalcemia as a Risk Factor for Cardiovascular Events and All-Cause Mortality among Patients Undergoing Incident Hemodialysis. Sci Rep 2020;10:4418. [PMID: 32157180 DOI: 10.1038/s41598-020-61459-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 150 |
Thadhani RI, Rosen S, Ofsthun NJ, Usvyat LA, Dalrymple LS, Maddux FW, Hymes JL. Conversion from Intravenous Vitamin D Analogs to Oral Calcitriol in Patients Receiving Maintenance Hemodialysis. Clin J Am Soc Nephrol 2020;15:384-91. [PMID: 32111702 DOI: 10.2215/CJN.07960719] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 151 |
Mizobuchi M, Ogata H, Koiwa F, Honda H. Early response of the parathyroid gland to withdrawal of a calcimimetic compound in uremic rats. Am J Physiol Renal Physiol 2020;318:F639-46. [PMID: 31961714 DOI: 10.1152/ajprenal.00479.2019] [Reference Citation Analysis]
|
| 152 |
Bacchetta J. Treatment of hyperphosphatemia: the dangers of high PTH levels. Pediatr Nephrol 2020;35:493-500. [PMID: 31696357 DOI: 10.1007/s00467-019-04400-w] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 153 |
Haffner D, Leifheit-Nestler M. Treatment of hyperphosphatemia: the dangers of aiming for normal PTH levels. Pediatr Nephrol 2020;35:485-91. [PMID: 31823044 DOI: 10.1007/s00467-019-04399-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 154 |
Kataoka Y, Luo Y, Chaimani A, Onishi A, Kimachi M, Tsujimoto Y, Murad MH, Li T, Cipriani A, Furukawa TA. Cumulative network meta-analyses, practice guidelines, and actual prescriptions for postmenopausal osteoporosis: a meta-epidemiological study. Arch Osteoporos 2020;15:21. [PMID: 32088774 DOI: 10.1007/s11657-020-0697-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 155 |
Baumbach SF, Pfahler V, Bechtold-Dalla Pozza S, Feist-Pagenstert I, Fürmetz J, Baur-Melnyk A, Stumpf UC, Saller MM, Straube A, Schmidmaier R, Leipe J. How We Manage Bone Marrow Edema-An Interdisciplinary Approach. J Clin Med 2020;9:E551. [PMID: 32085459 DOI: 10.3390/jcm9020551] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 156 |
Zhang Y, Lu Y, Feng S, Zhan Z, Shen H. Evaluation of laboratory parameters and symptoms after parathyroidectomy in dialysis patients with secondary hyperparathyroidism. Ren Fail 2019;41:921-9. [PMID: 31573378 DOI: 10.1080/0886022X.2019.1666724] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 157 |
Zeng M, Liu W, Zha X, Tang S, Liu J, Yang G, Mao H, Yu X, Sun B, Zhang B, Ouyang C, Zhang L, Guo J, Wang J, Huang Y, Purrunsing Y, Qian H, Wang N, Xing C. 99mTc-MIBI SPECT/CT imaging had high sensitivity in accurate localization of parathyroids before parathyroidectomy for patients with secondary hyperparathyroidism. Ren Fail 2019;41:885-92. [PMID: 31537128 DOI: 10.1080/0886022X.2019.1662804] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 158 |
Bover J, Ureña-Torres P, Mateu S, DaSilva I, Gràcia S, Sánchez-Baya M, Arana C, Fayos L, Guirado L, Cozzolino M. Evidence in chronic kidney disease-mineral and bone disorder guidelines: is it time to treat or time to wait? Clin Kidney J 2020;13:513-21. [PMID: 32905295 DOI: 10.1093/ckj/sfz187] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 159 |
Lalayiannis AD, Crabtree NJ, Fewtrell M, Biassoni L, Milford DV, Ferro CJ, Shroff R. Assessing bone mineralisation in children with chronic kidney disease: what clinical and research tools are available? Pediatr Nephrol 2020;35:937-57. [PMID: 31240395 DOI: 10.1007/s00467-019-04271-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 160 |
O'Dea M, Sweetman D, Bonifacio SL, El-Dib M, Austin T, Molloy EJ. Management of Multi Organ Dysfunction in Neonatal Encephalopathy. Front Pediatr 2020;8:239. [PMID: 32500050 DOI: 10.3389/fped.2020.00239] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 161 |
McAlister L, Pugh P, Greenbaum L, Haffner D, Rees L, Anderson C, Desloovere A, Nelms C, Oosterveld M, Paglialonga F, Polderman N, Qizalbash L, Renken-Terhaerdt J, Tuokkola J, Warady B, Walle JV, Shaw V, Shroff R. The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis-clinical practice recommendation from the Pediatric Renal Nutrition Taskforce. Pediatr Nephrol 2020;35:501-18. [PMID: 31667620 DOI: 10.1007/s00467-019-04370-z] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 13.7] [Reference Citation Analysis]
|
| 162 |
Warady BA, Ng E, Bloss L, Mo M, Schaefer F, Bacchetta J. Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis. Pediatr Nephrol 2020;35:1679-97. [PMID: 32367309 DOI: 10.1007/s00467-020-04516-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 163 |
Joseph DB, Baum MA, Tanaka ST, Frimberger DC, Misseri R, Khavari R, Baillie S, Yerkes EB, Wood H. Urologic guidelines for the care and management of people with spina bifida. J Pediatr Rehabil Med 2020;13:479-89. [PMID: 33252091 DOI: 10.3233/PRM-200712] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 164 |
Rapa SF, Di Iorio BR, Campiglia P, Heidland A, Marzocco S. Inflammation and Oxidative Stress in Chronic Kidney Disease-Potential Therapeutic Role of Minerals, Vitamins and Plant-Derived Metabolites. Int J Mol Sci. 2019;21. [PMID: 31906008 DOI: 10.3390/ijms21010263] [Cited by in Crossref: 100] [Cited by in F6Publishing: 108] [Article Influence: 25.0] [Reference Citation Analysis]
|
| 165 |
Druck A, Patel D, Bansal V, Hoppensteadt D, Fareed J. Osteopontin Levels in Patients With Chronic Kidney Disease Stage 5 on Hemodialysis Directly Correlate With Intact Parathyroid Hormone and Alkaline Phosphatase. Clin Appl Thromb Hemost 2019;25:1076029619896621. [PMID: 31876180 DOI: 10.1177/1076029619896621] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 166 |
Waziri B, Duarte R, Naicker S. Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Current Perspectives. Int J Nephrol Renovasc Dis 2019;12:263-76. [PMID: 31920363 DOI: 10.2147/IJNRD.S191156] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 167 |
Dreyer G, Kieswich J, Harwood S, Ahluwalia A, Yaqoob MM. Ergocalciferol improves endothelial vasodilatory and vasoconstrictor function in an in vivo model of mild uraemia. Biosci Rep 2019;39:BSR20190711. [PMID: 31789348 DOI: 10.1042/BSR20190711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 168 |
Bellasi A, Cozzolino M, Malberti F, Cancarini G, Esposito C, Guastoni CM, Ondei P, Pontoriero G, Teatini U, Vezzoli G, Pasquali M, Messa P, Locatelli F. New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of working group on CKD-MBD of the Italian Society of Nephrology. J Nephrol 2020;33:211-21. [PMID: 31853791 DOI: 10.1007/s40620-019-00677-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 169 |
Balbino KP, Juvanhol LL, Epifânio APS, Marota LD, Bressan J, Hermsdorff HHM. Dietary intake as a predictor for all-cause mortality in hemodialysis subjects (NUGE-HD study). PLoS One 2019;14:e0226568. [PMID: 31846484 DOI: 10.1371/journal.pone.0226568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 170 |
Slieker RC, van der Heijden AAWH, Nijpels G, Elders PJM, 't Hart LM, Beulens JWJ. Visit-to-visit variability of glycemia and vascular complications: the Hoorn Diabetes Care System cohort. Cardiovasc Diabetol 2019;18:170. [PMID: 31830993 DOI: 10.1186/s12933-019-0975-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 171 |
Niu Q, Zhao H, Wu B, Tsai S, Wu J, Zhang M, Lu L, Qiao J, Men C, Zuo L, Wang M. Abdominal aortic calcification is superior to other arteries calcification in predicting the mortality in peritoneal dialysis patients - a 8 years cohort study. BMC Nephrol 2019;20:439. [PMID: 31791277 DOI: 10.1186/s12882-019-1593-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 172 |
Weiner SM. [Treatment of rheumatic disease with renal insufficiency]. Orthopade 2019;48:927-35. [PMID: 31531703 DOI: 10.1007/s00132-019-03807-5] [Reference Citation Analysis]
|
| 173 |
Makarova TP, Kazan NV, Soldatova EE, Akhmadullina LI. Rapidly progressing glomerulonephritis in children. Ross vestn perinatol pediatr 2019;64:241-245. [DOI: 10.21508/1027-4065-2019-64-5-241-245] [Reference Citation Analysis]
|
| 174 |
Fuller DS, Dluzniewski PJ, Cooper K, Bradbury BD, Robinson BM, Tentori F. Combinations of mineral and bone disorder markers and risk of death and hospitalizations in the international Dialysis Outcomes and Practice Patterns Study. Clin Kidney J 2020;13:1056-62. [PMID: 33391749 DOI: 10.1093/ckj/sfz112] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 175 |
Fakih El Khoury C, Karavetian M, Halfens RJG, Crutzen R, El Chaar D, Schols JMGA. Dietary Application for the Management of Patients with Hemodialysis: A Formative Development Study. Healthc Inform Res 2019;25:262-73. [PMID: 31777669 DOI: 10.4258/hir.2019.25.4.262] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 176 |
Palmer SC, Chung EY, McGregor DO, Bachmann F, Strippoli GF. Interventions for preventing bone disease in kidney transplant recipients. Cochrane Database Syst Rev 2019;10:CD005015. [PMID: 31637698 DOI: 10.1002/14651858.CD005015.pub4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 177 |
Yang T, Wang W, Tang X, Shi P, Zhang L, Yu W, Xie Y, Guo D, Ding F. Association between mineral and bone disorder in patients with acute kidney injury following cardiac surgery and adverse outcomes. BMC Nephrol 2019;20:369. [PMID: 31615432 DOI: 10.1186/s12882-019-1572-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 178 |
King AJ, Siegel M, He Y, Nie B, Wang J, Koo-McCoy S, Minassian NA, Jafri Q, Pan D, Kohler J, Kumaraswamy P, Kozuka K, Lewis JG, Dragoli D, Rosenbaum DP, O'Neill D, Plain A, Greasley PJ, Jönsson-Rylander AC, Karlsson D, Behrendt M, Strömstedt M, Ryden-Bergsten T, Knöpfel T, Pastor Arroyo EM, Hernando N, Marks J, Donowitz M, Wagner CA, Alexander RT, Caldwell JS. Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability. Sci Transl Med 2018;10:eaam6474. [PMID: 30158152 DOI: 10.1126/scitranslmed.aam6474] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 15.8] [Reference Citation Analysis]
|
| 179 |
Wang AY, Akizawa T, Bavanandan S, Hamano T, Liew A, Lu KC, Lumlertgul D, Oh KH, Zhao MH, Ka-Shun Fung S, Obi Y, Sumida K, Choong LHL, Goh BL, Hao CM, Kwon YJ, Tarng DC, Zuo L, Wheeler DC, Tsukamoto Y, Fukagawa M. 2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report. Kidney Int Rep 2019;4:1523-37. [PMID: 31890994 DOI: 10.1016/j.ekir.2019.09.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 180 |
Kimoto M, Saraya T, Arai R, Tsushima H, Yamanishi K. A Case of Gastric Ulcer Caused by NSAIDs Patches. An Official Journal of the Japan Primary Care Association 2019;42:158-161. [DOI: 10.14442/generalist.42.158] [Reference Citation Analysis]
|
| 181 |
Rose M, Shepherd J, Harris P, Pickett K, Lord J. Etelcalcetide for Treating Secondary Hyperparathyroidism: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal. Pharmacoeconomics 2018;36:1299-308. [PMID: 29691773 DOI: 10.1007/s40273-018-0661-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 182 |
Kritmetapak K, Pongchaiyakul C. Parathyroid Hormone Measurement in Chronic Kidney Disease: From Basics to Clinical Implications. Int J Nephrol 2019;2019:5496710. [PMID: 31637056 DOI: 10.1155/2019/5496710] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 183 |
Sakoh T, Taniguchi M, Yamada S, Ohnaka S, Arase H, Tokumoto M, Yanagida T, Mitsuiki K, Hirakata H, Nakano T, Kitazono T, Tsuruya K. Short- and Long-term Effects of Dialysate Calcium Concentrations on Mineral and Bone Metabolism in Hemodialysis Patients: The K4 Study. Kidney Med 2019;1:296-306. [PMID: 32734210 DOI: 10.1016/j.xkme.2019.08.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 184 |
Westerberg PA, Sterner G, Ljunggren Ö, Isaksson E, Elvarson F, Dezfoolian H, Linde T. High doses of cholecalciferol alleviate the progression of hyperparathyroidism in patients with CKD Stages 3-4: results of a 12-week double-blind, randomized, controlled study. Nephrol Dial Transplant 2018;33:466-71. [PMID: 29156056 DOI: 10.1093/ndt/gfx059] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 185 |
Fukuma S, Fukuhara S, Shimizu S, Akizawa T, Fukagawa M. Population-level associations of achievement of targets for bone-mineral markers with survival in haemodialysis patients with mildly elevated intact-PTH levels: a case-cohort study. Sci Rep 2019;9:11301. [PMID: 31383933 DOI: 10.1038/s41598-019-47852-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 186 |
Pereira RC, Salusky IB, Bowen RE, Freymiller EG, Wesseling-Perry K. Vitamin D sterols increase FGF23 expression by stimulating osteoblast and osteocyte maturation in CKD bone. Bone 2019;127:626-34. [PMID: 31377240 DOI: 10.1016/j.bone.2019.07.026] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 187 |
Mannstadt M, Clarke BL, Bilezikian JP, Bone H, Denham D, Levine MA, Peacock M, Rothman J, Shoback DM, Warren ML, Watts NB, Lee HM, Sherry N, Vokes TJ. Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism. J Clin Endocrinol Metab 2019;104:5136-47. [PMID: 31369089 DOI: 10.1210/jc.2019-01010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 188 |
Ramalho J, Petrillo EM, Takeichi APM, Moyses RMA, Titan SM. Calcitriol and FGF-23, but neither PTH nor sclerostin, are associated with calciuria in CKD. Int Urol Nephrol 2019;51:1823-9. [PMID: 31368056 DOI: 10.1007/s11255-019-02215-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 189 |
Bover J, Cozzolino M. Small steps towards the potential of 'preventive' treatment of early phosphate loading in chronic kidney disease patients. Clin Kidney J 2019;12:673-7. [PMID: 31584564 DOI: 10.1093/ckj/sfz082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 190 |
Zhan Z, Smyth B, Toussaint ND, Gray NA, Zuo L, de Zoysa JR, Chan CT, Jin C, Scaria A, Hawley CM, Perkovic V, Jardine MJ, Zhang L. Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study. BMC Nephrol 2019;20:258. [PMID: 31299919 DOI: 10.1186/s12882-019-1438-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 191 |
Bentata Y. Benefit-risk balance of native vitamin D supplementation in chronic hemodialysis: what can we learn from the major clinical trials and international guidelines? Ren Fail 2019;41:607-15. [PMID: 31267807 DOI: 10.1080/0886022X.2019.1632719] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 192 |
Yalla N, Bobba G, Guo G, Stankiewicz A, Ostlund R. Parathyroid hormone reference ranges in healthy individuals classified by vitamin D status. J Endocrinol Invest 2019;42:1353-60. [PMID: 31273631 DOI: 10.1007/s40618-019-01075-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 193 |
Ge Y, Yang G, Wang N, Zha X, Yu X, Mao H, Sun B, Zeng M, Zhang B, Xing C. Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism. Int Urol Nephrol 2019;51:1443-9. [PMID: 31264087 DOI: 10.1007/s11255-019-02217-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 194 |
Pérez-Ricart A, Galicia-Basart M, Comas-Sugrañes D, Cruzado-Garrit JM, Segarra-Medrano A, Montoro-Ronsano JB. Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism. Kidney Res Clin Pract 2019;38:229-38. [PMID: 31022778 DOI: 10.23876/j.krcp.18.0088] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 195 |
Kwon YE, Choi HY, Kim S, Ryu DR, Oh HJ; ESRD Registry Committee of the Korean Society of Nephrology. Fracture risk in chronic kidney disease: A Korean population-based cohort study. Kidney Res Clin Pract 2019;38:220-8. [PMID: 31067609 DOI: 10.23876/j.krcp.18.0099] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 196 |
Hsu TW, Hsu CN, Wang SW, Huang CC, Li LC. Comparison of the Effects of Denosumab and Alendronate on Cardiovascular and Renal Outcomes in Osteoporotic Patients. J Clin Med 2019;8:E932. [PMID: 31261703 DOI: 10.3390/jcm8070932] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 197 |
Barreto FC, Barreto DV, Massy ZA, Drüeke TB. Strategies for Phosphate Control in Patients With CKD. Kidney Int Rep 2019;4:1043-56. [PMID: 31440695 DOI: 10.1016/j.ekir.2019.06.002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 198 |
Drube J, Wan M, Bonthuis M, Wühl E, Bacchetta J, Santos F, Grenda R, Edefonti A, Harambat J, Shroff R, Tönshoff B, Haffner D; European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders, Dialysis, and Transplantation Working Groups. Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease. Nat Rev Nephrol 2019;15:577-89. [PMID: 31197263 DOI: 10.1038/s41581-019-0161-4] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 15.8] [Reference Citation Analysis]
|
| 199 |
Fouque D, Vervloet M, Ketteler M. Targeting Gastrointestinal Transport Proteins to Control Hyperphosphatemia in Chronic Kidney Disease. Drugs 2018;78:1171-86. [PMID: 30022383 DOI: 10.1007/s40265-018-0950-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 200 |
Duong TV, Shih CK, Wong TC, Chen HH, Chen TH, Hsu YH, Peng SJ, Kuo KL, Liu HC, Lin ET, Su CT, Yang SH. Insulin Resistance and Cardiovascular Risks in Different Groups of Hemodialysis Patients: A Multicenter Study. Biomed Res Int 2019;2019:1541593. [PMID: 31309101 DOI: 10.1155/2019/1541593] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 201 |
Duong TV, Wong TC, Chen HH, Chen TH, Hsu YH, Peng SJ, Kuo KL, Liu HC, Lin ET, Yang SH. Impact of Percent Body Fat on All-Cause Mortality among Adequate Dialysis Patients with and without Insulin Resistance: A Multi-Center Prospective Cohort Study. Nutrients 2019;11:E1304. [PMID: 31181824 DOI: 10.3390/nu11061304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 202 |
Susantitaphong P, Vadcharavivad S, Susomboon T, Singhan W, Dumrongpisutikul N, Jakchairoongruang K, Eiam-Ong S, Praditpornsilpa K. The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism. Ren Fail 2019;41:326-33. [PMID: 31014177 DOI: 10.1080/0886022X.2018.1562356] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 203 |
Geng S, Kuang Z, Peissig P, Page D, Maursetter L, Hansen K. Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease. Osteoporos Int 2019;30:2019-25. [DOI: 10.1007/s00198-019-05033-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 204 |
Khalaf FK, Dube P, Kleinhenz AL, Malhotra D, Gohara A, Drummond CA, Tian J, Haller ST, Xie Z, Kennedy DJ. Proinflammatory Effects of Cardiotonic Steroids Mediated by NKA α-1 (Na+/K+-ATPase α-1)/Src Complex in Renal Epithelial Cells and Immune Cells. Hypertension 2019;74:73-82. [PMID: 31132948 DOI: 10.1161/HYPERTENSIONAHA.118.12605] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 205 |
Miyoshi H, Kameda H, Yamashita K, Nakamura A, Kurihara Y. Protective effect of sodium-glucose cotransporter 2 inhibitors in patients with rapid renal function decline, stage G3 or G4 chronic kidney disease and type 2 diabetes. J Diabetes Investig 2019;10:1510-7. [PMID: 31026373 DOI: 10.1111/jdi.13064] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 206 |
Fuller DS, Hallett D, Dluzniewski PJ, Fouqueray B, Jadoul M, Morgenstern H, Port FK, Tentori F, Pisoni RL. Predictors of cinacalcet discontinuation and reinitiation in hemodialysis patients: results from 7 European countries. BMC Nephrol 2019;20:169. [PMID: 31088377 DOI: 10.1186/s12882-019-1355-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 207 |
Keronen S, Martola L, Finne P, Burton IS, Kröger H, Honkanen E. Changes in Bone Histomorphometry after Kidney Transplantation. Clin J Am Soc Nephrol 2019;14:894-903. [PMID: 31088851 DOI: 10.2215/CJN.09950818] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 208 |
Chan K, Karaboyas A, Morgenstern H, Robinson BM, Port FK, Jacobson SH, Fukagawa M, Meier Y, Csomor PA, Pisoni RL. International and Racial Differences in Mineral and Bone Disorder Markers and Treatments Over the First 5 Years of Hemodialysis in the Dialysis Outcomes and Practice Patterns Study. Kidney Med 2019;1:86-96. [PMID: 32734189 DOI: 10.1016/j.xkme.2019.04.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 209 |
Salter ML, Liu X, Bae S, Chu NM, Miller Dunham A, Humbyrd C, Segev DL, McAdams-DeMarco MA. Fractures and Subsequent Graft Loss and Mortality among Older Kidney Transplant Recipients. J Am Geriatr Soc 2019;67:1680-8. [PMID: 31059126 DOI: 10.1111/jgs.15962] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 210 |
Chen P, Narayanan A, Wu B, Gisleskog PO, Gibbs JP, Chow AT, Melhem M. Population Pharmacokinetic and Pharmacodynamic Modeling of Etelcalcetide in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis. Clin Pharmacokinet 2018;57:71-85. [PMID: 28508378 DOI: 10.1007/s40262-017-0550-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 211 |
Lee SM, An WS. Supplementary nutrients for prevention of vascular calcification in patients with chronic kidney disease. Korean J Intern Med 2019;34:459-69. [PMID: 31048656 DOI: 10.3904/kjim.2019.125] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 212 |
Li A, Lee HY, Lin YC. The Effect of Ketoanalogues on Chronic Kidney Disease Deterioration: A Meta-Analysis. Nutrients 2019;11:E957. [PMID: 31035482 DOI: 10.3390/nu11050957] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 213 |
Kim ED, Watt J, Tereshchenko LG, Jaar BG, Sozio SM, Kao WHL, Estrella MM, Parekh RS. Associations of serum and dialysate electrolytes with QT interval and prolongation in incident hemodialysis: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study. BMC Nephrol 2019;20:133. [PMID: 30999887 DOI: 10.1186/s12882-019-1282-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 214 |
Assumpção LR, de Paula Ramos I, Nunes da Cunha G, de Mello Vianna CM, Araújo Maya MC, Araújo DV. Refractory secondary hyperparathyroidism in waiting list for parathyroidectomy: who we should operate first in a quaternary hospital in Brazil regarding survival. Ren Fail 2019;41:183-9. [PMID: 30942649 DOI: 10.1080/0886022X.2019.1590210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 215 |
Cunningham J, Block GA, Chertow GM, Cooper K, Evenepoel P, Iles J, Sun Y, Ureña-Torres P, Bushinsky DA. Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients. Kidney Int Rep 2019;4:987-94. [PMID: 31317120 DOI: 10.1016/j.ekir.2019.04.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 216 |
Saritas T, Reinartz SD, Nadal J, Schmoee J, Schmid M, Marwan M, Achenbach S, Störk S, Wanner C, Eckardt KU, Floege J, Peter Schneider M, Schlieper G. Epicardial fat, cardiovascular risk factors and calcifications in patients with chronic kidney disease. Clin Kidney J 2020;13:571-9. [PMID: 32905245 DOI: 10.1093/ckj/sfz030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 217 |
Shimada M, Shutto-Uchita Y, Yamabe H. Lack of Awareness of Dietary Sources of Phosphorus Is a Clinical Concern. In Vivo 2019;33:11-6. [PMID: 30587596 DOI: 10.21873/invivo.11432] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 218 |
Li J, Wang L, Han M, Xiong Y, Liao R, Li Y, Sun S, Maharjan A, Su B. The role of phosphate-containing medications and low dietary phosphorus-protein ratio in reducing intestinal phosphorus load in patients with chronic kidney disease. Nutr Diabetes 2019;9:14. [PMID: 30944300 DOI: 10.1038/s41387-019-0080-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 219 |
Rodelo-Haad C, Santamaria R, Muñoz-Castañeda JR, Pendón-Ruiz de Mier MV, Martin-Malo A, Rodriguez M. FGF23, Biomarker or Target? Toxins (Basel) 2019;11:E175. [PMID: 30909513 DOI: 10.3390/toxins11030175] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 220 |
Bhanot RD, Kaur J, Bhat Z. Severe Hypocalcemia and Dramatic Increase in Parathyroid Hormone after Denosumab in a Dialysis Patient: A Case Report and Review of the Literature. Case Rep Nephrol 2019;2019:3027419. [PMID: 31016056 DOI: 10.1155/2019/3027419] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 221 |
Xiong J, He T, Wang M, Nie L, Zhang Y, Wang Y, Huang Y, Feng B, Zhang J, Zhao J. Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis. J Nephrol. 2019;32:791-802. [PMID: 30888644 DOI: 10.1007/s40620-019-00601-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 222 |
Rottembourg J, Ureña-Torres P, Toledano D, Gueutin V, Hamani A, Coldefy O, Hebibi H, Guincestre T, Emery C. Factors associated with parathyroid hormone control in haemodialysis patients with secondary hyperparathyroidism treated with cinacalcet in real-world clinical practice: Mimosa study. Clin Kidney J 2019;12:871-9. [PMID: 31807302 DOI: 10.1093/ckj/sfz021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 223 |
Berg AH, Thadhani RI. Aiming Too Low: Reevaluation of Target Concentrations of Serum 25-Hydroxyvitamin D in Secondary Hyperparathyroidism. Am J Nephrol 2019;49:281-3. [PMID: 30879016 DOI: 10.1159/000499160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 224 |
Burns CM, Knopman DS, Tupper DE, Davey CS, Slinin YM, Lakshminarayan K, Rossom RC, Pederson SL, Gilbertson DT, Murray AM. Prevalence and Risk of Severe Cognitive Impairment in Advanced Chronic Kidney Disease. J Gerontol A Biol Sci Med Sci 2018;73:393-9. [PMID: 29244090 DOI: 10.1093/gerona/glx241] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 225 |
Block GA, Rosenbaum DP, Yan A, Chertow GM. Efficacy and Safety of Tenapanor in Patients with Hyperphosphatemia Receiving Maintenance Hemodialysis: A Randomized Phase 3 Trial. J Am Soc Nephrol 2019;30:641-52. [PMID: 30846557 DOI: 10.1681/ASN.2018080832] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 15.5] [Reference Citation Analysis]
|
| 226 |
Baralić M, Brković V, Stojanov V, Stanković S, Lalić N, Đurić P, Đukanović L, Kašiković M, Petrović M, Petrović M, Stošović M, Ležaić V. Dual Roles of the Mineral Metabolism Disorders Biomarkers in Prevalent Hemodilysis Patients: In Renal Bone Disease and in Vascular Calcification. J Med Biochem 2019;38:134-44. [PMID: 30867641 DOI: 10.2478/jomb-2018-0026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 227 |
Duong TV, Wu PY, Wong TC, Chen HH, Chen TH, Hsu YH, Peng SJ, Kuo KL, Liu HC, Lin ET, Feng YW, Yang SH. Mid-arm circumference, body fat, nutritional and inflammatory biomarkers, blood glucose, dialysis adequacy influence all-cause mortality in hemodialysis patients: A prospective cohort study. Medicine (Baltimore) 2019;98:e14930. [PMID: 30896655 DOI: 10.1097/MD.0000000000014930] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 228 |
Kefale B, Alebachew M, Tadesse Y, Engidawork E. Quality of life and its predictors among patients with chronic kidney disease: A hospital-based cross sectional study. PLoS One 2019;14:e0212184. [PMID: 30811447 DOI: 10.1371/journal.pone.0212184] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 229 |
Peugh J, Khalil A, Chan MR, Hansen KE. Teriparatide Treatment for Hypercalcemia Associated With Adynamic Bone Disease. JBMR Plus 2019;3:e10176. [PMID: 31372586 DOI: 10.1002/jbm4.10176] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 230 |
Zawierucha J, Malyszko J, Malyszko JS, Prystacki T, Marcinkowski WP, Dryl-Rydzynska T. Three Therapeutic Strategies: Cinacalcet, Paricalcitol or Both in Secondary Hyperparathyroidism Treatment in Hemodialysed Patients During 1-Year Observational Study-A Comparison. Front Endocrinol (Lausanne) 2019;10:40. [PMID: 30804890 DOI: 10.3389/fendo.2019.00040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 231 |
Lioufas N, Toussaint ND, Pedagogos E, Elder G, Badve SV, Pascoe E, Valks A, Hawley C; IMPROVE-CKD Writing Committee. Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study. BMJ Open 2019;9:e024382. [PMID: 30796122 DOI: 10.1136/bmjopen-2018-024382] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 232 |
Saurette M, Alexander RT. Intestinal phosphate absorption: The paracellular pathway predominates? Exp Biol Med (Maywood) 2019;244:646-54. [PMID: 30764666 DOI: 10.1177/1535370219831220] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 233 |
Dulfer RR, Koh EY, van der Plas WY, Engelsman AF, van Dijkum EJMN, Pol RA, Vogt L, de Borst MH, Kruijff S, Schepers A, Appelman-Dijkstra NM, Rotmans JI, Hesselink DA, van Eijck CHJ, Hoorn EJ, van Ginhoven TM; Dutch Hyperparathyroid Study Group. Parathyroidectomy versus cinacalcet for tertiary hyperparathyroidism; a retrospective analysis. Langenbecks Arch Surg 2019;404:71-9. [PMID: 30729318 DOI: 10.1007/s00423-019-01755-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 234 |
Moledina DG, Parikh CR. Phenotyping of Acute Kidney Injury: Beyond Serum Creatinine. Semin Nephrol 2018;38:3-11. [PMID: 29291759 DOI: 10.1016/j.semnephrol.2017.09.002] [Cited by in Crossref: 81] [Cited by in F6Publishing: 87] [Article Influence: 20.3] [Reference Citation Analysis]
|
| 235 |
Nafar M, Sabaghian T, Khoshdel A, Alipour B, Samavat S. Serum Calcium and Phosphorus Levels in Hemodialysis Patients: A Large Population-Based Multicenter Study. Iran Red Crescent Med J 2019;In Press. [DOI: 10.5812/ircmj.68772] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 236 |
Lim K, Hamano T, Thadhani R. Vitamin D and Calcimimetics in Cardiovascular Disease. Semin Nephrol 2018;38:251-66. [PMID: 29753401 DOI: 10.1016/j.semnephrol.2018.02.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 237 |
Niu Q, Zhao H, Wu B, Tsai S, Wu J, Zhang M, Lu L, Qiao J, Men C, Zuo L, Wang M. Study on the Prevalence of Vascular Calcification in Different Types of Arteries and Influencing Factors in Maintenance Peritoneal Dialysis Patients. Blood Purif 2019;47 Suppl 1:8-16. [PMID: 30699422 DOI: 10.1159/000496218] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 238 |
Yang G, Ge Y, Zha X, Mao H, Wang N, Xing C. Peritoneal dialysis can alleviate the clinical course of hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism. Int Urol Nephrol 2019;51:535-42. [PMID: 30689179 DOI: 10.1007/s11255-019-02076-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 239 |
Li Y, Yao L, Mao C, Srivastava A, Jiang X, Luo Y. Early Prediction of Acute Kidney Injury in Critical Care Setting Using Clinical Notes. Proceedings (IEEE Int Conf Bioinformatics Biomed) 2018;2018:683-6. [PMID: 33376624 DOI: 10.1109/bibm.2018.8621574] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 240 |
Hsiung JT, Kleine CE, Naderi N, Park C, Soohoo M, Moradi H, Rhee CM, Obi Y, Kopple JD, Kovesdy CP, Kalantar-Zadeh K, Streja E. Association of Pre-End-Stage Renal Disease Serum Albumin With Post-End-Stage Renal Disease Outcomes Among Patients Transitioning to Dialysis. J Ren Nutr 2019;29:310-21. [PMID: 30642656 DOI: 10.1053/j.jrn.2018.09.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 241 |
Johnson AE, Stone DJ, Celi LA, Pollard TJ. The MIMIC Code Repository: enabling reproducibility in critical care research. J Am Med Inform Assoc 2018;25:32-9. [PMID: 29036464 DOI: 10.1093/jamia/ocx084] [Cited by in Crossref: 137] [Cited by in F6Publishing: 151] [Article Influence: 34.3] [Reference Citation Analysis]
|
| 242 |
Chandran M, Wong J. Secondary and Tertiary Hyperparathyroidism in Chronic Kidney Disease: An Endocrine and Renal Perspective. Indian J Endocrinol Metab 2019;23:391-9. [PMID: 31741895 DOI: 10.4103/ijem.IJEM_292_19] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 243 |
Rabbani SA, Sridhar SB, Rao PGM, Kurian MT, Essawy BE. Use of Phosphate Binders in End-Stage Renal Disease: An Experience From a Secondary Care Hospital in United Arab Emirates. J Pharm Bioallied Sci 2019;11:148-54. [PMID: 31148891 DOI: 10.4103/jpbs.JPBS_290_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 244 |
Khouzam N, Wesseling-Perry K. Pathophysiology and treatment of cardiovascular disease in pediatric chronic kidney disease. Pediatr Nephrol 2019;34:1-10. [PMID: 28939921 DOI: 10.1007/s00467-017-3798-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 245 |
Chae SY, Chung W, Kim YH, Oh YK, Lee J, Choi KH, Ahn C, Kim YS. The Correlation of Serum Osteoprotegerin with Non-Traditional Cardiovascular Risk Factors and Arterial Stiffness in Patients with Pre-Dialysis Chronic Kidney Disease: Results from the KNOW-CKD Study. J Korean Med Sci 2018;33:e322. [PMID: 30595681 DOI: 10.3346/jkms.2018.33.e322] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 246 |
Yaseen M, Hassan W, Awad R, Ashqar B, Neyra J, Heister T, Malik O, El-Husseini A. Impact of Recent Clinical Trials on Nephrology Practice: Are We in a Stagnant Era? Kidney Dis (Basel). 2019;5:69-80. [PMID: 31019921 DOI: 10.1159/000495139] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 247 |
Negrea L. Active Vitamin D in Chronic Kidney Disease: Getting Right Back Where We Started from? Kidney Dis (Basel) 2019;5:59-68. [PMID: 31019920 DOI: 10.1159/000495138] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 248 |
Owaki A, Inaguma D, Aoyama I, Inaba S, Koide S, Ito E, Takahashi K, Hayashi H, Hasegawa M, Yuzawa Y; AICOPP group. Serum phosphate level at initiation of dialysis is associated with all-cause mortality: a multicenter prospective cohort study. Ren Fail 2018;40:475-82. [PMID: 30153079 DOI: 10.1080/0886022X.2018.1499530] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 249 |
Burgstaller T, Selberherr A, Brammen L, Scheuba C, Kaczirek K, Riss P. How radical is total parathyroidectomy in patients with renal hyperparathyroidism? Langenbecks Arch Surg 2018;403:1007-13. [PMID: 30519885 DOI: 10.1007/s00423-018-1739-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 250 |
Norris KC, Olabisi O, Barnett ME, Meng YX, Martins D, Obialo C, Lee JE, Nicholas SB. The Role of Vitamin D and Oxidative Stress in Chronic Kidney Disease. Int J Environ Res Public Health 2018;15:E2701. [PMID: 30513574 DOI: 10.3390/ijerph15122701] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 251 |
You M, Tang B, Wang ZJ, Wang KL, Wang H. Radiological manifestations of renal osteodystrophy in the orofacial region: a case report and literature review. Oral Radiol 2018;34:262-6. [PMID: 30484027 DOI: 10.1007/s11282-017-0291-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 252 |
Barreto FC, Costa CRVD, Reis LMD, Custódio MR. Bone biopsy in nephrology practice. J Bras Nefrol 2018;40:366-74. [PMID: 30525179 DOI: 10.1590/2175-8239-jbn-2017-0012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 253 |
Galbraith L, Jacobs C, Hemmelgarn BR, Donald M, Manns BJ, Jun M. Chronic disease management interventions for people with chronic kidney disease in primary care: a systematic review and meta-analysis. Nephrol Dial Transplant 2018;33:112-21. [PMID: 28096482 DOI: 10.1093/ndt/gfw359] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 254 |
Coutinho MN, Carvalho AB, Dalboni MA, Mouro MG, Higa EMS, Costa-Hong V, Bortolotto LA, Figueiredo RAO, Canziani MEF. There Is No Impact of Diabetes on the Endothelial Function of Chronic Kidney Disease Patients. J Diabetes Res 2018;2018:7926473. [PMID: 30596103 DOI: 10.1155/2018/7926473] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 255 |
Sánchez-gonzález C, Gonzalez-casaus ML, Sellares VL, Albalate M, Torregrosa J, Mas S, Ortiz A, Rodriguez M, Gonzalez-parra E. Higher Proportion of Non-1-84 PTH Fragments in Peritoneal Dialysis Patients Compared to Hemodialysis Patients Using Solutions Containing 1.75 mmol/l Calcium. Front Physiol 2018;9. [DOI: 10.3389/fphys.2018.01643] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 256 |
Damasiewicz MJ, Nickolas TL. Rethinking Bone Disease in Kidney Disease. JBMR Plus 2018;2:309-22. [PMID: 30460334 DOI: 10.1002/jbm4.10117] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 257 |
Jansz TT, van Reekum FE, Özyilmaz A, de Jong PA, Boereboom FTJ, Hoekstra T, Verhaar MC, van Jaarsveld BC. Coronary Artery Calcification in Hemodialysis and Peritoneal Dialysis. Am J Nephrol 2018;48:369-77. [PMID: 30423550 DOI: 10.1159/000494665] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 258 |
Yeh JC, Wu CC, Choy CS, Chang SW, Liou JC, Chen KS, Tung TH, Lin WN, Hsieh CY, Ho CT, Wang TM, Chang JF. Non-Hepatic Alkaline Phosphatase, hs-CRP and Progression of Vertebral Fracture in Patients with Rheumatoid Arthritis: A Population-Based Longitudinal Study. J Clin Med 2018;7:E439. [PMID: 30428612 DOI: 10.3390/jcm7110439] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 259 |
Boltenstål H, Qureshi AR, Behets GJ, Lindholm B, Stenvinkel P, D'Haese PC, Haarhaus M. Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients. Calcif Tissue Int 2019;104:214-23. [PMID: 30406279 DOI: 10.1007/s00223-018-0491-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 260 |
Chao JY, Chien HC, Kuo TH, Chang YT, Li CY, Wang MC, Kao Yang YH. Assessing the effect of oral activated vitamin D on overall survival in hemodialysis patients: a landmark analysis. BMC Nephrol 2018;19:309. [PMID: 30400889 DOI: 10.1186/s12882-018-1111-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 261 |
Hanudel MR, Laster M, Ramos G, Gales B, Salusky IB. Clinical experience with the use of ferric citrate as a phosphate binder in pediatric dialysis patients. Pediatr Nephrol 2018;33:2137-42. [PMID: 29956006 DOI: 10.1007/s00467-018-3999-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 262 |
Antlanger M, Dust T, Reiter T, Böhm A, Lamm WW, Gornicec M, Willenbacher E, Nachbaur D, Weger R, Rabitsch W, Rasoul-Rockenschaub S, Worel N, Lechner D, Greinix H, Keil F, Gisslinger H, Agis H, Krauth MT. Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study. BMC Cancer 2018;18:1008. [PMID: 30342509 DOI: 10.1186/s12885-018-4926-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 263 |
Goh BL, Soraya A, Goh A, Ang KL. Cost-Effectiveness Analysis for the Treatment of Hyperphosphatemia in Predialysis Patients: Calcium-Based versus Noncalcium-Based Phosphate Binders. Int J Nephrol 2018;2018:2138528. [PMID: 30327732 DOI: 10.1155/2018/2138528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 264 |
Lee SE, Lee J, Yoo TH, Cho IJ, Chang HJ. End-Stage Renal Disease Impairs the Multidirectional Movements of the Common Carotid Artery: Assessment Using Dimensional Speckle-Tracking Carotid Strain Ultrasonography. J Cardiovasc Imaging 2018;26:155-64. [PMID: 30310883 DOI: 10.4250/jcvi.2018.26.e16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 265 |
Fouque D, Roth H, Darné B, Bouchet JL, Daugas E, Drüeke TB, Hannedouche T, Jean G, London GM. Achievement of 2009 and 2017 Kidney Disease: Improving Global Outcomes mineral and bone targets and survival in a French cohort of chronic kidney disease Stages 4 and 5 non-dialysis patients. Clin Kidney J 2018;11:710-9. [PMID: 30288267 DOI: 10.1093/ckj/sfy015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 266 |
Melamed ML, Chonchol M, Gutiérrez OM, Kalantar-Zadeh K, Kendrick J, Norris K, Scialla JJ, Thadhani R. The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Am J Kidney Dis 2018;72:834-45. [PMID: 30297082 DOI: 10.1053/j.ajkd.2018.06.031] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 267 |
Kim Y, Yoo KD, Kim HJ, Koh J, Yu Y, Kwon YJ, Kim GH, Yoo TH, Lee J, Jin DC, Choi BS, Kim YH, Oh KH. Association of serum mineral parameters with mortality in hemodialysis patients: Data from the Korean end-stage renal disease registry. Kidney Res Clin Pract 2018;37:266-76. [PMID: 30254851 DOI: 10.23876/j.krcp.2018.37.3.266] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 268 |
Shevroja E, Lamy O, Hans D. Review on the Utility of Trabecular Bone Score, a Surrogate of Bone Micro-architecture, in the Chronic Kidney Disease Spectrum and in Kidney Transplant Recipients. Front Endocrinol (Lausanne) 2018;9:561. [PMID: 30319544 DOI: 10.3389/fendo.2018.00561] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 269 |
Niu Q, Hong Y, Lee CH, Men C, Zhao H, Zuo L. Abdominal aortic calcification can predict all-cause mortality and CV events in dialysis patients: A systematic review and meta-analysis. PLoS One 2018;13:e0204526. [PMID: 30240443 DOI: 10.1371/journal.pone.0204526] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 270 |
Burton JO, Goldsmith DJ, Ruddock N, Shroff R, Wan M. Renal association commentary on the KDIGO (2017) clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of CKD-MBD. BMC Nephrol 2018;19:240. [PMID: 30236082 DOI: 10.1186/s12882-018-1037-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 271 |
Duong TV, Wong TC, Chen HH, Chen TW, Chen TH, Hsu YH, Peng SJ, Kuo KL, Liu HC, Lin ET, Wang CS, Tseng IH, Feng YW, Chang TY, Su CT, Yang SH. Inadequate dietary energy intake associates with higher prevalence of metabolic syndrome in different groups of hemodialysis patients: a clinical observational study in multiple dialysis centers. BMC Nephrol 2018;19:236. [PMID: 30231860 DOI: 10.1186/s12882-018-1041-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 272 |
Tongpoo A, Sriapha C, Pradoo A, Udomsubpayakul U, Srisuma S, Wananukul W, Trakulsrichai S. Krait envenomation in Thailand. Ther Clin Risk Manag 2018;14:1711-7. [PMID: 30271155 DOI: 10.2147/TCRM.S169581] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 273 |
de Roij van Zuijdewijn CLM, de Haseth DE, van Dam B, Bax WA, Grooteman MPC, Bots ML, Blankestijn PJ, Nubé MJ, van den Dorpel MA, Ter Wee PM, Penne EL. Role of Albumin Assay on Calcium Levels and Prescription of Phosphate Binders in Chronic Hemodialysis Patients. Nephron 2018;140:211-7. [PMID: 30212837 DOI: 10.1159/000492238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 274 |
Santamaría R, Díaz-Tocados JM, Pendón-Ruiz de Mier MV, Robles A, Salmerón-Rodríguez MD, Ruiz E, Vergara N, Aguilera-Tejero E, Raya A, Ortega R, Felsenfeld A, Muñoz-Castañeda JR, Martín-Malo A, Aljama P, Rodríguez M. Increased Phosphaturia Accelerates The Decline in Renal Function: A Search for Mechanisms. Sci Rep 2018;8:13701. [PMID: 30209259 DOI: 10.1038/s41598-018-32065-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 275 |
Vanden Wyngaert K, Van Craenenbroeck AH, Van Biesen W, Dhondt A, Tanghe A, Van Ginckel A, Celie B, Calders P. The effects of aerobic exercise on eGFR, blood pressure and VO2peak in patients with chronic kidney disease stages 3-4: A systematic review and meta-analysis. PLoS One 2018;13:e0203662. [PMID: 30204785 DOI: 10.1371/journal.pone.0203662] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 276 |
Du L, Zhang X, Yan L, Zhang H, Tang X, Kong X, Liu G, Huang J. A practical self-made device in parathyroid autotransplantation for patients with secondary hyperparathyroidism. J Int Med Res 2019;47:59-65. [PMID: 30198369 DOI: 10.1177/0300060518794840] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 277 |
Cavalier E, Sagou Yayo E, Attoungbre-Hauhouot ML, Konan JL, Yao-Yapo C, Monnet D, Gnionsahé A, Souberbielle JC, Delanaye P. Vitamin D, bone alkaline phosphatase and parathyroid hormone in healthy subjects and haemodialysed patients from West Africa: impact of reference ranges and parathyroid hormone generation assays on the KDIGO guidelines. Clin Kidney J 2019;12:288-93. [PMID: 30976410 DOI: 10.1093/ckj/sfy074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 278 |
Custodio MR, Elias RM, Velasquez WD, Dos Reis LM, Oliveira IB, Moysés RMA, Carvalho AB, Jorgetti V. The unexpected presence of iron in bone biopsies of hemodialysis patients. Int Urol Nephrol 2018;50:1907-12. [PMID: 30136087 DOI: 10.1007/s11255-018-1936-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 279 |
Ruospo M, Palmer SC, Natale P, Craig JC, Vecchio M, Elder GJ, Strippoli GF. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD). Cochrane Database Syst Rev 2018;8:CD006023. [PMID: 30132304 DOI: 10.1002/14651858.CD006023.pub3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 48] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 280 |
Brunerová L, Lažanská R, Kasalický P, Verešová J, Potočková J, Fialová A, Rychlík I. Predictors of bone fractures in a single-centre cohort of hemodialysis patients: a 2-year follow-up study. Int Urol Nephrol 2018;50:1721-8. [PMID: 30117013 DOI: 10.1007/s11255-018-1958-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 281 |
Kadri AN, Kaw R, Al-Khadra Y, Abuamsha H, Ravakhah K, Hernandez AV, Tang WHW. The role of B-type natriuretic peptide in diagnosing acute decompensated heart failure in chronic kidney disease patients. Arch Med Sci 2018;14:1003-9. [PMID: 30154881 DOI: 10.5114/aoms.2018.77263] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 282 |
Rodrigues AT, Colugnati FAB, Bastos MG. Evaluation of variables associated with the patency of arteriovenous fistulas for hemodialysis created by a nephrologist. J Bras Nefrol 2018;40:326-32. [PMID: 30080914 DOI: 10.1590/2175-8239-jbn-2017-0014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 283 |
Yang G, Zha X, Mao H, Yu X, Wang N, Xing C. Hypocalcemia-based prediction of hungry bone syndrome after parathyroidectomy in hemodialysis patients with refractory secondary hyperparathyroidism. J Int Med Res 2018;46:4985-94. [PMID: 30064280 DOI: 10.1177/0300060518788744] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 284 |
Richardson KL, Weiss NS, Halbach S. Chronic School Absenteeism of Children with Chronic Kidney Disease. J Pediatr 2018;199:267-71. [PMID: 29706492 DOI: 10.1016/j.jpeds.2018.03.031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 285 |
Vangala C, Pan J, Cotton RT, Ramanathan V. Mineral and Bone Disorders After Kidney Transplantation. Front Med (Lausanne) 2018;5:211. [PMID: 30109232 DOI: 10.3389/fmed.2018.00211] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 286 |
Goldenstein PT, Graciolli FG, Antunes GL, Dominguez WV, Dos Reis LM, Moe S, Elias RM, Jorgetti V, Moysés RMA. A prospective study of the influence of the skeleton on calcium mass transfer during hemodialysis. PLoS One 2018;13:e0198946. [PMID: 30059531 DOI: 10.1371/journal.pone.0198946] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 287 |
Yamada S, Tokumoto M, Taniguchi M, Yoshida H, Arase H, Tatsumoto N, Hirakata H, Kitazono T, Tsuruya K. Use of phosphate-binders and risk of infection-related and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort Study. Sci Rep 2018;8:11387. [PMID: 30061632 DOI: 10.1038/s41598-018-29757-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 288 |
Kefale B, Tadesse Y, Alebachew M, Engidawork E. Management practice, and adherence and its contributing factors among patients with chronic kidney disease at Tikur Anbessa Specialized Hospital: A hospital-based cross-sectional study. PLoS One 2018;13:e0200415. [PMID: 30044830 DOI: 10.1371/journal.pone.0200415] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 289 |
Keung L, Perwad F. Vitamin D and kidney disease. Bone Rep 2018;9:93-100. [PMID: 30591927 DOI: 10.1016/j.bonr.2018.07.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 290 |
Lee SM, Lee HW, Son YK, Kim SE, An WS. Abdominal aortic calcification score among several vascular calcification scores of plain radiograph is the most reliable predictor of severe coronary artery calcification in dialysis patients. Ren Fail 2017;39:729-35. [PMID: 29157086 DOI: 10.1080/0886022X.2017.1398666] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 291 |
Ureña-Torres PA, Vervloet M, Mazzaferro S, Oury F, Brandenburg V, Bover J, Cavalier E, Cohen-Solal M, Covic A, Drüeke TB, Hindié E, Evenepoel P, Frazão J, Goldsmith D, Kazama JJ, Cozzolino M, Massy ZA; ERA-EDTA CKD-MBD Working Group. Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease. Clin Kidney J 2019;12:269-80. [PMID: 30976408 DOI: 10.1093/ckj/sfy061] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 292 |
Casella C, Galani A, Totaro L, Ministrini S, Lai S, Dimko M, Portolani N. Total Parathyroidectomy with Subcutaneous Parathyroid Forearm Autotransplantation in the Treatment of Secondary Hyperparathyroidism: A Single-Center Experience. Int J Endocrinol 2018;2018:6065720. [PMID: 30123263 DOI: 10.1155/2018/6065720] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 293 |
Oh HJ, Ryu DR. Why do we need regional chronic kidney disease-mineral bone disorders guidelines? Kidney Res Clin Pract 2018;37:101-2. [PMID: 29971203 DOI: 10.23876/j.krcp.2018.37.2.101] [Reference Citation Analysis]
|
| 294 |
Jin K, Ban TH, Jung JY, Kim AJ, Kim Y, Lee SY, Yang DH, Choi BS, Oh KH, Kim J, Kwon YJ, Choi JW, Kim GH. Stabilization of serum alkaline phosphatase in hemodialysis patients by implementation of local chronic kidney disease-mineral bone disorder management strategy: A quality improvement study. Kidney Res Clin Pract 2018;37:157-66. [PMID: 29971211 DOI: 10.23876/j.krcp.2018.37.2.157] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 295 |
Bruzda-Zwiech A, Szczepańska J, Zwiech R. Xerostomia, thirst, sodium gradient and inter-dialytic weight gain in hemodialysis diabetic vs. non-diabetic patients. Med Oral Patol Oral Cir Bucal 2018;23:e406-12. [PMID: 29924756 DOI: 10.4317/medoral.22294] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 296 |
Park S, Lee CJ, Jhee JH, Yun HR, Kim H, Jung SY, Kee YK, Yoon CY, Park JT, Kim HC, Han SH, Kang SW, Park S, Yoo TH. Extracellular Fluid Excess Is Significantly Associated With Coronary Artery Calcification in Patients With Chronic Kidney Disease. J Am Heart Assoc 2018;7:e008935. [PMID: 29960990 DOI: 10.1161/JAHA.118.008935] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 297 |
Swallow EA, Aref MW, Chen N, Byiringiro I, Hammond MA, McCarthy BP, Territo PR, Kamocka MM, Winfree S, Dunn KW, Moe SM, Allen MR. Skeletal accumulation of fluorescently tagged zoledronate is higher in animals with early stage chronic kidney disease. Osteoporos Int 2018;29:2139-46. [PMID: 29947866 DOI: 10.1007/s00198-018-4589-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 298 |
Havlin J, Vankova S. Intradialytic alkalinization is a neglected factor affecting calcium mass balance and parathyroid hormone level during haemodiafiltration. Clin Kidney J 2019;12:149-56. [PMID: 30746142 DOI: 10.1093/ckj/sfy047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 299 |
Stremke ER, McCabe LD, McCabe GP, Martin BR, Moe SM, Weaver CM, Peacock M, Hill Gallant KM. Twenty-Four-Hour Urine Phosphorus as a Biomarker of Dietary Phosphorus Intake and Absorption in CKD: A Secondary Analysis from a Controlled Diet Balance Study. Clin J Am Soc Nephrol 2018;13:1002-12. [PMID: 29921736 DOI: 10.2215/CJN.00390118] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 300 |
Jean G, Lafage-Proust MH, Souberbielle JC, Lechevallier S, Deleaval P, Lorriaux C, Hurot JM, Mayor B, Mehdi M, Chazot C. Severe secondary hyperparathyroidism in patients on haemodialysis is associated with a high initial serum parathyroid hormone and beta-CrossLaps level: Results from an incident cohort. PLoS One 2018;13:e0199140. [PMID: 29912988 DOI: 10.1371/journal.pone.0199140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 301 |
Neves MCD, Rocha LAD, Cervantes O, Santos RO. Initial surgical results of 500 Parathyroidectomies for Hyperparathyroidism related to chronic kidney disease - mineral and bone disorder. J Bras Nefrol 2018;40:319-25. [PMID: 29944161 DOI: 10.1590/2175-8239-jbn-3924] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 302 |
Yoon HE, Kim Y, Kim SD, Oh JK, Chung YA, Shin SJ, Yang CW, Seo SM. A Pilot Trial to Examine the Changes in Carotid Arterial Inflammation in Renal Transplant Recipients as Assessed by 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography Computed Tomography (PET/CT). Ann Transplant 2018;23:412-21. [PMID: 29904040 DOI: 10.12659/AOT.909212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 303 |
Gimba ZM, Abene EE, Agbaji OOO, Agaba EI. Secondary hyperparathyroidism among Nigerians with chronic kidney disease. Afr Health Sci 2018;18:446-57. [PMID: 30602972 DOI: 10.4314/ahs.v18i2.30] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 304 |
Duong TV, Wong TC, Su CT, Chen HH, Chen TW, Chen TH, Hsu YH, Peng SJ, Kuo KL, Liu HC, Lin ET, Yang SH. Associations of dietary macronutrients and micronutrients with the traditional and nontraditional risk factors for cardiovascular disease among hemodialysis patients: A clinical cross-sectional study. Medicine (Baltimore) 2018;97:e11306. [PMID: 29953017 DOI: 10.1097/MD.0000000000011306] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 305 |
Cho SY, Hur M. Neutrophil Gelatinase-Associated Lipocalin as a Promising Novel Biomarker for Early Detection of Kidney Injury. Ann Lab Med 2018;38:393-4. [PMID: 29797807 DOI: 10.3343/alm.2018.38.5.393] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 306 |
Sharma AK, Toussaint ND, Masterson R, Holt SG, Rajapakse CS, Ebeling PR, Mohanty ST, Baldock P, Elder GJ. Deterioration of Cortical Bone Microarchitecture: Critical Component of Renal Osteodystrophy Evaluation. Am J Nephrol 2018;47:376-84. [PMID: 29791896 DOI: 10.1159/000489671] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 307 |
Rinfret F, Lambert F, Youmbissi JT, Arcand JF, Turcot R, Bessette MA, Bourque S, Moreau V, Tousignant K, Deschênes D, Cloutier L. Cross-Sectional Assessment of Achievement of Therapeutic Goals in a Canadian Multidisciplinary Clinic for Patients With Advanced Chronic Kidney Disease. Can J Kidney Health Dis 2018;5:2054358118775097. [PMID: 29785274 DOI: 10.1177/2054358118775097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 308 |
Nishiwaki H, Fukuma S, Hasegawa T, Kimachi M, Akizawa T, Fukuhara S. Dialysis-related practice patterns among hemodialysis patients with cancer. Health Sci Rep 2018;1:e46. [PMID: 30623084 DOI: 10.1002/hsr2.46] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 309 |
Ruderman I, Smith ER, Toussaint ND, Hewitson TD, Holt SG. Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism. BMC Nephrol 2018;19:113. [PMID: 29764395 DOI: 10.1186/s12882-018-0910-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 310 |
Scialla JJ. Evidence basis for integrated management of mineral metabolism in patients with end-stage renal disease. Curr Opin Nephrol Hypertens 2018;27:258-67. [PMID: 29677006 DOI: 10.1097/MNH.0000000000000417] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 311 |
Zheng S, Chen Y, Zheng Y, Zhou Z, Li Z. Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients. Eur J Med Res 2018;23:18. [PMID: 29665846 DOI: 10.1186/s40001-018-0315-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 312 |
Sethi SK, Bansal SB, Wadhwani N, Makasana M, Nandwani A, Kher V, Raina R. Myelofibrosis-Induced Erythropoietin-Resistant Anemia Due to Severe Refractory Hyperparathyroidism. Kidney Int Rep 2018;3:1010-4. [PMID: 29988982 DOI: 10.1016/j.ekir.2018.04.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 313 |
Shroff R, Wan M, Nagler EV, Bakkaloglu S, Fischer DC, Bishop N, Cozzolino M, Bacchetta J, Edefonti A, Stefanidis CJ, Vande Walle J, Haffner D, Klaus G, Schmitt CP; European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders and Dialysis Working Groups. Clinical practice recommendations for native vitamin D therapy in children with chronic kidney disease Stages 2-5 and on dialysis. Nephrol Dial Transplant 2017;32:1098-113. [PMID: 28873969 DOI: 10.1093/ndt/gfx065] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 11.4] [Reference Citation Analysis]
|
| 314 |
Shroff R, Wan M, Nagler EV, Bakkaloglu S, Cozzolino M, Bacchetta J, Edefonti A, Stefanidis CJ, Vande Walle J, Ariceta G, Klaus G, Haffner D, Schmitt CP; European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders and Dialysis Working Groups. Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease Stages 2-5 and on dialysis. Nephrol Dial Transplant 2017;32:1114-27. [PMID: 28873971 DOI: 10.1093/ndt/gfx080] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 315 |
Hill Gallant KM, Spiegel DM. Calcium Balance in Chronic Kidney Disease. Curr Osteoporos Rep 2017;15:214-21. [PMID: 28474258 DOI: 10.1007/s11914-017-0368-x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 316 |
Hanudel MR, Salusky IB. Treatment of Pediatric Chronic Kidney Disease-Mineral and Bone Disorder. Curr Osteoporos Rep 2017;15:198-206. [PMID: 28455644 DOI: 10.1007/s11914-017-0365-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 317 |
Moe SM. Renal Osteodystrophy or Kidney-Induced Osteoporosis? Curr Osteoporos Rep 2017;15:194-7. [PMID: 28497212 DOI: 10.1007/s11914-017-0364-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 318 |
Ott SM. Renal Osteodystrophy-Time for Common Nomenclature. Curr Osteoporos Rep 2017;15:187-93. [PMID: 28466454 DOI: 10.1007/s11914-017-0367-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 319 |
Isaksson E, Ivarsson K, Akaberi S, Muth A, Sterner G, Karl-Göran P, Clyne N, Almquist M. The Effect of Parathyroidectomy on Risk of Hip Fracture in Secondary Hyperparathyroidism. World J Surg 2017;41:2304-11. [PMID: 28341917 DOI: 10.1007/s00268-017-4000-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 320 |
Liabeuf S, Van Stralen KJ, Caskey F, Tentori F, Pisoni RL, Sajjad A, Jager KJ, Massy ZA. Attainment of guideline targets in EURODOPPS haemodialysis patients: are differences related to a country's healthcare expenditure and nephrologist workforce? Nephrol Dial Transplant 2017;32:1737-49. [PMID: 28057873 DOI: 10.1093/ndt/gfw409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 321 |
Fukagawa M, Yokoyama K, Shigematsu T, Akiba T, Fujii A, Kuramoto T, Odani M, Akizawa T; ONO-5163 Study Group. A phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese haemodialysis patients. Nephrol Dial Transplant 2017;32:1723-30. [PMID: 28057872 DOI: 10.1093/ndt/gfw408] [Cited by in Crossref: 9] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 322 |
Salam S, Gallagher O, Gossiel F, Paggiosi M, Khwaja A, Eastell R. Diagnostic Accuracy of Biomarkers and Imaging for Bone Turnover in Renal Osteodystrophy. J Am Soc Nephrol 2018;29:1557-65. [PMID: 29555831 DOI: 10.1681/ASN.2017050584] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 11.8] [Reference Citation Analysis]
|
| 323 |
Jansz TT, Özyilmaz A, Grooteman MPC, Hoekstra T, Romijn M, Blankestijn PJ, Bots ML, van Jaarsveld BC. Long-term clinical parameters after switching to nocturnal haemodialysis: a Dutch propensity-score-matched cohort study comparing patients on nocturnal haemodialysis with patients on three-times-a-week haemodialysis/haemodiafiltration. BMJ Open 2018;8:e019900. [PMID: 29523566 DOI: 10.1136/bmjopen-2017-019900] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 324 |
Bellasi A, Morrone L, Mereu MC, Massimetti C, Pelizzaro E, Cianciolo G, Pasquali M, Panuccio V; working group on CKD-MBD of the Italian Society of Nephrology. CKD-MBD management: what is the role of parathyroidectomy? Results from a nationwide survey in Italy. J Nephrol 2018;31:585-91. [PMID: 29516322 DOI: 10.1007/s40620-018-0481-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 325 |
Greeviroj P, Kitrungphaiboon T, Katavetin P, Praditpornsilpa K, Eiam-ong S, Jaber B, Susantitaphong P. Cinacalcet for Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: A Meta-Analysis of Randomized Controlled Trials. Nephron 2018;139:197-210. [DOI: 10.1159/000487546] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 326 |
Nowak KL, Hung A, Ikizler TA, Farmer-Bailey H, Salas-Cruz N, Sarkar S, Hoofnagle A, You Z, Chonchol M. Interleukin-1 inhibition, chronic kidney disease-mineral and bone disorder, and physical function
. Clin Nephrol 2017;88:132-43. [PMID: 28699886 DOI: 10.5414/CN109122] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 327 |
Segaud N, Legroux I, Hazzan M, Noel C, Cortet B. Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort. Osteoporos Int 2018;29:1165-75. [DOI: 10.1007/s00198-018-4383-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 328 |
Yajima A, Tsuchiya K, Bonewald LF, Inaba M, Tominaga Y, Tanizawa T, Ito A, Nitta K. Case report: Electron microscopic evaluation of bone from a patient treated with cinacalcet hydrochloride, maxacalcitol, and alfacalcidol for hyperparathyroid bone disease with secondary hyperparathyroidism. Osteoporos Int 2018;29:1203-9. [PMID: 29492624 DOI: 10.1007/s00198-018-4402-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 329 |
Nambiar S, Pillai UK, Devasahayam J, Oliver T, Karippot A. Colonic Mucosal Ulceration and Gastrointestinal Bleeding Associated with Sevelamer Crystal Deposition in a Patient with End Stage Renal Disease. Case Rep Nephrol 2018;2018:4708068. [PMID: 29682371 DOI: 10.1155/2018/4708068] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 330 |
Isaksson E, Almquist M, Seeberger A, Sterner G. Is low pre-transplant parathyroid hormone a risk marker for cardiovascular disease in long-term follow-up of renal transplant recipients? Clin Exp Nephrol 2018;22:1188-97. [PMID: 29478201 DOI: 10.1007/s10157-018-1543-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 331 |
Capusa C, Popescu D. Mechanisms and Clinical Implications of Vascular Calcifications in Chronic Kidney Disease. Chronic Kidney Disease - from Pathophysiology to Clinical Improvements 2018. [DOI: 10.5772/intechopen.72717] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 332 |
Park KM, Jun HH, Bae J, Choi YB, Yang DH, Jeong HY, Lee MJ, Lee SY. 25-hydroxyvitamin D Levels was not Associated with Blood Pressure and Arterial Stiffness in Patients with Chronic Kidney Disease. Electrolyte Blood Press 2017;15:27-36. [PMID: 29399021 DOI: 10.5049/EBP.2017.15.2.27] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 333 |
Przedlacki J, Buczyńska-Chyl J, Koźmiński P, Niemczyk E, Wojtaszek E, Gieglis E, Żebrowski P, Podgórzak A, Wściślak J, Wieliczko M, Matuszkiewicz-Rowińska J; Mazovia Fracture Study Group. The utility of FRAX® in predicting bone fractures in patients with chronic kidney disease on hemodialysis: a two-year prospective multicenter cohort study. Osteoporos Int 2018;29:1105-15. [PMID: 29411069 DOI: 10.1007/s00198-018-4406-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 334 |
Eidman KE, Wetmore JB. Managing hyperparathyroidism in hemodialysis: role of etelcalcetide. Int J Nephrol Renovasc Dis 2018;11:69-80. [PMID: 29440923 DOI: 10.2147/IJNRD.S128252] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 335 |
Jørgensen HS, Winther S, Bøttcher M, Hauge EM, Rejnmark L, Svensson M, Ivarsen P. Bioavailable Testosterone Is Positively Associated With Bone Mineral Density in Male Kidney Transplantation Candidates. Kidney Int Rep 2018;3:661-70. [PMID: 29854974 DOI: 10.1016/j.ekir.2018.01.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 336 |
Frauscher B, Artinger K, Kirsch AH, Aringer I, Moschovaki-Filippidou F, Kétszeri M, Schabhüttl C, Rainer PP, Schmidt A, Stojakovic T, Fahrleitner-Pammer A, Rosenkranz AR, Eller P, Eller K. A New Murine Model of Chronic Kidney Disease-Mineral and Bone Disorder. Int J Endocrinol 2017;2017:1659071. [PMID: 29387084 DOI: 10.1155/2017/1659071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 337 |
Evans M, Methven S, Gasparini A, Barany P, Birnie K, MacNeill S, May MT, Caskey FJ, Carrero JJ. Cinacalcet use and the risk of cardiovascular events, fractures and mortality in chronic kidney disease patients with secondary hyperparathyroidism. Sci Rep 2018;8:2103. [PMID: 29391567 DOI: 10.1038/s41598-018-20552-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 338 |
Rong S, Qiu X, Jin X, Shang M, Huang Y, Tang Z, Yuan W. Risk factors for heart valve calcification in chronic kidney disease. Medicine (Baltimore) 2018;97:e9804. [PMID: 29384880 DOI: 10.1097/MD.0000000000009804] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 339 |
Vetchinnikova ON. Modern approaches to correction mineral and bone disorders in kidney transplant recipients. RJTAO 2018;19:130-140. [DOI: 10.15825/1995-1191-2017-4-130-140] [Reference Citation Analysis]
|
| 340 |
Wang Z, Jiang A, Wei F, Chen H. Cardiac valve calcification and risk of cardiovascular or all-cause mortality in dialysis patients: a meta-analysis. BMC Cardiovasc Disord 2018;18:12. [PMID: 29370754 DOI: 10.1186/s12872-018-0747-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 341 |
Ginsberg C, Ix JH. Nicotinamide and phosphate homeostasis in chronic kidney disease. Curr Opin Nephrol Hypertens 2016;25:285-91. [PMID: 27219041 DOI: 10.1097/MNH.0000000000000236] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 342 |
Brown SJ, Ruppe MD, Tabatabai LS. The Parathyroid Gland and Heart Disease. Methodist Debakey Cardiovasc J 2017;13:49-54. [PMID: 28740581 DOI: 10.14797/mdcj-13-2-49] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 343 |
Stenvinkel P, Painer J, Kuro-O M, Lanaspa M, Arnold W, Ruf T, Shiels PG, Johnson RJ. Novel treatment strategies for chronic kidney disease: insights from the animal kingdom. Nat Rev Nephrol 2018;14:265-84. [PMID: 29332935 DOI: 10.1038/nrneph.2017.169] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 12.6] [Reference Citation Analysis]
|
| 344 |
Chen L, He JX, Chen YY, Ling YS, Lin CH, Guan TJ. Intensified treatment of hyperphosphatemia associated with reduction in parathyroid hormone in patients on maintenance hemodialysis. Ren Fail 2018;40:15-21. [PMID: 29295646 DOI: 10.1080/0886022X.2017.1419966] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 345 |
Silverstein DM. Growth and Nutrition in Pediatric Chronic Kidney Disease. Front Pediatr 2018;6:205. [PMID: 30155452 DOI: 10.3389/fped.2018.00205] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 346 |
Stancu S, Chiriac C, Maria DT, Mota E, Mircescu G, Capusa C. NUTRITIONAL OR ACTIVE VITAMIN D FOR THE CORRECTION OF MINERAL METABOLISM ABNORMALITIES IN NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS? Acta Endocrinol (Buchar) 2018;14:505-13. [PMID: 31149304 DOI: 10.4183/aeb.2018.505] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 347 |
Bielesz B, Reiter T, Marculescu R, Gleiss A, Bojic M, Kieweg H, Cejka D. Calcification Propensity of Serum is Independent of Excretory Renal Function. Sci Rep 2017;7:17941. [PMID: 29263429 DOI: 10.1038/s41598-017-18336-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 348 |
Nafar M, Rashid Farokhi F, Zeraati AA, Ossareh S, Atapour A, Nemati E, Poor Reza Gholi F, Sagheb MM, Hakemi MS, Argani H, Tara SA, Afshar R, Reza Ahmadi JM, Karimi N, Mamdouhi F, Mahdavi-mazdeh M, Sabaghian T. Clinical Practices and Therapeutic Management of Mineral and Bone Disorders in Chronic Kidney Disease 4, 5 and 5D: The OCEANOS Study in Iran. Nephro-Urol Mon 2017;10. [DOI: 10.5812/numonthly.61632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 349 |
Mori Y, Masuda T, Kosugi T, Yoshioka T, Hori M, Nagaya H, Maeda K, Sato Y, Kojima H, Kato N, Ishimoto T, Katsuno T, Yuzawa Y, Kadomatsu K, Maruyama S. The clinical relevance of plasma CD147/basigin in biopsy-proven kidney diseases. Clin Exp Nephrol 2018;22:815-24. [PMID: 29234893 DOI: 10.1007/s10157-017-1518-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 350 |
Waziri B, Duarte R, Dickens C, Dix Peek T, George J, Rekhviashvili V, Paget G, Naicker S. Racial Variations in the Markers of Mineral Bone Disorders in CKD Patients in South Africa. Kidney Int Rep 2018;3:583-91. [PMID: 29854965 DOI: 10.1016/j.ekir.2017.12.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 351 |
Pereira L, Meng C, Marques D, Frazão JM. Old and new calcimimetics for treatment of secondary hyperparathyroidism: impact on biochemical and relevant clinical outcomes. Clin Kidney J 2018;11:80-8. [PMID: 29423207 DOI: 10.1093/ckj/sfx125] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 352 |
Vorland CJ, Martin BR, Weaver CM, Peacock M, Hill Gallant KM. Phosphorus Balance in Adolescent Girls and the Effect of Supplemental Dietary Calcium. JBMR Plus 2018;2:103-8. [PMID: 29577111 DOI: 10.1002/jbm4.10026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 353 |
Zhu JG, Chen JB, Cheng BC, Lee CH, Long G, Chien YS. Association between Extreme Values of Markers of Chronic Kidney Disease: Mineral and Bone Disorder and 5-Year Mortality among Prevalent Hemodialysis Patients. Blood Purif 2018;45:1-7. [PMID: 29161692 DOI: 10.1159/000478972] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 354 |
David CN, Mello RB, Bruscato NM, Moriguchi EH. Overweight and Abdominal Obesity Association with All-Cause and Cardiovascular Mortality in the Elderly Aged 80 and Over: A Cohort Study. J Nutr Health Aging 2017;21:597-603. [PMID: 28448093 DOI: 10.1007/s12603-016-0812-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 355 |
Fukuoka K, Sato Y, Sakurai H, Kawashima S, Kaname S, Arimura Y. A Dialysis Patient With Hyperphosphatemia, Hyperkalemia, and Azotemia Without an Excessive Intake. Kidney Int Rep 2017;2:770-3. [PMID: 29142992 DOI: 10.1016/j.ekir.2017.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 356 |
El-Husseini A, Wang K, Edon A, Saxon D, Lima F, Sloan D, Sawaya BP. Value of Intraoperative Parathyroid Hormone Assay during Parathyroidectomy in Dialysis and Renal Transplant Patients with Secondary and Tertiary Hyperparathyroidism. Nephron 2018;138:119-28. [PMID: 29131092 DOI: 10.1159/000482016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 357 |
Apetrii M, Goldsmith D, Nistor I, Siriopol D, Voroneanu L, Scripcariu D, Vervloet M, Covic A. Impact of surgical parathyroidectomy on chronic kidney disease-mineral and bone disorder (CKD-MBD) - A systematic review and meta-analysis. PLoS One 2017;12:e0187025. [PMID: 29107998 DOI: 10.1371/journal.pone.0187025] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 358 |
Kim SM, Liu S, Long J, Montez-Rath ME, Leonard MB, Chertow GM. Declining Rates of Hip Fracture in End-Stage Renal Disease: Analysis From the 2003-2011 Nationwide Inpatient Sample. J Bone Miner Res 2017;32:2297-303. [PMID: 28639740 DOI: 10.1002/jbmr.3201] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 359 |
Yuan H, Shi Y, Li Y, Yang L, Tang Y, Hu Z, Du R, Li X, Gu L, Wang H, Xi C, Tang C. Evaluation of a TPTX model induced by ischemia. Exp Anim 2017;66:345-56. [PMID: 28674286 DOI: 10.1538/expanim.17-0029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 360 |
Lambert K, Mullan J, Mansfield K. An integrative review of the methodology and findings regarding dietary adherence in end stage kidney disease. BMC Nephrol 2017;18:318. [PMID: 29061163 DOI: 10.1186/s12882-017-0734-z] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 361 |
Wu MY, Chen YC, Lin CH, Wu YC, Tu YK, Tarng DC. Safety and efficacy of ferric citrate in phosphate reduction and iron supplementation in patients with chronic kidney disease. Oncotarget 2017;8:107283-94. [PMID: 29291028 DOI: 10.18632/oncotarget.21990] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 362 |
Jäger MD, Serttas M, Beneke J, Müller JA, Schrem H, Kaltenborn A, Ramackers W, Ringe BP, Gwiasda J, Tränkenschuh W, Klempnauer J, Scheumann GFW. Risk-factors for nodular hyperplasia of parathyroid glands in sHPT patients. PLoS One 2017;12:e0186093. [PMID: 29040300 DOI: 10.1371/journal.pone.0186093] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 363 |
Cozzolino M. CKD-MBD KDIGO guidelines: how difficult is reaching the 'target'? Clin Kidney J 2018;11:70-2. [PMID: 29423205 DOI: 10.1093/ckj/sfx116] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 364 |
Malluche HH, Monier-Faugere MC, Blomquist G, Davenport DL. Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors. Osteoporos Int 2018;29:125-34. [PMID: 28993865 DOI: 10.1007/s00198-017-4228-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 365 |
Delanaye P, Warling X, Moonen M, Smelten N, Jouret F, Krzesinski JM, Maillard N, Pottel H, Cavalier E. Variations of parathyroid hormone and bone biomarkers are concordant only after a long term follow-up in hemodialyzed patients. Sci Rep 2017;7:12623. [PMID: 28974744 DOI: 10.1038/s41598-017-12808-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 366 |
Molina P, Carrero JJ, Bover J, Chauveau P, Mazzaferro S, Torres PU; European Renal Nutrition (ERN) and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Working Groups of the European Renal Association-European Dialysis Transplant Association (ERA-EDTA). Vitamin D, a modulator of musculoskeletal health in chronic kidney disease. J Cachexia Sarcopenia Muscle 2017;8:686-701. [PMID: 28675610 DOI: 10.1002/jcsm.12218] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 367 |
Zhou S, Glowacki J. Chronic kidney disease and vitamin D metabolism in human bone marrow-derived MSCs. Ann N Y Acad Sci 2017;1402:43-55. [PMID: 28926112 DOI: 10.1111/nyas.13464] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 368 |
Ishigami J, Jaar BG, Rebholz CM, Grams ME, Michos ED, Wolf M, Kovesdy CP, Uchida S, Coresh J, Lutsey PL, Matsushita K. Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study. J Clin Endocrinol Metab 2017;102:4648-57. [PMID: 29029099 DOI: 10.1210/jc.2017-01868] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 369 |
Baker DE. Formulary Drug Review: Etelcalcetide. Hosp Pharm 2017;52:669-74. [PMID: 29276237 DOI: 10.1177/0018578717733478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 370 |
Fouque D, Roth H, Darné B, Jean-Bouchet L, Daugas E, Drüeke TB, Hannedouche T, Jean G, London GM; French Phosphorus and Calcium Observatory. Achievement of Kidney Disease: Improving Global Outcomes mineral and bone targets between 2010 and 2014 in incident dialysis patients in France: the Photo-Graphe3 study. Clin Kidney J 2018;11:73-9. [PMID: 29423206 DOI: 10.1093/ckj/sfx101] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 371 |
Jørgensen HS, Winther S, Bøttcher M, Hauge EM, Rejnmark L, Svensson M, Ivarsen P. Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study. BMC Nephrol 2017;18:284. [PMID: 28874132 DOI: 10.1186/s12882-017-0692-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 372 |
Zhuo L, Zhang N, Zou G, Chen D, Li W. Clinical characteristics and outcomes of biopsy-proven diabetic nephropathy. Front Med 2017;11:386-92. [PMID: 28871455 DOI: 10.1007/s11684-017-0574-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 373 |
Xie Y, Su P, Sun Y, Zhang H, Zhao R, Li L, Meng L. Comparative efficacy and safety of paricalcitol versus vitamin D receptor activators for dialysis patients with secondary hyperparathyroidism: a meta-analysis of randomized controlled trials. BMC Nephrol 2017;18:272. [PMID: 28841848 DOI: 10.1186/s12882-017-0691-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 374 |
Azpiazu D, González-Parra E, Ortiz A, Egido J, Villa-Bellosta R. Impact of post-dialysis calcium level on ex vivo rat aortic wall calcification. PLoS One 2017;12:e0183730. [PMID: 28832652 DOI: 10.1371/journal.pone.0183730] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 375 |
Lim CTS, Kalaiselvam T, Kitan N, Goh BL. Clinical course after parathyroidectomy in adults with end-stage renal disease on maintenance dialysis. Clin Kidney J 2018;11:265-9. [PMID: 29644069 DOI: 10.1093/ckj/sfx086] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 376 |
Song KK, Zhao DL, Wang YD, Wang Y, Sun XF, Miao LN, Ni ZH, Lin HL, Liu FY, Li Y, He YN, Wang NS, Wang CL, Zhang AH, Chen MH, Yang XP, Deng YY, Shao FM, Fu SX, Fang JA, Cai GY, Chen XM. Analysis of Factors Associated with Death in Maintenance Hemodialysis Patients: A Multicenter Study in China. Chin Med J (Engl) 2017;130:885-91. [PMID: 28397716 DOI: 10.4103/0366-6999.204103] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 377 |
Fung E, Chang TI, Chertow GM, Thomas IC, Asch SM, Kurella Tamura M. Receipt of Nephrology Care and Clinical Outcomes Among Veterans With Advanced CKD. Am J Kidney Dis 2017;70:705-14. [PMID: 28811048 DOI: 10.1053/j.ajkd.2017.06.025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 378 |
Larsson TE, Kameoka C, Nakajo I, Taniuchi Y, Yoshida S, Akizawa T, Smulders RA. NPT-IIb Inhibition Does Not Improve Hyperphosphatemia in CKD. Kidney Int Rep 2018;3:73-80. [PMID: 29340316 DOI: 10.1016/j.ekir.2017.08.003] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 379 |
Fukuma S, Ikenoue T, Akizawa T, Fukuhara S. Impact of nutritional index on the association between phosphorus concentrations and mortality in haemodialysis patients: a cohort study from dialysis outcomes and practice pattern study in Japan. BMJ Open 2017;7:e016682. [PMID: 28790041 DOI: 10.1136/bmjopen-2017-016682] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 380 |
Batacchi Z, Robinson-Cohen C, Hoofnagle AN, Isakova T, Kestenbaum B, Martin KJ, Wolf MS, de Boer IH. Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD. Clin J Am Soc Nephrol 2017;12:1498-506. [PMID: 28768705 DOI: 10.2215/CJN.00530117] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 381 |
Souberbielle J, Prié D, Piketty M, Rothenbuhler A, Delanaye P, Chanson P, Cavalier E. Evaluation of a New Fully Automated Assay for Plasma Intact FGF23. Calcif Tissue Int 2017;101:510-8. [DOI: 10.1007/s00223-017-0307-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 382 |
Murkamilov IT, Aitbaev KA, Fomin VV. [Gender features of cardiovascular events in patients with chronic glomerulonephritis at the pre-dialysis stage of the disease]. Ter Arkh 2017;89:56-61. [PMID: 28745690 DOI: 10.17116/terarkh201789656-61] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 383 |
Ma L, Zhao S, Li Z. Effects of parathyroidectomy on bone metabolism in haemodialysis patients with secondary hyperparathyroidism. Scand J Clin Lab Invest 2017;77:527-34. [PMID: 28741963 DOI: 10.1080/00365513.2017.1354256] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 384 |
Sekercioglu N, Curtis B, Murphy S, Blackhouse G, Barrett B. Estimates of health utility scores in chronic kidney disease. Int Urol Nephrol 2017;49:2043-9. [PMID: 28733768 DOI: 10.1007/s11255-017-1664-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 385 |
Watanabe K, Tominari T, Hirata M, Matsumoto C, Hirata J, Murphy G, Nagase H, Miyaura C, Inada M. Indoxyl sulfate, a uremic toxin in chronic kidney disease, suppresses both bone formation and bone resorption. FEBS Open Bio 2017;7:1178-85. [PMID: 28781957 DOI: 10.1002/2211-5463.12258] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 386 |
Giannini S, Mazzaferro S, Minisola S, De Nicola L, Rossini M, Cozzolino M. Raising awareness on the therapeutic role of cholecalciferol in CKD: a multidisciplinary-based opinion. Endocrine 2018;59:242-59. [PMID: 28726185 DOI: 10.1007/s12020-017-1369-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 387 |
Da Silva Martins J, Castro JH, Sainz Rueda NA, Dos Reis LM, Jorgetti V, Affonso Moysés RM, Caramori JT. Renal osteodystrophy in the obesity era: Is metabolic syndrome relevant? PLoS One 2017;12:e0180387. [PMID: 28719612 DOI: 10.1371/journal.pone.0180387] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 388 |
Komaba H, Wang M, Taniguchi M, Yamamoto S, Nomura T, Schaubel DE, Smith AR, Zee J, Karaboyas A, Bieber B, Fukagawa M, Tentori F. Initiation of Sevelamer and Mortality among Hemodialysis Patients Treated with Calcium-Based Phosphate Binders. Clin J Am Soc Nephrol 2017;12:1489-97. [PMID: 28724618 DOI: 10.2215/CJN.13091216] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 389 |
Yu MY, Lee SW, Baek SH, Na KY, Chae DW, Chin HJ, Kim S. Hypoalbuminemia at admission predicts the development of acute kidney injury in hospitalized patients: A retrospective cohort study. PLoS One 2017;12:e0180750. [PMID: 28723973 DOI: 10.1371/journal.pone.0180750] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 390 |
Locatelli F, Del Vecchio L. Iron-based phosphate binders: a paradigm shift in the treatment of hyperphosphatemic anemic CKD patients? J Nephrol 2017;30:755-65. [PMID: 28717990 DOI: 10.1007/s40620-017-0421-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 391 |
Elias RM, Moysés RMA. Elderly patients with chronic kidney disease have higher risk of hyperparathyroidism. Int Urol Nephrol 2017;49:1815-21. [PMID: 28695313 DOI: 10.1007/s11255-017-1650-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 392 |
Xi QP, Xie XS, Zhang L, Zhang R, Xiao YF, Jin CG, Li YB, Wang L, Zhang XX, Du ST. Impact of Different Levels of iPTH on All-Cause Mortality in Dialysis Patients with Secondary Hyperparathyroidism after Parathyroidectomy. Biomed Res Int 2017;2017:6934706. [PMID: 28656147 DOI: 10.1155/2017/6934706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 393 |
Yuan Q, Xiong QC, Gupta M, López-Pintor RM, Chen XL, Seriwatanachai D, Densmore M, Man Y, Gong P. Dental implant treatment for renal failure patients on dialysis: a clinical guideline. Int J Oral Sci 2017;9:125-32. [PMID: 28644432 DOI: 10.1038/ijos.2017.23] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 394 |
Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2011) 2017;7:1-59. [PMID: 30675420 DOI: 10.1016/j.kisu.2017.04.001] [Cited by in Crossref: 761] [Cited by in F6Publishing: 383] [Article Influence: 126.8] [Reference Citation Analysis]
|
| 395 |
Olivo RE, Scialla JJ. Getting Out of the Phosphate Bind: Trials to Guide Treatment Targets. Clin J Am Soc Nephrol 2017;12:868-70. [PMID: 28550079 DOI: 10.2215/CJN.04380417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 396 |
Aoun M, Makki M, Azar H, Matta H, Chelala DN. High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K2, A pre-post intervention clinical trial. BMC Nephrol 2017;18:191. [PMID: 28592319 DOI: 10.1186/s12882-017-0609-3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 397 |
Lazrak HH, René É, Elftouh N, Leblanc M, Lafrance JP. Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis. BMC Nephrol 2017;18:187. [PMID: 28592259 DOI: 10.1186/s12882-017-0596-4] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 398 |
Filler G, Kobrzynski M, Sidhu HK, Belostotsky V, Huang SS, McIntyre C, Yang L. A cross-sectional study measuring vanadium and chromium levels in paediatric patients with CKD. BMJ Open 2017;7:e014821. [PMID: 28592575 DOI: 10.1136/bmjopen-2016-014821] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 399 |
Jalalzadeh M, Mousavinasab SN, Rostami A. Relationship of circulating levels of 25(OH)D with parathyroid hormone in various stages of chronic kidney disease. J Renal Inj Prev 2017;6:264-268. [DOI: 10.15171/jrip.2017.50] [Reference Citation Analysis]
|
| 400 |
Buchebner D, Malmgren L, Christensson A, McGuigan F, Gerdhem P, Ridderstråle M, Åkesson K. Longitudinal Assessment of PTH in Community-Dwelling Older Women-Elevations Are Not Associated With Mortality. J Endocr Soc 2017;1:615-24. [PMID: 29264515 DOI: 10.1210/js.2017-00104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 401 |
Parra E, Arenas MD, Alonso M, Martínez MF, Gamen Á, Aguarón J, Escobar MT, Moreno-Jiménez JM, Alvarez-Ude F. Assessing value-based health care delivery for haemodialysis. J Eval Clin Pract 2017;23:477-85. [PMID: 26662940 DOI: 10.1111/jep.12483] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 402 |
Waziri B, Duarte R, Naicker S. Biochemical markers of mineral bone disorder in South African patients on maintenance haemodialysis. Afr Health Sci 2017;17:445-52. [PMID: 29062340 DOI: 10.4314/ahs.v17i2.19] [Reference Citation Analysis]
|
| 403 |
Yamamoto S, Fukagawa M. Uremic Toxicity and Bone in CKD. J Nephrol 2017;30:623-7. [PMID: 28573386 DOI: 10.1007/s40620-017-0406-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 404 |
Cozzolino M, Galassi A, Conte F, Mangano M, Di Lullo L, Bellasi A. Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide. Ther Clin Risk Manag 2017;13:679-89. [PMID: 28615947 DOI: 10.2147/TCRM.S108490] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 405 |
Carlson N, Mortensen OH, Axelsen M, Pedersen RS, Heaf JG. Clearance of Sclerostin, Osteocalcin, Fibroblast Growth Factor 23, and Osteoprotegerin by Dialysis. Blood Purif 2017;44:122-8. [PMID: 28554171 DOI: 10.1159/000465513] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 406 |
Wald R, Rabbat CG, Girard L, Garg AX, Tennankore K, Tyrwhitt J, Smyth A, Rathe-Skafel A, Gao P, Mazzetti A, Bosch J, Yan AT, Parfrey P, Manns BJ, Walsh M. Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial. Clin J Am Soc Nephrol 2017;12:965-73. [PMID: 28550080 DOI: 10.2215/CJN.10941016] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 407 |
Verhulst A, Neven E, D'Haese PC. Characterization of an Animal Model to Study Risk Factors and New Therapies for the Cardiorenal Syndrome, a Major Health Issue in Our Aging Population. Cardiorenal Med 2017;7:234-44. [PMID: 28736564 DOI: 10.1159/000462984] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 408 |
Jamme M, Raimbourg Q, Chauveau D, Seguin A, Presne C, Perez P, Gobert P, Wynckel A, Provôt F, Delmas Y, Mousson C, Servais A, Vrigneaud L, Veyradier A, Rondeau E, Coppo P; French Thrombotic Microangiopathies Reference Centre. Predictive features of chronic kidney disease in atypical haemolytic uremic syndrome. PLoS One 2017;12:e0177894. [PMID: 28542627 DOI: 10.1371/journal.pone.0177894] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 409 |
St-Jules DE, Goldfarb DS, Pompeii ML, Sevick MA. Phosphate Additive Avoidance in Chronic Kidney Disease. Diabetes Spectr 2017;30:101-6. [PMID: 28588376 DOI: 10.2337/ds16-0048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 410 |
Haarhaus M, Brandenburg V, Kalantar-Zadeh K, Stenvinkel P, Magnusson P. Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD. Nat Rev Nephrol 2017;13:429-42. [PMID: 28502983 DOI: 10.1038/nrneph.2017.60] [Cited by in Crossref: 147] [Cited by in F6Publishing: 153] [Article Influence: 24.5] [Reference Citation Analysis]
|
| 411 |
Vervloet MG, Brandenburg VM; CKD-MBD working group of ERA-EDTA. Circulating markers of bone turnover. J Nephrol 2017;30:663-70. [PMID: 28502032 DOI: 10.1007/s40620-017-0408-8] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 412 |
Demian MN, Lam NN, Mac-Way F, Sapir-Pichhadze R, Fernandez N. Opportunities for Engaging Patients in Kidney Research. Can J Kidney Health Dis 2017;4:2054358117703070. [PMID: 28491336 DOI: 10.1177/2054358117703070] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 413 |
Friedl C, Zitt E. Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. Int J Nephrol Renovasc Dis 2017;10:109-22. [PMID: 28546765 DOI: 10.2147/IJNRD.S97637] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 414 |
Gosmanova EO, Gosmanov AR. Osteoporosis in patients with diabetes after kidney transplantation. Rev Endocr Metab Disord 2017;18:97-106. [PMID: 27866309 DOI: 10.1007/s11154-016-9397-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 415 |
Wang M, Obi Y, Streja E, Rhee CM, Lau WL, Chen J, Hao C, Hamano T, Kovesdy CP, Kalantar-Zadeh K. Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function. Clin J Am Soc Nephrol 2017;12:1118-27. [PMID: 28487345 DOI: 10.2215/CJN.11931116] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 416 |
Hanudel MR, Froch L, Gales B, Jüppner H, Salusky IB. Fractures and Osteomalacia in a Patient Treated With Frequent Home Hemodialysis. Am J Kidney Dis 2017;70:445-8. [PMID: 28495360 DOI: 10.1053/j.ajkd.2017.03.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 417 |
Disthabanchong S, Boongird S. Role of different imaging modalities of vascular calcification in predicting outcomes in chronic kidney disease. World J Nephrol 2017; 6(3): 100-110 [PMID: 28540199 DOI: 10.5527/wjn.v6.i3.100] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 418 |
Filipov JJ, Zlatkov BK, Dimitrov EP. Vitamin D and Renal Disease. A Critical Evaluation of Vitamin D - Clinical Overview 2017. [DOI: 10.5772/64552] [Reference Citation Analysis]
|
| 419 |
Ronzani FAT, Kirchmaier FM, Monteze NM, Magacho EJC, Bastos MG, Fernandes NMDS. Routine mammography: an opportunity for the diagnosis of chronic degenerative diseases? A cross-sectional study. Radiol Bras 2017;50:82-9. [PMID: 28428650 DOI: 10.1590/0100-3984.2015.0173] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 420 |
Bover J, Bailone L, López-báez V, Benito S, Ciceri P, Galassi A, Cozzolino M. Osteoporosis, bone mineral density and CKD–MBD: treatment considerations. J Nephrol 2017;30:677-87. [DOI: 10.1007/s40620-017-0404-z] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 421 |
Patecki M, Lehmann G, Bräsen JH, Schmitz J, Bertram A, Berthold LD, Haller H, Gwinner W. A case report of severe calciphylaxis - suggested approach for diagnosis and treatment. BMC Nephrol 2017;18:137. [PMID: 28431568 DOI: 10.1186/s12882-017-0556-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 422 |
Salam SN, Khwaja A, Wilkie ME. Pharmacological Management of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease. Drugs 2016;76:841-52. [PMID: 27142279 DOI: 10.1007/s40265-016-0575-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 423 |
Zhang JJ, Yu GZ, Zheng ZH, Liu YF, Du YY, Quan SX, Liu YJ, Lv JC, Zhang H. Dividing CKD stage 3 into G3a and G3b could better predict the prognosis of IgA nephropathy. PLoS One. 2017;12:e0175828. [PMID: 28414748 DOI: 10.1371/journal.pone.0175828] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 424 |
Vetchinnikova ON. Kidney transplantation and bone disease: risk factors of development and diagnostics. RJTAO 2017;19:111-121. [DOI: 10.15825/1995-1191-2017-1-111-121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 425 |
Hiller RG, Patecki M, Neunaber C, Reifenrath J, Kielstein JT, Kielstein H. A comparative study of bone biopsies from the iliac crest, the tibial bone, and the lumbar spine. BMC Nephrol 2017;18:134. [PMID: 28407760 DOI: 10.1186/s12882-017-0550-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 426 |
Fukagawa M, Komaba H. Chronic Kidney Disease-Mineral and Bone Disorder in Asia. Kidney Dis (Basel) 2017;3:1-7. [PMID: 28785558 DOI: 10.1159/000470909] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 427 |
Yuste C, Mérida E, Hernández E, García-Santiago A, Rodríguez Y, Muñoz T, Gómez GJ, Sevillano Á, Praga M. Gastrointestinal complications induced by sevelamer crystals. Clin Kidney J 2017;10:539-44. [PMID: 28852493 DOI: 10.1093/ckj/sfx013] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 428 |
Cirillo C, Bilancio G, Natale F, Concilio C, Russo MG, Calabrò P, Cirillo M. Cardiovascular calcification and subcortical bone demineralization in hypertension. Hypertens Res 2017;40:825-30. [PMID: 28381870 DOI: 10.1038/hr.2017.44] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 429 |
Hernandes FR, Canziani ME, Barreto FC, Santos RO, Moreira VM, Rochitte CE, Carvalho AB. The shift from high to low turnover bone disease after parathyroidectomy is associated with the progression of vascular calcification in hemodialysis patients: A 12-month follow-up study. PLoS One 2017;12:e0174811. [PMID: 28384171 DOI: 10.1371/journal.pone.0174811] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 430 |
Torres PAU, Cohen-Solal M. Evaluation of fracture risk in chronic kidney disease. J Nephrol 2017;30:653-61. [PMID: 28386879 DOI: 10.1007/s40620-017-0398-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 431 |
Filipozzi P, Ayav C, Ngueyon Sime W, Laurain E, Kessler M, Brunaud L, Frimat L. Trajectories of CKD-MBD biochemical parameters over a 2-year period following diagnosis of secondary hyperparathyroidism: a pharmacoepidemiological study. BMJ Open 2017;7:e011482. [PMID: 28348181 DOI: 10.1136/bmjopen-2016-011482] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 432 |
Coco M, Pullman JM. Noninvasive Imaging of Bone Microarchitecture in Patients Receiving Renal Transplant: Can it Replace Histology? Clin J Am Soc Nephrol 2017;12:562-4. [PMID: 28348029 DOI: 10.2215/CJN.02210217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 433 |
van Ballegooijen AJ, Zelnick L, Hoofnagle AN, Hamburg NM, Robinson-Cohen C, Roy-Chaudhury P, Cheung AK, Shiu YT, de Boer IH, Himmelfarb J, Beck G, Imrey PB, Kusek JW, Kestenbaum B; Hemodialysis Fistula Maturation (HFM) Study Group. Association of Vitamin D Metabolites With Arterial Function in the Hemodialysis Fistula Maturation Study. Am J Kidney Dis 2017;69:805-14. [PMID: 28359657 DOI: 10.1053/j.ajkd.2017.01.049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 434 |
Jean G, Souberbielle JC, Chazot C. Vitamin D in Chronic Kidney Disease and Dialysis Patients. Nutrients 2017;9:E328. [PMID: 28346348 DOI: 10.3390/nu9040328] [Cited by in Crossref: 135] [Cited by in F6Publishing: 146] [Article Influence: 22.5] [Reference Citation Analysis]
|
| 435 |
Iwasaki Y, Kazama JJ, Fukagawa M. Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease. Biomed Res Int 2017;2017:3485785. [PMID: 28421193 DOI: 10.1155/2017/3485785] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 436 |
Raggi P, O'Neill WC. Imaging for Vascular Calcification. Semin Dial 2017;30:347-52. [PMID: 28332217 DOI: 10.1111/sdi.12596] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 437 |
Gielen E, Bergmann P, Bruyère O, Cavalier E, Delanaye P, Goemaere S, Kaufman JM, Locquet M, Reginster JY, Rozenberg S, Vandenbroucke AM, Body JJ. Osteoporosis in Frail Patients: A Consensus Paper of the Belgian Bone Club. Calcif Tissue Int 2017;101:111-31. [PMID: 28324124 DOI: 10.1007/s00223-017-0266-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 438 |
Perl J, Dember LM, Bargman JM, Browne T, Charytan DM, Flythe JE, Hickson LJ, Hung AM, Jadoul M, Lee TC, Meyer KB, Moradi H, Shafi T, Teitelbaum I, Wong LP, Chan CT; American Society of Nephrology Dialysis Advisory Group. The Use of a Multidimensional Measure of Dialysis Adequacy-Moving beyond Small Solute Kinetics. Clin J Am Soc Nephrol 2017;12:839-47. [PMID: 28314806 DOI: 10.2215/CJN.08460816] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 439 |
Chen H, Wang DG, Yuan L, Liu GL, He HJ, Wang J, Zhang S, Hao L. Clinical Characteristics of Patients with Diabetic Nephropathy on Maintenance Hemodialysis: A Multicenter Cross-sectional Survey in Anhui Province, Eastern China. Chin Med J (Engl) 2016;129:1291-7. [PMID: 27231165 DOI: 10.4103/0366-6999.182832] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 440 |
Yokoyama K, Kurita N, Fukuma S, Akizawa T, Fukagawa M, Onishi Y, Kurokawa K, Fukuhara S. Frequent monitoring of mineral metabolism in hemodialysis patients with secondary hyperparathyroidism: associations with achievement of treatment goals and with adjustments in therapy. Nephrol Dial Transplant 2017;32:534-41. [PMID: 26945054 DOI: 10.1093/ndt/gfw020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 441 |
Kwon YE, Lee MJ, Park KS, Han SH, Yoo TH, Oh KH, Lee J, Lee KB, Chung W, Kim YH, Ahn C, Choi KH. Cystatin C is Better than Serum Creatinine for Estimating Glomerular Filtration Rate to Detect Osteopenia in Chronic Kidney Disease Patients. Yonsei Med J 2017;58:380-7. [PMID: 28120569 DOI: 10.3349/ymj.2017.58.2.380] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 442 |
Obi Y, Nguyen DV, Streja E, Rivara MB, Rhee CM, Lau WL, Chen Y, Kovesdy CP, Mehrotra R, Kalantar-Zadeh K. Development and Validation of a Novel Laboratory-Specific Correction Equation for Total Serum Calcium and Its Association With Mortality Among Hemodialysis Patients. J Bone Miner Res 2017;32:549-59. [PMID: 27714897 DOI: 10.1002/jbmr.3013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 443 |
Sekercioglu N, Angeliki Veroniki A, Thabane L, Busse JW, Akhtar-Danesh N, Iorio A, Cruz Lopes L, Guyatt GH. Effects of different phosphate lowering strategies in patients with CKD on laboratory outcomes: A systematic review and NMA. PLoS One 2017;12:e0171028. [PMID: 28248961 DOI: 10.1371/journal.pone.0171028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 444 |
Zhang L, Yang S, Chen J, Ma J, Ren Y. Associations of parathyroid hormone levels and mineral parameters with heart rate variability in patients with end-stage renal disease. Int Urol Nephrol 2017;49:1079-85. [PMID: 28243964 DOI: 10.1007/s11255-017-1513-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 445 |
Liu CT, Lin YC, Lin YC, Kao CC, Chen HH, Hsu CC, Wu MS. Roles of Serum Calcium, Phosphorus, PTH and ALP on Mortality in Peritoneal Dialysis Patients: A Nationwide, Population-based Longitudinal Study Using TWRDS 2005-2012. Sci Rep 2017;7:33. [PMID: 28232731 DOI: 10.1038/s41598-017-00080-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 446 |
Gojaseni P, Pattarathitinan D, Chittinandana A. Efficacy of low-dose cinacalcet on alternate days for the treatment of secondary hyperparathyroidism in hemodialysis patients: a single-center study. Int J Nephrol Renovasc Dis 2017;10:47-53. [PMID: 28223837 DOI: 10.2147/IJNRD.S124844] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 447 |
Yokoyama K, Fukagawa M, Shigematsu T, Akiba T, Fujii A, Yamauchi A, Odani M, Akizawa T; ONO-5163 Study Group. A Single- and Multiple-Dose, Multicenter Study of Etelcalcetide in Japanese Hemodialysis Patients With Secondary Hyperparathyroidism. Kidney Int Rep 2017;2:634-44. [PMID: 29142982 DOI: 10.1016/j.ekir.2017.01.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 448 |
Sun YP, Yang WJ, Li SH, Han YY, Liu J. Clinical Epidemiology of Mineral Bone Disorder Markers in Prevalent Hemodialysis Patients in the Xinjiang Uyghur Autonomous Region in China. Biomed Res Int 2017;2017:2516934. [PMID: 28299319 DOI: 10.1155/2017/2516934] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 449 |
Imtiaz R, Hawken S, McCormick BB, Leung S, Hiremath S, Zimmerman DL. Diabetes Mellitus and Younger Age Are Risk Factors for Hyperphosphatemia in Peritoneal Dialysis Patients. Nutrients 2017;9:E152. [PMID: 28218647 DOI: 10.3390/nu9020152] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 450 |
Bielesz B, Patsch JM, Fischer L, Bojic M, Winnicki W, Weber M, Cejka D. Cortical porosity not superior to conventional densitometry in identifying hemodialysis patients with fragility fracture. PLoS One 2017;12:e0171873. [PMID: 28199411 DOI: 10.1371/journal.pone.0171873] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 451 |
Wilson RJ, Copley JB. Elemental calcium intake associated with calcium acetate/calcium carbonate in the treatment of hyperphosphatemia. Drugs Context 2017;6:212302. [PMID: 28182142 DOI: 10.7573/dic.212302] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 452 |
Moldovan D, Rusu C, Potra A, Moldovan I, Patiu IM, Gherman-Caprioara M, Kacso IM. Osteoprotegerin and uremic osteoporosis in chronic hemodialysis patients. Int Urol Nephrol 2017;49:895-901. [PMID: 28161839 DOI: 10.1007/s11255-017-1529-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 453 |
Block GA, Rosenbaum DP, Leonsson-Zachrisson M, Åstrand M, Johansson S, Knutsson M, Langkilde AM, Chertow GM. Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis. J Am Soc Nephrol 2017;28:1933-42. [PMID: 28159782 DOI: 10.1681/ASN.2016080855] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 454 |
Jeong S, Oh JM, Oh KH, Kim IW. Differentially expressed miR-3680-5p is associated with parathyroid hormone regulation in peritoneal dialysis patients. PLoS One 2017;12:e0170535. [PMID: 28152049 DOI: 10.1371/journal.pone.0170535] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 455 |
Kim CS, Bae EH, Ma SK, Han SH, Lee KB, Lee J, Oh KH, Chae DW, Kim SW; KNOW-CKD Study Group. Chronic Kidney Disease-Mineral Bone Disorder in Korean Patients: a Report from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD). J Korean Med Sci 2017;32:240-8. [PMID: 28049234 DOI: 10.3346/jkms.2017.32.2.240] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 456 |
Chan S, Au K, Francis RS, Mudge DW, Johnson DW, Pillans PI. Phosphate binders in patients with chronic kidney disease. Aust Prescr 2017;40:10-4. [PMID: 28246429 DOI: 10.18773/austprescr.2017.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 457 |
Obi Y, Hamano T, Wada A, Tsubakihara Y; Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy. Vitamin D Receptor Activator Use and Cause-specific Death among dialysis Patients: a Nationwide Cohort Study using Coarsened Exact Matching. Sci Rep 2017;7:41170. [PMID: 28139665 DOI: 10.1038/srep41170] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 458 |
Jankovic A, Damjanovic T, Djuric Z, Marinkovic J, Schlieper G, Djuric P, Dragovic JT, Bulatovic A, Mitrovic M, Popovic J, Floege J, Dimkovic N. Calcification in arteriovenous fistula blood vessels may predict arteriovenous fistula failure: a 5-year follow-up study. Int Urol Nephrol 2017;49:881-7. [PMID: 28124305 DOI: 10.1007/s11255-017-1515-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 459 |
Torremadé N, Bozic M, Goltzman D, Fernandez E, Valdivielso JM. Effects of the Administration of 25(OH) Vitamin D3 in an Experimental Model of Chronic Kidney Disease in Animals Null for 1-Alpha-Hydroxylase. PLoS One 2017;12:e0170654. [PMID: 28107527 DOI: 10.1371/journal.pone.0170654] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 460 |
de Waha S, Graf T, Desch S, Fuernau G, Eitel I, Pöss J, Jobs A, Stiermaier T, Ledwoch J, Wiedau A, Lurz P, Schuler G, Thiele H. Outcome of elderly undergoing extracorporeal life support in refractory cardiogenic shock. Clin Res Cardiol 2017;106:379-85. [DOI: 10.1007/s00392-016-1068-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 461 |
Susantitaphong P, Nakwan S, Peerapornratana S, Tiranathanagul K, Katavetin P, Srisawat N, Praditpornsilpa K, Eiam-Ong S. A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria. BMC Nephrol 2017;18:19. [PMID: 28088187 DOI: 10.1186/s12882-017-0436-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 462 |
Fukagawa M, Inaba M, Yokoyama K, Shigematsu T, Ando R, Miyamoto KI; For Japan CKD-MBD Forum. An introduction to CKD-MBD research: restart for the future. Clin Exp Nephrol 2017;21:1-3. [PMID: 28083765 DOI: 10.1007/s10157-016-1372-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 463 |
Pronai W, Rosenkranz AR, Bock A, Klauser-Braun R, Jäger C, Pendl G, Hemetsberger M, Lhotta K. Management of secondary hyperparathyroidism: practice patterns and outcomes of cinacalcet treatment with or without active vitamin D in Austria and Switzerland - the observational TRANSIT Study. Wien Klin Wochenschr 2017;129:317-28. [PMID: 28091752 DOI: 10.1007/s00508-016-1153-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 464 |
Fishbane S, Block GA, Loram L, Neylan J, Pergola PE, Uhlig K, Chertow GM. Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia. J Am Soc Nephrol 2017;28:1851-8. [PMID: 28082519 DOI: 10.1681/ASN.2016101053] [Cited by in Crossref: 77] [Cited by in F6Publishing: 76] [Article Influence: 12.8] [Reference Citation Analysis]
|
| 465 |
Waziri B, Duarte R, Naicker S. High Serum Alkaline Phosphatase, Hypercalcaemia, Race, and Mortality in South African Maintenance Haemodialysis Patients. Int J Nephrol 2017;2017:2795432. [PMID: 28168054 DOI: 10.1155/2017/2795432] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 466 |
Ho LY, Wong PN, Sin HK, Wong YY, Lo KC, Chan SF, Lo MW, Lo KY, Mak SK, Wong AK. Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism. BMC Nephrol 2017;18:12. [PMID: 28073343 DOI: 10.1186/s12882-016-0421-5] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 467 |
Wetmore JB, Kimber C, Mahnken JD, Stubbs JR. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial. Br J Nutr 2016;116:2074-81. [PMID: 28065190 DOI: 10.1017/S000711451600427X] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 468 |
Komaba H, Kakuta T, Fukagawa M. Management of secondary hyperparathyroidism: how and why? Clin Exp Nephrol 2017;21:37-45. [PMID: 28044233 DOI: 10.1007/s10157-016-1369-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 469 |
Oleson CV. Osteoporosis in Cardiopulmonary, Kidney and Liver Disorders. Osteoporosis Rehabilitation 2017. [DOI: 10.1007/978-3-319-45084-1_14] [Reference Citation Analysis]
|
| 470 |
Choksi P, Lawson BR. Secondary Hyperparathyroidism. Medical and Surgical Treatment of Parathyroid Diseases 2017. [DOI: 10.1007/978-3-319-26794-4_7] [Reference Citation Analysis]
|
| 471 |
Brodmann D. Diagnostik und Therapie. Einführung in die Nephrologie und Nierenersatzverfahren 2017. [DOI: 10.1007/978-3-662-54583-6_3] [Reference Citation Analysis]
|
| 472 |
McHorney CA, Bensink ME, Burke LB, Belozeroff V, Gwaltney C. Development and psychometric validation of the Nausea/Vomiting Symptom Assessment patient-reported outcome (PRO) instrument for adults with secondary hyperparathyroidism. J Patient Rep Outcomes 2017;2:6. [PMID: 29757328 DOI: 10.1186/s41687-018-0029-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 473 |
LaRosa DA, Ellery SJ, Walker DW, Dickinson H. Understanding the Full Spectrum of Organ Injury Following Intrapartum Asphyxia. Front Pediatr 2017;5:16. [PMID: 28261573 DOI: 10.3389/fped.2017.00016] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 474 |
Webb NJA, Lerner G, Warady BA, Dell KM, Greenbaum LA, Ariceta G, Hoppe B, Linde P, Lee HJ, Eldred A, Dufek MB. Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease. Pediatr Nephrol 2017;32:1221-32. [PMID: 28332096 DOI: 10.1007/s00467-017-3579-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 475 |
Khan A, Chen T, Khan A, Chan E, Byth K, Tan J, Harris D. Lanthanum carbonate for dialysis patients with hyperphosphataemia resistant to sevelamer: A retrospective cohort study. Cogent Medicine 2016;3:1262095. [DOI: 10.1080/2331205x.2016.1262095] [Reference Citation Analysis]
|
| 476 |
Gubensek J, Orsag A, Ponikvar R, Buturovic-Ponikvar J. Calcium Mass Balance during Citrate Hemodialysis: A Randomized Controlled Trial Comparing Normal and Low Ionized Calcium Target Ranges. PLoS One 2016;11:e0168593. [PMID: 28030601 DOI: 10.1371/journal.pone.0168593] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 477 |
Salomo L, Kamper AL, Poulsen GM, Poulsen SK, Astrup A, Rix M. Habitual dietary phosphorus intake and urinary excretion in chronic kidney disease patients: a 3-day observational study. Eur J Clin Nutr 2017;71:798-800. [PMID: 27966564 DOI: 10.1038/ejcn.2016.247] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 478 |
Pasch A, Block GA, Bachtler M, Smith ER, Jahnen-Dechent W, Arampatzis S, Chertow GM, Parfrey P, Ma X, Floege J. Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial. Clin J Am Soc Nephrol 2017;12:315-22. [PMID: 27940458 DOI: 10.2215/CJN.04720416] [Cited by in Crossref: 97] [Cited by in F6Publishing: 98] [Article Influence: 13.9] [Reference Citation Analysis]
|
| 479 |
Greenblatt MB, Tsai JN, Wein MN. Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease. Clin Chem 2017;63:464-74. [PMID: 27940448 DOI: 10.1373/clinchem.2016.259085] [Cited by in Crossref: 134] [Cited by in F6Publishing: 139] [Article Influence: 19.1] [Reference Citation Analysis]
|
| 480 |
Kültür T, Çifci A, İnanır A. Bone-minerale metabolism disorders (renal osteodystrophy) in chronic kidney disease and treatment approach. Ortadogu Tıp Derg 2016;8:214-217. [DOI: 10.21601/ortadogutipdergisi.272239] [Reference Citation Analysis]
|
| 481 |
Wetmore JB, Liu J, Dluzniewski PJ, Ishani A, Block GA, Collins AJ. Geographic variation of parathyroidectomy in patients receiving hemodialysis: a retrospective cohort analysis. BMC Surg 2016;16:77. [PMID: 27899108 DOI: 10.1186/s12893-016-0193-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 482 |
Taketani Y, Koiwa F, Yokoyama K. Management of phosphorus load in CKD patients. Clin Exp Nephrol 2017;21:27-36. [PMID: 27896453 DOI: 10.1007/s10157-016-1360-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 483 |
Liu Y, Lee WC, Cheng BC, Li LC, Lee CH, Chang WX, Chen JB. Association between the Achievement of Target Range CKD-MBD Markers and Mortality in Prevalent Hemodialysis Patients in Taiwan by Using the Kidney Disease: Improving Global Outcomes Clinical Guidelines. Biomed Res Int 2016;2016:1523124. [PMID: 28003998 DOI: 10.1155/2016/1523124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 484 |
Sato M, Ye W, Sugihara T, Isaka Y. Fracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database. BMC Musculoskelet Disord 2016;17:489. [PMID: 27887655 DOI: 10.1186/s12891-016-1344-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 485 |
Vervloet MG, Sezer S, Massy ZA, Johansson L, Cozzolino M, Fouque D; ERA–EDTA Working Group on Chronic Kidney Disease–Mineral and Bone Disorders and the European Renal Nutrition Working Group. The role of phosphate in kidney disease. Nat Rev Nephrol 2017;13:27-38. [PMID: 27867189 DOI: 10.1038/nrneph.2016.164] [Cited by in Crossref: 121] [Cited by in F6Publishing: 122] [Article Influence: 17.3] [Reference Citation Analysis]
|
| 486 |
Kim CS, Bae EH, Ma SK, Han SH, Choi KH, Lee J, Chae DW, Oh KH, Ahn C, Kim SW; Representatives of the KNOW-CKD Investigator Group. Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study. PLoS One 2016;11:e0166792. [PMID: 27855207 DOI: 10.1371/journal.pone.0166792] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 487 |
Diao Z, Wang L, Li D, Liu W. Efficacy of microwave ablation for severe secondary hyperparathyroidism in subjects undergoing hemodialysis. Ren Fail 2017;39:140-5. [PMID: 27845598 DOI: 10.1080/0886022X.2016.1256307] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 488 |
Yamada S, Giachelli CM. Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho. Bone 2017;100:87-93. [PMID: 27847254 DOI: 10.1016/j.bone.2016.11.012] [Cited by in Crossref: 151] [Cited by in F6Publishing: 134] [Article Influence: 21.6] [Reference Citation Analysis]
|
| 489 |
Fuller DS, Robinson BM. Facility Practice Variation to Help Understand the Effects of Public Policy: Insights from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2017;12:190-9. [PMID: 28062678 DOI: 10.2215/CJN.03930416] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 490 |
Carvalho C, Magalhães J, Neto R, Pereira L, Branco P, Adragão T, Frazão JM. Cortical bone analysis in a predialysis population: a comparison with a dialysis population. J Bone Miner Metab 2017;35:513-21. [PMID: 27830383 DOI: 10.1007/s00774-016-0781-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 491 |
Rauscher S, Lafrance J, Pichette V, Bell RZ, Desforges K, Lepage L, Ouellet G, Ouimet D, Leblanc M, Lamarche C, Bezzaoucha S, Vallee M. Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients. Int Urol Nephrol 2017;49:325-8. [DOI: 10.1007/s11255-016-1446-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 492 |
Block GA, Yusuf AA, Danese MD, Wirtz HS, Hu Y, Do TP, Cooper K, Gilbertson DT, Bradbury BD, Collins AJ. Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis. BMC Nephrol 2016;17:166. [PMID: 27814753 DOI: 10.1186/s12882-016-0382-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 493 |
Sekercioglu N, Al-Khalifah R, Ewusie JE, Elias RM, Thabane L, Busse JW, Akhtar-Danesh N, Iorio A, Isayama T, Martínez JP, Florez ID, Guyatt GH. A critical appraisal of chronic kidney disease mineral and bone disorders clinical practice guidelines using the AGREE II instrument. Int Urol Nephrol 2017;49:273-84. [PMID: 27804080 DOI: 10.1007/s11255-016-1436-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 494 |
St-Jules DE, Jagannathan R, Gutekunst L, Kalantar-Zadeh K, Sevick MA. Examining the Proportion of Dietary Phosphorus From Plants, Animals, and Food Additives Excreted in Urine. J Ren Nutr 2017;27:78-83. [PMID: 27810171 DOI: 10.1053/j.jrn.2016.09.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 495 |
Johansson S, Leonsson-Zachrisson M, Knutsson M, Spencer AG, Labonté ED, Deshpande D, Kohler J, Kozuka K, Charmot D, Rosenbaum DP. Preclinical and Healthy Volunteer Studies of Potential Drug-Drug Interactions Between Tenapanor and Phosphate Binders. Clin Pharmacol Drug Dev 2017;6:448-56. [PMID: 27654985 DOI: 10.1002/cpdd.307] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 496 |
Moe SM, Nickolas TL. Fractures in Patients with CKD: Time for Action. Clin J Am Soc Nephrol 2016;11:1929-31. [PMID: 27797903 DOI: 10.2215/CJN.09500916] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 497 |
Naylor KL, Prior J, Garg AX, Berger C, Langsetmo L, Adachi JD, Goltzman D, Kovacs CS, Josse RG, Leslie WD. Trabecular Bone Score and Incident Fragility Fracture Risk in Adults with Reduced Kidney Function. Clin J Am Soc Nephrol 2016;11:2032-40. [PMID: 27797885 DOI: 10.2215/CJN.00720116] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 498 |
Shah BV, Patel ZM. Role of low protein diet in management of different stages of chronic kidney disease - practical aspects. BMC Nephrol 2016;17:156. [PMID: 27769183 DOI: 10.1186/s12882-016-0360-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 499 |
Ruiz-Andres O, Sanchez-Niño MD, Moreno JA, Ruiz-Ortega M, Ramos AM, Sanz AB, Ortiz A. Downregulation of kidney protective factors by inflammation: role of transcription factors and epigenetic mechanisms. Am J Physiol Renal Physiol 2016;311:F1329-40. [PMID: 27760772 DOI: 10.1152/ajprenal.00487.2016] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 500 |
Jean G, Souberbielle JC, Zaoui E, Lorriaux C, Hurot JM, Mayor B, Deleaval P, Mehdi M, Chazot C. Analysis of the kinetics of the parathyroid hormone, and of associated patient outcomes, in a cohort of haemodialysis patients. BMC Nephrol 2016;17:153. [PMID: 27756251 DOI: 10.1186/s12882-016-0365-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 501 |
Grzegorzewska AE, Paciorkowski M, Mostowska A, Frycz B, Warchoł W, Stolarek I, Figlerowicz M, Jagodziński PP. Associations of the calcium-sensing receptor gene CASR rs7652589 SNP with nephrolithiasis and secondary hyperparathyroidism in haemodialysis patients. Sci Rep 2016;6:35188. [PMID: 27739473 DOI: 10.1038/srep35188] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 502 |
Sturgeon CM, Sprague S, Almond A, Cavalier E, Fraser WD, Algeciras-Schimnich A, Singh R, Souberbielle JC, Vesper HW; IFCC Working Group for PTH. Perspective and priorities for improvement of parathyroid hormone (PTH) measurement - A view from the IFCC Working Group for PTH. Clin Chim Acta 2017;467:42-7. [PMID: 27746210 DOI: 10.1016/j.cca.2016.10.016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 503 |
Clarke BL, Vokes TJ, Bilezikian JP, Shoback DM, Lagast H, Mannstadt M. Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study. Endocrine 2017;55:273-82. [PMID: 27734257 DOI: 10.1007/s12020-016-1141-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 504 |
Agarwal G, Hirachan P, Gelfond J, Fanti P, Hura C, Bansal S. Ergocalciferol treatment does Not improve erythropoietin utilization and hospitalization rate in hemodialysis patients. BMC Nephrol 2016;17:144. [PMID: 27717322 DOI: 10.1186/s12882-016-0359-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 505 |
Pawlak D, Oksztulska-Kolanek E, Znorko B, Domaniewski T, Rogalska J, Roszczenko A, Brzóska MM, Pryczynicz A, Kemona A, Pawlak K. The Association between Elevated Levels of Peripheral Serotonin and Its Metabolite - 5-Hydroxyindoleacetic Acid and Bone Strength and Metabolism in Growing Rats with Mild Experimental Chronic Kidney Disease. PLoS One 2016;11:e0163526. [PMID: 27711209 DOI: 10.1371/journal.pone.0163526] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 506 |
Zhou C, Wang F, Wang JW, Zhang LX, Zhao MH. Mineral and Bone Disorder and Its Association with Cardiovascular Parameters in Chinese Patients with Chronic Kidney Disease. Chin Med J (Engl) 2016;129:2275-80. [PMID: 27647184 DOI: 10.4103/0366-6999.190678] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 507 |
Hajizadeh N, Mehrkash M, Fahimi D, Qorbani M, Shafa N. Association of bone mineral density with biochemical markers of bone turnover in hemodialysis children. J Renal Inj Prev 2016;5:174-8. [PMID: 27689118 DOI: 10.15171/jrip.2016.37] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 508 |
Heaf JG. Chronic Kidney Disease-Mineral Bone Disorder in the Elderly Peritoneal Dialysis Patient. Perit Dial Int 2015;35:640-4. [PMID: 26702005 DOI: 10.3747/pdi.2014.00339] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 509 |
Mann MC, Exner DV, Hemmelgarn BR, Hanley DA, Turin TC, MacRae JM, Wheeler DC, Sola DY, Ramesh S, Ahmed SB. The VITAH Trial-Vitamin D Supplementation and Cardiac Autonomic Tone in Patients with End-Stage Kidney Disease on Hemodialysis: A Blinded, Randomized Controlled Trial. Nutrients 2016;8:E608. [PMID: 27690095 DOI: 10.3390/nu8100608] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 510 |
Jokihaara J, Pörsti IH, Sievänen H, Kööbi P, Kannus P, Niemelä O, Turner RT, Iwaniec UT, Järvinen TL. Phosphate Binding with Sevelamer Preserves Mechanical Competence of Bone Despite Acidosis in Advanced Experimental Renal Insufficiency. PLoS One 2016;11:e0163022. [PMID: 27658028 DOI: 10.1371/journal.pone.0163022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 511 |
Sugatani T, Agapova OA, Fang Y, Berman AG, Wallace JM, Malluche HH, Faugere MC, Smith W, Sung V, Hruska KA. Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease. Kidney Int 2017;91:86-95. [PMID: 27666759 DOI: 10.1016/j.kint.2016.07.039] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 512 |
Soussi S, Deniau B, Ferry A, Levé C, Benyamina M, Maurel V, Chaussard M, Le Cam B, Blet A, Mimoun M, Lambert J, Chaouat M, Mebazaa A, Legrand M; PRONOBURN group. Low cardiac index and stroke volume on admission are associated with poor outcome in critically ill burn patients: a retrospective cohort study. Ann Intensive Care 2016;6:87. [PMID: 27620877 DOI: 10.1186/s13613-016-0192-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 513 |
Biyik Z, Selcuk NY, Tonbul HZ, Anil M, Uyar M. Assessment of abdominal aortic calcification at different stages of chronic kidney disease. Int Urol Nephrol. 2016;48:2061-2068. [PMID: 27620901 DOI: 10.1007/s11255-016-1413-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 514 |
Molina P, Górriz JL, Molina MD, Beltrán S, Vizcaíno B, Escudero V, Kanter J, Ávila AI, Bover J, Fernández E, Nieto J, Cigarrán S, Gruss E, Fernández-Juárez G, Martínez-Castelao A, Navarro-González JF, Romero R, Pallardó LM. What is the optimal level of vitamin D in non-dialysis chronic kidney disease population? World J Nephrol 2016; 5(5): 471-481 [PMID: 27648411 DOI: 10.5527/wjn.v5.i5.471] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 515 |
Sharaf El Din UAA, Salem MM, Abdulazim DO. Vascular calcification: When should we interfere in chronic kidney disease patients and how? World J Nephrol 2016; 5(5): 398-417 [PMID: 27648404 DOI: 10.5527/wjn.v5.i5.398] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 516 |
Pérez-Ricart A, Galicia-Basart M, Alcalde-Rodrigo M, Segarra-Medrano A, Suñé-Negre JM, Montoro-Ronsano JB. Effectiveness of Cinacalcet in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Not Receiving Dialysis. PLoS One 2016;11:e0161527. [PMID: 27588942 DOI: 10.1371/journal.pone.0161527] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 517 |
Melek E, Aynacı S, Atmış B, Yöntem A, Uğuz A, Bayazıt AK. A rare manifestation of renal osteodystrophy in a non-compliant child on hemodialysis: Answers. Pediatr Nephrol 2016;31:1451-3. [PMID: 25966786 DOI: 10.1007/s00467-015-3124-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 518 |
Blomquist GA, Davenport DL, Mawad HW, Monier-Faugere MC, Malluche HH. Diagnosis of low bone mass in CKD-5D patients. Clin Nephrol 2016;85:77-83. [PMID: 26587778 DOI: 10.5414/CN108708] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 519 |
Bacchetta J, Greco M, Bertholet-Thomas A, Nobili F, Zustin J, Cochat P, Emma F, Boivin G. Skeletal implications and management of cystinosis: three case reports and literature review. Bonekey Rep 2016;5:828. [PMID: 27579165 DOI: 10.1038/bonekey.2016.55] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 520 |
Zahed NS, Zamanifar N, Nikbakht H. Effect of low dose nicotinic acid on hyperphosphatemia in patients with end stage renal disease. Indian J Nephrol 2016;26:239-43. [PMID: 27512294 DOI: 10.4103/0971-4065.161020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 521 |
Carvalho C, Alves CM, Frazão JM. The role of bone biopsy for the diagnosis of renal osteodystrophy: a short overview and future perspectives. J Nephrol 2016;29:617-26. [PMID: 27473148 DOI: 10.1007/s40620-016-0339-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 522 |
van der Plas WY, Engelsman AF, Özyilmaz A, van der Horst-Schrivers AN, Meijer K, van Dam GM, Pol RA, de Borst MH, Kruijff S. Impact of the Introduction of Calcimimetics on Timing of Parathyroidectomy in Secondary and Tertiary Hyperparathyroidism. Ann Surg Oncol 2017;24:15-22. [PMID: 27459979 DOI: 10.1245/s10434-016-5450-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 523 |
Wei Y, Lin J, Yang F, Li X, Hou Y, Lu R, Shi X, Liu Z, Du Y. Risk factors associated with secondary hyperparathyroidism in patients with chronic kidney disease. Exp Ther Med 2016;12:1206-12. [PMID: 27446345 DOI: 10.3892/etm.2016.3438] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 524 |
Yuen NK, Ananthakrishnan S, Campbell MJ. Hyperparathyroidism of Renal Disease. Perm J 2016;20:15-127. [PMID: 27479950 DOI: 10.7812/TPP/15-127] [Cited by in Crossref: 28] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 525 |
Mitch WE, Remuzzi G. Diets for patients with chronic kidney disease, should we reconsider? BMC Nephrol 2016;17:80. [PMID: 27401192 DOI: 10.1186/s12882-016-0283-x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 526 |
Wani MM, Khan I, Bhat RA, Ahmad M. Fabry's Disease: Case Series and Review of Literature. Ann Med Health Sci Res 2016;6:193-7. [PMID: 27398254 DOI: 10.4103/2141-9248.183935] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 527 |
Bellizzi V, Cupisti A, Locatelli F, Bolasco P, Brunori G, Cancarini G, Caria S, De Nicola L, Di Iorio BR, Di Micco L, Fiaccadori E, Garibotto G, Mandreoli M, Minutolo R, Oldrizzi L, Piccoli GB, Quintaliani G, Santoro D, Torraca S, Viola BF; “Conservative Treatment of CKD” study group of the Italian Society of Nephrology. Low-protein diets for chronic kidney disease patients: the Italian experience. BMC Nephrol 2016;17:77. [PMID: 27401096 DOI: 10.1186/s12882-016-0280-0] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 528 |
Rizk R. Cost-effectiveness of phosphate binders among patients with chronic kidney disease not yet on dialysis: a long way to go. BMC Nephrol 2016;17:75. [PMID: 27393192 DOI: 10.1186/s12882-016-0286-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 529 |
Koiwa F, Terao A. Dose-response efficacy and safety of PA21 in Japanese hemodialysis patients with hyperphosphatemia: a randomized, placebo-controlled, double-blind, Phase II study. Clin Exp Nephrol 2017;21:513-22. [PMID: 27389681 DOI: 10.1007/s10157-016-1299-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 530 |
Seifert ME, Hruska KA. The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone Disorder. Transplantation 2016;100:497-505. [PMID: 26356179 DOI: 10.1097/TP.0000000000000903] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 531 |
Robinson-Cohen C, Katz R, Price BL, Harju-Baker S, Mikacenic C, Himmelfarb J, Liles WC, Wurfel MM. Association of markers of endothelial dysregulation Ang1 and Ang2 with acute kidney injury in critically ill patients. Crit Care 2016;20:207. [PMID: 27372077 DOI: 10.1186/s13054-016-1385-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 532 |
Johansson S, Rosenbaum DP, Knutsson M, Leonsson-Zachrisson M. A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers. Clin Exp Nephrol 2017;21:407-16. [PMID: 27368672 DOI: 10.1007/s10157-016-1302-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 533 |
Melamed ML, Buttar RS, Coco M. CKD-Mineral Bone Disorder in Stage 4 and 5 CKD: What We Know Today? Adv Chronic Kidney Dis 2016;23:262-9. [PMID: 27324680 DOI: 10.1053/j.ackd.2016.03.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 534 |
Vikrant S, Parashar A. Prevalence and severity of disordered mineral metabolism in patients with chronic kidney disease: A study from a tertiary care hospital in India. Indian J Endocrinol Metab 2016;20:460-7. [PMID: 27366711 DOI: 10.4103/2230-8210.183457] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 535 |
Kasiske BL, Kumar R, Kimmel PL, Pesavento TE, Kalil RS, Kraus ES, Rabb H, Posselt AM, Anderson-Haag TL, Steffes MW, Israni AK, Snyder JJ, Singh RJ, Weir MR. Abnormalities in biomarkers of mineral and bone metabolism in kidney donors. Kidney Int 2016;90:861-8. [PMID: 27370408 DOI: 10.1016/j.kint.2016.05.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 536 |
Arai Y, Kanda E, Iimori S, Naito S, Noda Y, Kawasaki T, Sato H, Ando R, Sasaki S, Sohara E, Okado T, Rai T, Uchida S. The use of vitamin D analogs is independently associated with the favorable renal prognosis in chronic kidney disease stages 4-5: the CKD-ROUTE study. Clin Exp Nephrol 2017;21:481-7. [PMID: 27344335 DOI: 10.1007/s10157-016-1300-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 537 |
Naylor KL, Zou G, Leslie WD, Hodsman AB, Lam NN, McArthur E, Fraser LA, Knoll GA, Adachi JD, Kim SJ, Garg AX. Risk factors for fracture in adult kidney transplant recipients. World J Transplant 2016; 6(2): 370-379 [PMID: 27358782 DOI: 10.5500/wjt.v6.i2.370] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 538 |
Wee HL, Seng BJ, Lee JJ, Chong KJ, Tyagi P, Vathsala A, How P. Association of anemia and mineral and bone disorder with health-related quality of life in Asian pre-dialysis patients. Health Qual Life Outcomes 2016;14:94. [PMID: 27342630 DOI: 10.1186/s12955-016-0477-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 539 |
Jiang Y, Zhang J, Yuan Y, Zha X, Xing C, Shen C, Shen Z, Qin C, Zeng M, Yang G, Mao H, Zhang B, Yu X, Sun B, Ouyang C, Xu X, Ge Y, Wang J, Zhang L, Cheng C, Yin C, Zhang J, Chen H, Ma H, Wang N. Association of Increased Serum Leptin with Ameliorated Anemia and Malnutrition in Stage 5 Chronic Kidney Disease Patients after Parathyroidectomy. Sci Rep 2016;6:27918. [PMID: 27307101 DOI: 10.1038/srep27918] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 540 |
Robison R, Cooney D, Low MB, Desai N. Sevelamer Carbonate and Lanthanum Usage Evaluation and Cost Considerations at a Veteran's Affairs Medical Center. Hosp Pharm 2016;51:312-9. [PMID: 27303079 DOI: 10.1310/hpj5104-312] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 541 |
Wetmore JB, Liu J, Wirtz HS, Gilbertson DT, Cooper K, Nieman KM, Collins AJ, Bradbury BD. Geovariation in Fracture Risk among Patients Receiving Hemodialysis. Clin J Am Soc Nephrol 2016;11:1413-21. [PMID: 27269611 DOI: 10.2215/CJN.11651115] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 542 |
Kim SM, Long J, Montez-Rath ME, Leonard MB, Norton JA, Chertow GM. Rates and Outcomes of Parathyroidectomy for Secondary Hyperparathyroidism in the United States. Clin J Am Soc Nephrol 2016;11:1260-7. [PMID: 27269300 DOI: 10.2215/CJN.10370915] [Cited by in Crossref: 64] [Cited by in F6Publishing: 70] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 543 |
Becherucci F, Roperto RM, Materassi M, Romagnani P. Chronic kidney disease in children. Clin Kidney J 2016;9:583-91. [PMID: 27478602 DOI: 10.1093/ckj/sfw047] [Cited by in Crossref: 107] [Cited by in F6Publishing: 113] [Article Influence: 15.3] [Reference Citation Analysis]
|
| 544 |
Auguste BL, Yuen D, Chan CT. Conventional hemodialysis is associated with greater bone loss than nocturnal hemodialysis: a retrospective observational study of a convenience cohort. Can J Kidney Health Dis 2016;3:27. [PMID: 27252880 DOI: 10.1186/s40697-016-0118-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 545 |
Obi Y, Mehrotra R, Rivara MB, Streja E, Rhee CM, Lau WL, Kovesdy CP, Kalantar-Zadeh K. Hidden Hypercalcemia and Mortality Risk in Incident Hemodialysis Patients. J Clin Endocrinol Metab 2016;101:2440-9. [PMID: 27045726 DOI: 10.1210/jc.2016-1369] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 546 |
Zhang L, Xing C, Shen C, Zeng M, Yang G, Mao H, Zhang B, Yu X, Cui Y, Sun B, Ouyang C, Ge Y, Jiang Y, Yin C, Zha X, Wang N. Diagnostic Accuracy Study of Intraoperative and Perioperative Serum Intact PTH Level for Successful Parathyroidectomy in 501 Secondary Hyperparathyroidism Patients. Sci Rep 2016;6:26841. [PMID: 27231027 DOI: 10.1038/srep26841] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 547 |
Konturek A, Barczyński M, Stopa M, Nowak W. Subtotal parathyroidectomy for secondary renal hyperparathyroidism: a 20-year surgical outcome study. Langenbecks Arch Surg 2016;401:965-74. [PMID: 27233241 DOI: 10.1007/s00423-016-1447-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 548 |
Lee SA, Lee MJ, Ryu GW, Jhee JH, Kim HW, Park S, Jung SY, Oh HJ, Park JT, Han SH, Kang SW, Yoo TH. Low serum intact parathyroid hormone level is an independent risk factor for overall mortality and major adverse cardiac and cerebrovascular events in incident dialysis patients. Osteoporos Int 2016;27:2717-26. [PMID: 27216997 DOI: 10.1007/s00198-016-3636-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 549 |
Gadalean F, Lighezan D, Stoian D, Schiller O, Timar R, Timar B, Bob F, Donciu MD, Munteanu M, Mihaescu A, Covic A, Schiller A. The Survival of Roma Minority Patients on Chronic Hemodialysis Therapy - A Romanian Multicenter Survey. PLoS One 2016;11:e0155271. [PMID: 27196564 DOI: 10.1371/journal.pone.0155271] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 550 |
Locatelli F, Mazzaferro S, Yee J. Iron Therapy Challenges for the Treatment of Nondialysis CKD Patients. Clin J Am Soc Nephrol 2016;11:1269-80. [PMID: 27185524 DOI: 10.2215/CJN.00080116] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 551 |
Cheng Z, Lin J, Qian Q. Role of Vitamin D in Cognitive Function in Chronic Kidney Disease. Nutrients 2016;8:E291. [PMID: 27187460 DOI: 10.3390/nu8050291] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 552 |
Hill Gallant KM, Weaver CM, Towler DA, Thuppal SV, Bailey RL. Nutrition in Cardioskeletal Health. Adv Nutr 2016;7:544-55. [PMID: 27184281 DOI: 10.3945/an.115.011189] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 553 |
Sekercioglu N, Busse JW, Sekercioglu MF, Agarwal A, Shaikh S, Lopes LC, Mustafa RA, Guyatt GH, Thabane L. Cinacalcet versus standard treatment for chronic kidney disease: a systematic review and meta-analysis. Renal Failure 2016;38:857-74. [DOI: 10.3109/0886022x.2016.1172468] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 554 |
Seifert ME, Ashoor IF, Chiang ML, Chishti AS, Dietzen DJ, Gipson DS, Janjua HS, Selewski DT, Hruska KA. Fibroblast growth factor-23 and chronic allograft injury in pediatric renal transplant recipients: a Midwest Pediatric Nephrology Consortium study. Pediatr Transplant 2016;20:378-87. [PMID: 26880121 DOI: 10.1111/petr.12682] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 555 |
Nef S, Neuhaus TJ, Spartà G, Weitz M, Buder K, Wisser J, Gobet R, Willi U, Laube GF. Outcome after prenatal diagnosis of congenital anomalies of the kidney and urinary tract. Eur J Pediatr 2016;175:667-76. [PMID: 26805407 DOI: 10.1007/s00431-015-2687-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 556 |
Singer RF, Williams O, Mercado C, Chen B, Talaulikar G, Walters G, Roberts DM. Regional citrate anticoagulation in hemodialysis: an observational study of safety, efficacy, and effect on calcium balance during routine care. Can J Kidney Health Dis 2016;3:22. [PMID: 27099775 DOI: 10.1186/s40697-016-0113-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 557 |
Morrone LF, Bolasco P, Camerini C, Cianciolo G, Cupisti A, Galassi A, Mazzaferro S, Russo D, Russo L, Cozzolino M. Vitamin D in patients with chronic kidney disease: a position statement of the Working Group "Trace Elements and Mineral Metabolism" of the Italian Society of Nephrology. J Nephrol 2016;29:305-28. [PMID: 27062486 DOI: 10.1007/s40620-016-0305-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 558 |
Pereira RC, Andersen TL, Friedman PA, Tumber N, Salusky IB, Wesseling-Perry K. Bone Canopies in Pediatric Renal Osteodystrophy. PLoS One 2016;11:e0152871. [PMID: 27045269 DOI: 10.1371/journal.pone.0152871] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 559 |
Cavalier E, Bergmann P, Bruyère O, Delanaye P, Durnez A, Devogelaer J, Ferrari SL, Gielen E, Goemaere S, Kaufman J, Toukap AN, Reginster J, Rousseau A, Rozenberg S, Scheen AJ, Body J. The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club. Osteoporos Int 2016;27:2181-95. [DOI: 10.1007/s00198-016-3561-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 560 |
Lau T, Leung S, Lau W. Gabapentin for uremic pruritus in hemodialysis patients: a qualitative systematic review. Can J Kidney Health Dis 2016;3:14. [PMID: 27022475 DOI: 10.1186/s40697-016-0107-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 561 |
Moldovan D, Rusu C, Kacso IM, Potra A, Patiu IM, Gherman-Caprioara M. Mineral and bone disorders, morbidity and mortality in end-stage renal failure patients on chronic dialysis. Clujul Med 2016;89:94-103. [PMID: 27004031 DOI: 10.15386/cjmed-515] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 562 |
Peeters MJ, van den Brand JA, van Zuilen AD, Koster Y, Bots ML, Vervloet MG, Blankestijn PJ, Wetzels JF. Abdominal aortic calcification in patients with CKD. J Nephrol. 2017;30:109-118. [PMID: 27003153 DOI: 10.1007/s40620-015-0260-7] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 563 |
Park KS, Park J, Choi SH, Ann SH, Singh GB, Shin ES, Lee JS, Chung HC. Serum Phosphorus Concentration and Coronary Artery Calcification in Subjects without Renal Dysfunction. PLoS One 2016;11:e0151007. [PMID: 26992166 DOI: 10.1371/journal.pone.0151007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 564 |
Nakashima A, Yokoyama K, Yokoo T, Urashima M. Role of vitamin D in diabetes mellitus and chronic kidney disease. World J Diabetes 2016; 7(5): 89-100 [PMID: 26981182 DOI: 10.4239/wjd.v7.i5.89] [Cited by in CrossRef: 75] [Cited by in F6Publishing: 76] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 565 |
Soohoo M, Feng M, Obi Y, Streja E, Rhee CM, Lau WL, Wang J, Ravel VA, Brunelli S, Kovesdy CP, Kalantar-Zadeh K. Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients. Am J Nephrol 2016;43:85-96. [PMID: 26950688 DOI: 10.1159/000444890] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 566 |
Zitt E, Lhotta K. [Management of secondary hyperparathyroidism-current impact of parathyroidectomy]. Wien Med Wochenschr 2016;166:254-8. [PMID: 26913524 DOI: 10.1007/s10354-016-0444-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 567 |
Adejumo OA, Okaka EI, Madumezia G, Okwuonu CG, Ojogwu LI. Assessment of some cardiovascular risk factors in predialysis chronic kidney disease patients in Southern Nigeria. Niger Med J 2015;56:394-9. [PMID: 26903696 DOI: 10.4103/0300-1652.171616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 568 |
Sag AA, Covic A, London G, Vervloet M, Goldsmith D, Gorriz JL, Kanbay M. Clinical imaging of vascular disease in chronic kidney disease. Int Urol Nephrol 2016;48:827-37. [PMID: 26898824 DOI: 10.1007/s11255-016-1240-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 569 |
Bouquegneau A, Salam S, Delanaye P, Eastell R, Khwaja A. Bone Disease after Kidney Transplantation. Clin J Am Soc Nephrol 2016;11:1282-96. [PMID: 26912549 DOI: 10.2215/CJN.11371015] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 570 |
Wesseling-Perry K. Defective skeletal mineralization in pediatric CKD. Curr Osteoporos Rep 2015;13:98-105. [PMID: 25638580 DOI: 10.1007/s11914-015-0253-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 571 |
St-Jules DE, Woolf K, Pompeii ML, Kalantar-Zadeh K, Sevick MA. Reexamining the Phosphorus-Protein Dilemma: Does Phosphorus Restriction Compromise Protein Status? J Ren Nutr 2016;26:136-40. [PMID: 26873260 DOI: 10.1053/j.jrn.2015.12.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 572 |
Merle E, Roth H, London GM, Jean G, Hannedouche T, Bouchet JL, Drüeke T, Fouque D, Daugas E; French Calcium and Phosphate Observatory. Low parathyroid hormone status induced by high dialysate calcium is an independent risk factor for cardiovascular death in hemodialysis patients. Kidney Int 2016;89:666-74. [PMID: 26880460 DOI: 10.1016/j.kint.2015.12.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 573 |
Noce A, Canale MP, Capria A, Rovella V, Tesauro M, Splendiani G, Annicchiarico-Petruzzelli M, Manzuoli M, Simonetti G, Di Daniele N. Coronary artery calcifications predict long term cardiovascular events in non diabetic Caucasian hemodialysis patients. Aging (Albany NY) 2015;7:269-79. [PMID: 26131456 DOI: 10.18632/aging.100740] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 574 |
Garneata L, Stancu A, Dragomir D, Stefan G, Mircescu G. Ketoanalogue-Supplemented Vegetarian Very Low-Protein Diet and CKD Progression. J Am Soc Nephrol 2016;27:2164-76. [PMID: 26823552 DOI: 10.1681/ASN.2015040369] [Cited by in Crossref: 167] [Cited by in F6Publishing: 168] [Article Influence: 23.9] [Reference Citation Analysis]
|
| 575 |
Rodriguez M, Salmeron MD, Martin-Malo A, Barbieri C, Mari F, Molina RI, Costa P, Aljama P. A New Data Analysis System to Quantify Associations between Biochemical Parameters of Chronic Kidney Disease-Mineral Bone Disease. PLoS One 2016;11:e0146801. [PMID: 26808154 DOI: 10.1371/journal.pone.0146801] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 576 |
Abdallah E, Mosbah O, Khalifa G, Metwaly A, El-Bendary O. Assessment of the relationship between serum soluble Klotho and carotid intima-media thickness and left ventricular dysfunction in hemodialysis patients. Kidney Res Clin Pract 2016;35:42-9. [PMID: 27069857 DOI: 10.1016/j.krcp.2015.12.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 577 |
Naylor KL, Zou G, Leslie WD, McArthur E, Lam NN, Knoll GA, Kim SJ, Fraser LA, Adachi JD, Hodsman AB, Garg AX. Frequency of bone mineral density testing in adult kidney transplant recipients from Ontario, Canada: a population-based cohort study. Can J Kidney Health Dis 2016;3:2. [PMID: 26779343 DOI: 10.1186/s40697-016-0092-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 578 |
Fukagawa M, Drüeke TB. Parathyroidectomy or Calcimimetic to Treat Hypercalcemia after Kidney Transplantation? J Am Soc Nephrol 2016;27:2221-4. [PMID: 26772195 DOI: 10.1681/ASN.2015121349] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 579 |
Ko EJ, Kim BH, Jeong HY, Soe SU, Yang DH, Lee SY. Serum 25-hydroxyvitamin D as a predictor of hospitalization-free survival in predialysis and dialysis patients with chronic kidney disease: a single-center prospective observational analysis. Kidney Res Clin Pract 2016;35:22-8. [PMID: 27069854 DOI: 10.1016/j.krcp.2015.12.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 580 |
Sekercioglu N, Busse JW, Mustafa RA, Guyatt GH, Thabane L. Cinacalcet versus standard treatment for chronic kidney disease: a protocol for a systematic review and meta-analysis. Syst Rev 2016;5:2. [PMID: 26729302 DOI: 10.1186/s13643-015-0177-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 581 |
Selamet U, Tighiouart H, Sarnak MJ, Beck G, Levey AS, Block G, Ix JH. Relationship of dietary phosphate intake with risk of end-stage renal disease and mortality in chronic kidney disease stages 3-5: The Modification of Diet in Renal Disease Study. Kidney Int 2016;89:176-84. [PMID: 26422502 DOI: 10.1038/ki.2015.284] [Cited by in Crossref: 53] [Cited by in F6Publishing: 59] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 582 |
Mihai S, Codrici E, Popescu ID, Enciu AM, Rusu E, Zilisteanu D, Albulescu R, Anton G, Tanase C. Proteomic Biomarkers Panel: New Insights in Chronic Kidney Disease. Dis Markers 2016;2016:3185232. [PMID: 27667892 DOI: 10.1155/2016/3185232] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 583 |
Chuang SH, Wong HC, Vathsala A, Lee E, How PP. Prevalence of chronic kidney disease-mineral and bone disorder in incident peritoneal dialysis patients and its association with short-term outcomes. Singapore Med J 2016;57:603-9. [PMID: 26778726 DOI: 10.11622/smedj.2015195] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 584 |
Pereira RC, Bischoff DS, Yamaguchi D, Salusky IB, Wesseling-Perry K. Micro-CT in the Assessment of Pediatric Renal Osteodystrophy by Bone Histomorphometry. Clin J Am Soc Nephrol 2016;11:481-7. [PMID: 26712809 DOI: 10.2215/CJN.04810515] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 585 |
Taweesedt PT, Disthabanchong S. Mineral and bone disorder after kidney transplantation. World J Transplant 2015; 5(4): 231-242 [PMID: 26722650 DOI: 10.5500/wjt.v5.i4.231] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 586 |
Ok E, Asci G, Bayraktaroglu S, Toz H, Ozkahya M, Yilmaz M, Kircelli F, Sevinc Ok E, Ceylan N, Duman S, Cirit M, Monier-Faugere MC, Malluche HH. Reduction of Dialysate Calcium Level Reduces Progression of Coronary Artery Calcification and Improves Low Bone Turnover in Patients on Hemodialysis. J Am Soc Nephrol 2016;27:2475-86. [PMID: 26701977 DOI: 10.1681/ASN.2015030268] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 587 |
Miskulin DC, Majchrzak K, Tighiouart H, Muther RS, Kapoian T, Johnson DS, Weiner DE. Ergocalciferol Supplementation in Hemodialysis Patients With Vitamin D Deficiency: A Randomized Clinical Trial. J Am Soc Nephrol 2016;27:1801-10. [PMID: 26677862 DOI: 10.1681/ASN.2015040468] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 588 |
Kestenbaum B. Con: Phosphate binders in chronic kidney disease. Nephrol Dial Transplant 2016;31:189-94. [PMID: 26681747 DOI: 10.1093/ndt/gfv406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 589 |
Mohamed A, M. Abbas H, Kassem JM, Bayoumi HM, Kassem SM, Shoman TM, Hassanane MM. Effect of Emulsifying Salt Type on Physiochemical Properties of Processed Cheese as Well as Genetic and Biochemical Changes in Male Mice. International J of Dairy Science 2015;11:1-10. [DOI: 10.3923/ijds.2016.1.10] [Reference Citation Analysis]
|
| 590 |
Patel L, Bernard LM, Elder GJ. Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials. Clin J Am Soc Nephrol 2016;11:232-44. [PMID: 26668024 DOI: 10.2215/CJN.06800615] [Cited by in Crossref: 115] [Cited by in F6Publishing: 119] [Article Influence: 14.4] [Reference Citation Analysis]
|
| 591 |
Leung S, McCormick B, Wagner J, Biyani M, Lavoie S, Imtiaz R, Zimmerman D. Meal phosphate variability does not support fixed dose phosphate binder schedules for patients treated with peritoneal dialysis: a prospective cohort study. BMC Nephrol 2015;16:205. [PMID: 26645271 DOI: 10.1186/s12882-015-0205-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 592 |
Souberbielle JC, Massart C, Brailly-Tabard S, Cormier C, Cavalier E, Delanaye P, Chanson P. Serum PTH reference values established by an automated third-generation assay in vitamin D-replete subjects with normal renal function: consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients. Eur J Endocrinol 2016;174:315-23. [PMID: 26628583 DOI: 10.1530/EJE-15-0595] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 593 |
Cozzolino M, Funk F, Rakov V, Phan O, Teitelbaum I. Preclinical Pharmacokinetics, Pharmacodynamics and Safety of Sucroferric Oxyhydroxide. Curr Drug Metab 2014;15:953-65. [PMID: 25658128 DOI: 10.2174/1389200216666150206124424] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 594 |
Chen L, Ling YS, Lin CH, He JX, Guan TJ. High Dose ESAs Are Associated with High iPTH Levels in Hemodialysis Patients with End-Stage Kidney Disease: A Retrospective Analysis. Front Public Health 2015;3:258. [PMID: 26636058 DOI: 10.3389/fpubh.2015.00258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 595 |
Tentori F, Zepel L, Fuller DS, Wang M, Bieber BA, Robinson BM, Pisoni RL. The DOPPS Practice Monitor for US Dialysis Care: PTH Levels and Management of Mineral and Bone Disorder in US Hemodialysis Patients. Am J Kidney Dis 2015;66:536-9. [PMID: 26300197 DOI: 10.1053/j.ajkd.2015.07.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 596 |
Lamb EJ, Delaney MP. Does PTH offer additive value to ALP measurement in assessing CKD-MBD? Perit Dial Int 2014;34:687-91. [PMID: 25520480 DOI: 10.3747/pdi.2014.00246] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 597 |
Pun PH, Abdalla S, Block GA, Chertow GM, Correa-Rotter R, Dehmel B, Drüeke TB, Floege J, Goodman WG, Herzog CA, London GM, Mahaffey KW, Moe SM, Parfrey PS, Wheeler DC, Middleton JP. Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial. Hemodial Int 2016;20:421-31. [PMID: 26564024 DOI: 10.1111/hdi.12382] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 598 |
Kinsella S, Murphy K, Breen M, O'Neill S, McLaughlin P, Coyle J, Bogue C, O'Neill F, Moore N, McGarrigle A, Molloy MG, Maher MM, Eustace JA. Comparison of single CT scan assessment of bone mineral density, vascular calcification and fat mass with standard clinical measurements in renal transplant subjects: the ABC HeART study. BMC Nephrol 2015;16:188. [PMID: 26558994 DOI: 10.1186/s12882-015-0182-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 599 |
Olowu WA. Pre-treatment considerations in childhood hypertension due to chronic kidney disease. World J Nephrol 2015; 4(5): 500-510 [PMID: 26558187 DOI: 10.5527/wjn.v4.i5.500] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 600 |
Reams BD, Dluzniewski PJ, Do TP, Yue SV, Bradbury BD, Kshirsagar AV, Brookhart MA. Dynamics of cinacalcet use and biochemical control in hemodialysis patients: a retrospective New-user cohort design. BMC Nephrol 2015;16:175. [PMID: 26510587 DOI: 10.1186/s12882-015-0174-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 601 |
Karavetian M, Rizk R. Development and evaluation of continuing education course in renal nutrition. Nutr Res Pract 2016;10:99-107. [PMID: 26865922 DOI: 10.4162/nrp.2016.10.1.99] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 602 |
Ennis J, Gillen D, Rubenstein A, Worcester E, Brecher ME, Asplin J, Coe F. Clinical decision support improves physician guideline adherence for laboratory monitoring of chronic kidney disease: a matched cohort study. BMC Nephrol 2015;16:163. [PMID: 26471846 DOI: 10.1186/s12882-015-0159-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 603 |
Samal L, Wright A, Waikar SS, Linder JA. Nephrology co-management versus primary care solo management for early chronic kidney disease: a retrospective cross-sectional analysis. BMC Nephrol 2015;16:162. [PMID: 26458541 DOI: 10.1186/s12882-015-0154-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 604 |
Barros X, Rodríguez NY, Fuster D, Rodas L, Esforzado N, Mazza A, Rubello D, Campos F, Tapias A, Torregrosa JV. Comparison of two different vitamin D supplementation regimens with oral calcifediol in kidney transplant patients. J Nephrol 2016;29:703-9. [PMID: 26454858 DOI: 10.1007/s40620-015-0237-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 605 |
Keyzer CA, Lambers-Heerspink HJ, Joosten MM, Deetman PE, Gansevoort RT, Navis G, Kema IP, de Zeeuw D, Bakker SJ, de Borst MH; PREVEND Study Group. Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake. Clin J Am Soc Nephrol 2015;10:2119-27. [PMID: 26450935 DOI: 10.2215/CJN.03830415] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 606 |
Huang CW, Lee MJ, Lee PT, Hsu CY, Huang WC, Chen CL, Chou KJ, Fang HC. Low Potassium Dialysate as a Protective Factor of Sudden Cardiac Death in Hemodialysis Patients with Hyperkalemia. PLoS One 2015;10:e0139886. [PMID: 26440515 DOI: 10.1371/journal.pone.0139886] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 607 |
Molostvov G, Hiemstra TF, Fletcher S, Bland R, Zehnder D. Arterial Expression of the Calcium-Sensing Receptor Is Maintained by Physiological Pulsation and Protects against Calcification. PLoS One 2015;10:e0138833. [PMID: 26436544 DOI: 10.1371/journal.pone.0138833] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 608 |
Lorenz K, Bartsch DK, Sancho JJ, Guigard S, Triponez F. Surgical management of secondary hyperparathyroidism in chronic kidney disease--a consensus report of the European Society of Endocrine Surgeons. Langenbecks Arch Surg 2015;400:907-27. [PMID: 26429790 DOI: 10.1007/s00423-015-1344-5] [Cited by in Crossref: 73] [Cited by in F6Publishing: 79] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 609 |
Parikh C, Gutgarts V, Eisenberg E, Melamed ML. Vitamin D and Clinical Outcomes in Dialysis. Semin Dial 2015;28:604-9. [PMID: 26424141 DOI: 10.1111/sdi.12446] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 610 |
Sinha MD, Turner C, Booth CJ, Waller S, Rasmussen P, Goldsmith DJ, Simpson JM. Relationship of FGF23 to indexed left ventricular mass in children with non-dialysis stages of chronic kidney disease. Pediatr Nephrol 2015;30:1843-52. [PMID: 25975437 DOI: 10.1007/s00467-015-3125-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 611 |
Baia LC, Heilberg IP, Navis G, de Borst MH; NIGRAM investigators. Phosphate and FGF-23 homeostasis after kidney transplantation. Nat Rev Nephrol 2015;11:656-66. [PMID: 26416497 DOI: 10.1038/nrneph.2015.153] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 612 |
Hewitson TD, Holt SG, Smith ER. Animal Models to Study Links between Cardiovascular Disease and Renal Failure and Their Relevance to Human Pathology. Front Immunol. 2015;6:465. [PMID: 26441970 DOI: 10.3389/fimmu.2015.00465] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 613 |
Moldovan D, Racasan S, Kacso IM, Rusu C, Potra A, Bondor C, Patiu IM, Gherman-Căprioară M. Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism. Int Urol Nephrol 2015;47:1871-7. [PMID: 26377492 DOI: 10.1007/s11255-015-1106-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 614 |
Zisman AL, Evan AP, Coe FL, Worcester EM. Do kidney stone formers have a kidney disease? Kidney Int 2015;88:1240-9. [PMID: 26376133 DOI: 10.1038/ki.2015.254] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 615 |
Wolf M. Mineral (Mal)Adaptation to Kidney Disease--Young Investigator Award Address: American Society of Nephrology Kidney Week 2014. Clin J Am Soc Nephrol 2015;10:1875-85. [PMID: 26350436 DOI: 10.2215/CJN.04430415] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 616 |
Di Lullo L, Gorini A, Bellasi A, Morrone LF, Rivera R, Russo L, Santoboni A, Russo D. Fibroblast growth factor 23 and parathyroid hormone predict extent of aortic valve calcifications in patients with mild to moderate chronic kidney disease. Clin Kidney J 2015;8:732-6. [PMID: 26613033 DOI: 10.1093/ckj/sfv073] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 617 |
Perez-Gomez MV, Gonzalez-Parra E, Ortiz A. Haemodialysate: long neglected, difficult to optimize, may modify hard outcomes. Clin Kidney J 2015;8:576-9. [PMID: 26413284 DOI: 10.1093/ckj/sfv088] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 618 |
Okoye JU, Arodiwe EB, Ulasi II, Ijoma CK, Onodugo OD. Prevalence of CKD-MBD in pre-dialysis patients using biochemical markers in Enugu, South-East Nigeria. Afr Health Sci 2015;15:941-8. [PMID: 26957985 DOI: 10.4314/ahs.v15i3.31] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
|
| 619 |
Kaku Y, Ookawara S, Miyazawa H, Ito K, Ueda Y, Hirai K, Hoshino T, Mori H, Yoshida I, Morishita Y, Tabei K. Approximation of Corrected Calcium Concentrations in Advanced Chronic Kidney Disease Patients with or without Dialysis Therapy. Nephron Extra 2015;5:39-49. [PMID: 26557841 DOI: 10.1159/000437215] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 620 |
González-Parra E, Aceña Á, Lorenzo Ó, Tarín N, González-Casaus ML, Cristóbal C, Huelmos A, Mahíllo-Fernández I, Pello AM, Carda R, Hernández-González I, Alonso J, Rodríguez-Artalejo F, López-Bescós L, Ortiz A, Egido J, Tuñón J. Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate. J Bone Miner Metab 2016;34:587-98. [PMID: 26298279 DOI: 10.1007/s00774-015-0706-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 621 |
Bhargava R, Kalra PA, Brenchley P, Hurst H, Hutchison A. A Study to Inform the Design of a National Multicentre Randomised Controlled Trial to Evaluate If Reducing Serum Phosphate to Normal Levels Improves Clinical Outcomes including Mortality, Cardiovascular Events, Bone Pain, or Fracture in Patients on Dialysis. Int J Nephrol 2015;2015:579434. [PMID: 26366297 DOI: 10.1155/2015/579434] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 622 |
Scialla JJ, Parekh RS, Eustace JA, Astor BC, Plantinga L, Jaar BG, Shafi T, Coresh J, Powe NR, Melamed ML. Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis. Am J Nephrol 2015;42:25-34. [PMID: 26287973 DOI: 10.1159/000438999] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 623 |
Kendrick J, Chonchol M. Novel Therapeutic Options for the Treatment of Mineral Metabolism Abnormalities in End Stage Renal Disease. Semin Dial 2015;28:610-9. [PMID: 26278462 DOI: 10.1111/sdi.12412] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 624 |
Kong X, Tang L, Ma X, Liu W, Wang Z, Cui M, Xu D. Relationship between mild-to-moderate chronic kidney disease and decreased bone mineral density in Chinese adult population. Int Urol Nephrol 2015;47:1547-53. [PMID: 26265108 DOI: 10.1007/s11255-015-1082-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 625 |
Zitt E, Sprenger-Mähr H, Mündle M, Lhotta K. Efficacy and safety of body weight-adapted oral cholecalciferol substitution in dialysis patients with vitamin D deficiency. BMC Nephrol 2015;16:128. [PMID: 26238347 DOI: 10.1186/s12882-015-0116-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 626 |
Liu ZH; China Dialysis Calcification Study (CDCS) Group. Vascular calcification burden of Chinese patients with chronic kidney disease: methodology of a cohort study. BMC Nephrol 2015;16:129. [PMID: 26238717 DOI: 10.1186/s12882-015-0132-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 627 |
Cheng SP, Lee JJ, Liu TP, Chen HH, Wu CJ, Liu CL. Aluminum overload hampers symptom improvement following parathyroidectomy for secondary hyperparathyroidism. World J Surg 2014;38:2838-44. [PMID: 25002247 DOI: 10.1007/s00268-014-2695-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 628 |
Bover J, Ureña P, Ruiz-García C, daSilva I, Lescano P, del Carpio J, Ballarín J, Cozzolino M. Clinical and Practical Use of Calcimimetics in Dialysis Patients With Secondary Hyperparathyroidism. Clin J Am Soc Nephrol 2016;11:161-74. [PMID: 26224878 DOI: 10.2215/CJN.01760215] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 629 |
Jovanovich A, Chonchol M. Chronic kidney disease: Reductions in FGF-23 levels associated with improved outcomes. Nat Rev Nephrol 2015;11:572-3. [PMID: 26215510 DOI: 10.1038/nrneph.2015.125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 630 |
Song L, Xie XB, Peng LK, Yu SJ, Peng YT. Mechanism and Treatment Strategy of Osteoporosis after Transplantation. Int J Endocrinol 2015;2015:280164. [PMID: 26273295 DOI: 10.1155/2015/280164] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 631 |
Greig SL, Plosker GL. Sucroferric oxyhydroxide: a review in hyperphosphataemia in chronic kidney disease patients undergoing dialysis. Drugs 2015;75:533-42. [PMID: 25761962 DOI: 10.1007/s40265-015-0366-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 632 |
Liabeuf S, Desjardins L, Diouf M, Temmar M, Renard C, Choukroun G, Massy ZA. The Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney Disease. PLoS One. 2015;10:e0131707. [PMID: 26181592 DOI: 10.1371/journal.pone.0131707] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 633 |
Di Lullo L, Gorini A, Russo D, Santoboni A, Ronco C. Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment. Cardiorenal Med 2015;5:254-66. [PMID: 26648942 DOI: 10.1159/000435838] [Cited by in Crossref: 117] [Cited by in F6Publishing: 120] [Article Influence: 14.6] [Reference Citation Analysis]
|
| 634 |
Gajjala PR, Sanati M, Jankowski J. Cellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its Comorbidities. Front Immunol 2015;6:340. [PMID: 26217336 DOI: 10.3389/fimmu.2015.00340] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 635 |
Schleck ML, Souberbielle JC, Jandrain B, Da Silva S, De Niet S, Vanderbist F, Scheen A, Cavalier E. A Randomized, Double-Blind, Parallel Study to Evaluate the Dose-Response of Three Different Vitamin D Treatment Schemes on the 25-Hydroxyvitamin D Serum Concentration in Patients with Vitamin D Deficiency. Nutrients 2015;7:5413-22. [PMID: 26151178 DOI: 10.3390/nu7075227] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 636 |
Davies EW, Matza LS, Worth G, Feeny DH, Kostelec J, Soroka S, Mendelssohn D, McFarlane P, Belozeroff V. Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis. Health Qual Life Outcomes 2015;13:90. [PMID: 26122041 DOI: 10.1186/s12955-015-0266-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 637 |
Jean G, Souberbielle JC, Lechevallier S, Chazot C. Kinetics of serum 25-hydroxyvitamin D in haemodialysis patients treated with monthly oral cholecalciferol. Clin Kidney J 2015;8:388-92. [PMID: 26251704 DOI: 10.1093/ckj/sfv052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 638 |
Boriani G, Savelieva I, Dan GA, Deharo JC, Ferro C, Israel CW, Lane DA, La Manna G, Morton J, Mitjans AM, Vos MA, Turakhia MP, Lip GY; Document reviewers. Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. Europace 2015;17:1169-96. [PMID: 26108808 DOI: 10.1093/europace/euv202] [Cited by in Crossref: 109] [Cited by in F6Publishing: 109] [Article Influence: 13.6] [Reference Citation Analysis]
|
| 639 |
Hutchison AJ, Wilkie M. Use of magnesium as a drug in chronic kidney disease. Clin Kidney J 2012;5:i62-70. [PMID: 26069822 DOI: 10.1093/ndtplus/sfr168] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 640 |
Lurati A, Laria A, Paolotti D, Scarpellini M. Calciphylaxis in a patient affected by rheumatoid arthritis, chronic renal failure, and hyperparathyroidism: a case report. Int Med Case Rep J 2015;8:117-20. [PMID: 26064073 DOI: 10.2147/IMCRJ.S80441] [Reference Citation Analysis]
|
| 641 |
Palit S, Kendrick J. Vascular calcification in chronic kidney disease: role of disordered mineral metabolism. Curr Pharm Des 2014;20:5829-33. [PMID: 24533939 DOI: 10.2174/1381612820666140212194926] [Cited by in Crossref: 66] [Cited by in F6Publishing: 72] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 642 |
Jean G, Granjon S, Zaoui E, Deleaval P, Hurot JM, Lorriaux C, Mayor B, Chazot C. Usefulness and feasibility of measuring ionized calcium in haemodialysis patients. Clin Kidney J 2015;8:378-87. [PMID: 26251703 DOI: 10.1093/ckj/sfv039] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 643 |
Arsalanizadeh B, Westacott R. Osteoclastomas ('brown tumours') and spinal cord compression: a review. Clin Kidney J 2013;6:220-3. [PMID: 26019852 DOI: 10.1093/ckj/sft021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 644 |
Basile C, Lomonte C. A neglected issue in dialysis practice: haemodialysate. Clin Kidney J 2015;8:393-9. [PMID: 26251705 DOI: 10.1093/ckj/sfv038] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 645 |
Prnjavorac B, Irejiz N, Kurbasic Z, Krajina K, Deljkic A, Sinanovic A, Fejzic J. Analysis of Adequacy of 25-Hydroxi vitamin D3 Supplementation in Patients on Hemodialysis and Parathormone, Calcium and Phosphorus Level in the Blood of These Patients. Mater Sociomed 2015;27:83-6. [PMID: 26005381 DOI: 10.5455/msm.2015.27.83-86] [Reference Citation Analysis]
|
| 646 |
Gillespie IA, Floege J, Gioni I, Drüeke TB, de Francisco AL, Anker SD, Kubo Y, Wheeler DC, Froissart M; on behalf the ARO Steering Committee collaborators. Propensity score matching and persistence correction to reduce bias in comparative effectiveness: the effect of cinacalcet use on all-cause mortality. Pharmacoepidemiol Drug Saf 2015;24:738-47. [PMID: 26011775 DOI: 10.1002/pds.3789] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 647 |
Perry CM, Plosker GL. Sevelamer carbonate: a review in hyperphosphataemia in adults with chronic kidney disease. Drugs 2014;74:771-92. [PMID: 24811546 DOI: 10.1007/s40265-014-0215-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 648 |
Gallieni M, De Luca N, Santoro D, Meneghel G, Formica M, Grandaliano G, Pizzarelli F, Cossu M, Segoloni G, Quintaliani G, Di Giulio S, Pisani A, Malaguti M, Marseglia C, Oldrizzi L, Pacilio M, Conte G, Dal Canton A, Minutolo R. Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study.J Nephrol. 2016;29:71-78. [PMID: 25986389 DOI: 10.1007/s40620-015-0202-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 649 |
Kraus MA, Kalra PA, Hunter J, Menoyo J, Stankus N. The prevalence of vascular calcification in patients with end-stage renal disease on hemodialysis: a cross-sectional observational study. Ther Adv Chronic Dis 2015;6:84-96. [PMID: 25984289 DOI: 10.1177/2040622315578654] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 650 |
Massy ZA, Drüeke TB. Magnesium and cardiovascular complications of chronic kidney disease. Nat Rev Nephrol 2015;11:432-42. [PMID: 25963594 DOI: 10.1038/nrneph.2015.74] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 651 |
Isakova T, Ix JH, Sprague SM, Raphael KL, Fried L, Gassman JJ, Raj D, Cheung AK, Kusek JW, Flessner MF. Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD. J Am Soc Nephrol. 2015;26:2328-2339. [PMID: 25967123 DOI: 10.1681/asn.2015020117] [Cited by in Crossref: 98] [Cited by in F6Publishing: 102] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 652 |
Guessous I. Role of Vitamin D deficiency in extraskeletal complications: predictor of health outcome or marker of health status? Biomed Res Int 2015;2015:563403. [PMID: 26075246 DOI: 10.1155/2015/563403] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 653 |
West SL, Lok CE, Langsetmo L, Cheung AM, Szabo E, Pearce D, Fusaro M, Wald R, Weinstein J, Jamal SA. Bone mineral density predicts fractures in chronic kidney disease. J Bone Miner Res 2015;30:913-9. [PMID: 25400209 DOI: 10.1002/jbmr.2406] [Cited by in Crossref: 149] [Cited by in F6Publishing: 148] [Article Influence: 18.6] [Reference Citation Analysis]
|
| 654 |
Holden RM, Booth SL, Day AG, Clase CM, Zimmerman D, Moist L, Shea MK, McCabe KM, Jamal SA, Tobe S, Weinstein J, Madhumathi R, Adams MA, Heyland DK. Inhibiting the progression of arterial calcification with vitamin K in HemoDialysis patients (iPACK-HD) trial: rationale and study design for a randomized trial of vitamin K in patients with end stage kidney disease. Can J Kidney Health Dis 2015;2:17. [PMID: 26075081 DOI: 10.1186/s40697-015-0053-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 655 |
Ma TL, Hung PH, Jong IC, Hiao CY, Hsu YH, Chiang PC, Guo HR, Hung KY. Parathyroidectomy Is Associated with Reduced Mortality in Hemodialysis Patients with Secondary Hyperparathyroidism. Biomed Res Int 2015;2015:639587. [PMID: 26064934 DOI: 10.1155/2015/639587] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 656 |
Riegersperger M, Herkner H, Sunder-Plassmann G. Pulsed oral sirolimus in advanced autosomal-dominant polycystic kidney disease (Vienna RAP Study): study protocol for a randomized controlled trial. Trials 2015;16:182. [PMID: 25899445 DOI: 10.1186/s13063-015-0692-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 657 |
Oltmann SC, Madkhali TM, Sippel RS, Chen H, Schneider DF. Kidney Disease Improving Global Outcomes guidelines and parathyroidectomy for renal hyperparathyroidism. J Surg Res 2015;199:115-20. [PMID: 25982045 DOI: 10.1016/j.jss.2015.04.046] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 658 |
Cozzolino M. Vitamin D: something new under the sun. Clin Kidney J. 2012;5:285-287. [PMID: 25874081 DOI: 10.1093/ckj/sfs080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 659 |
Yamamoto S, Kido R, Onishi Y, Fukuma S, Akizawa T, Fukagawa M, Kazama JJ, Narita I, Fukuhara S. Use of renin-angiotensin system inhibitors is associated with reduction of fracture risk in hemodialysis patients. PLoS One 2015;10:e0122691. [PMID: 25874620 DOI: 10.1371/journal.pone.0122691] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 660 |
Kuo CH, Hsieh TC, Wang CH, Chou CL, Lai YH, Chen YY, Lin YL, Wu ST, Fang TC. Increased risks of mortality and atherosclerotic complications in incident hemodialysis patients subsequently with bone fractures: a nationwide case-matched cohort study. PLoS One 2015;10:e0121705. [PMID: 25874794 DOI: 10.1371/journal.pone.0121705] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 661 |
Malluche HH, Blomquist G, Monier-Faugere MC, Cantor TL, Davenport DL. High parathyroid hormone level and osteoporosis predict progression of coronary artery calcification in patients on dialysis. J Am Soc Nephrol. 2015;26:2534-2544. [PMID: 25838468 DOI: 10.1681/asn.2014070686] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 662 |
Hedgeman E, Lipworth L, Lowe K, Saran R, Do T, Fryzek J. International burden of chronic kidney disease and secondary hyperparathyroidism: a systematic review of the literature and available data. Int J Nephrol 2015;2015:184321. [PMID: 25918645 DOI: 10.1155/2015/184321] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 663 |
Obi Y, Hamano T, Isaka Y. Prevalence and prognostic implications of vitamin D deficiency in chronic kidney disease. Dis Markers 2015;2015:868961. [PMID: 25883412 DOI: 10.1155/2015/868961] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 664 |
Pawlowska M, Kapeluto JE, Kendler DL. A case report of osteomalacia unmasking primary biliary cirrhosis. Osteoporos Int 2015;26:2035-8. [PMID: 25801184 DOI: 10.1007/s00198-015-3102-5] [Reference Citation Analysis]
|
| 665 |
Komaba H, Taniguchi M, Wada A, Iseki K, Tsubakihara Y, Fukagawa M. Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism. Kidney Int 2015;88:350-9. [PMID: 25786097 DOI: 10.1038/ki.2015.72] [Cited by in Crossref: 112] [Cited by in F6Publishing: 121] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 666 |
Dave V, Chiang CY, Booth J, Mount PF. Hypocalcemia post denosumab in patients with chronic kidney disease stage 4-5. Am J Nephrol 2015;41:129-37. [PMID: 25790847 DOI: 10.1159/000380960] [Cited by in Crossref: 79] [Cited by in F6Publishing: 84] [Article Influence: 9.9] [Reference Citation Analysis]
|
| 667 |
Bhan I, Dobens D, Tamez H, Deferio JJ, Li YC, Warren HS, Ankers E, Wenger J, Tucker JK, Trottier C, Pathan F, Kalim S, Nigwekar SU, Thadhani R. Nutritional vitamin D supplementation in dialysis: a randomized trial. Clin J Am Soc Nephrol 2015;10:611-9. [PMID: 25770176 DOI: 10.2215/CJN.06910714] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 668 |
Górriz JL, Molina P, Cerverón MJ, Vila R, Bover J, Nieto J, Barril G, Martínez-Castelao A, Fernández E, Escudero V. Vascular calcification in patients with nondialysis CKD over 3 years. Clin J Am Soc Nephrol. 2015;10:654-666. [PMID: 25770175 DOI: 10.2215/cjn.07450714] [Cited by in Crossref: 104] [Cited by in F6Publishing: 105] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 669 |
Ennis JL, Worcester EM, Coe FL, Sprague SM. Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low. J Nephrol 2016;29:63-70. [PMID: 25736620 DOI: 10.1007/s40620-015-0186-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 670 |
Umanath K, Jalal DI, Greco BA, Umeukeje EM, Reisin E, Manley J, Zeig S, Negoi DG, Hiremath AN, Blumenthal SS, Sika M, Niecestro R, Koury MJ, Ma KN, Greene T, Lewis JB, Dwyer JP; Collaborative Study Group. Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD. J Am Soc Nephrol 2015;26:2578-87. [PMID: 25736045 DOI: 10.1681/ASN.2014080842] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 671 |
Holmar J, Uhlin F, Fernström A, Luman M, Jankowski J, Fridolin I. An optical method for serum calcium and phosphorus level assessment during hemodialysis. Toxins (Basel) 2015;7:719-27. [PMID: 25734785 DOI: 10.3390/toxins7030719] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 672 |
Cada DJ, Cong J, Baker DE. Ferric citrate. Hosp Pharm 2015;50:139-51. [PMID: 25717210 DOI: 10.1310/hpj5002-139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 673 |
Hwang E, Choi BS, Oh KH, Kwon YJ, Kim GH. Management of chronic kidney disease-mineral and bone disorder: Korean working group recommendations. Kidney Res Clin Pract 2015;34:4-12. [PMID: 26484013 DOI: 10.1016/j.krcp.2015.02.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 674 |
Shobeiri N, Adams MA, Holden RM. Phosphate: an old bone molecule but new cardiovascular risk factor. Br J Clin Pharmacol 2014;77:39-54. [PMID: 23506202 DOI: 10.1111/bcp.12117] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 675 |
Parfrey PS, Drüeke TB, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Kubo Y, Dehmel B, Goodman WG, Chertow GM; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators. The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. Clin J Am Soc Nephrol 2015;10:791-9. [PMID: 25710802 DOI: 10.2215/CJN.07730814] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 676 |
Sun N, Guo Y, Liu W, Densmore M, Shalhoub V, Erben RG, Ye L, Lanske B, Yuan Q. FGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice. Sci Rep 2015;5:8304. [PMID: 25665715 DOI: 10.1038/srep08304] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 677 |
Doyon A, Fischer DC, Bayazit AK, Canpolat N, Duzova A, Sözeri B, Bacchetta J, Balat A, Büscher A, Candan C, Cakar N, Donmez O, Dusek J, Heckel M, Klaus G, Mir S, Özcelik G, Sever L, Shroff R, Vidal E, Wühl E, Gondan M, Melk A, Querfeld U, Haffner D, Schaefer F; 4C Study Consortium. Markers of bone metabolism are affected by renal function and growth hormone therapy in children with chronic kidney disease. PLoS One 2015;10:e0113482. [PMID: 25659076 DOI: 10.1371/journal.pone.0113482] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 678 |
Naylor KL, Garg AX, Zou G, Langsetmo L, Leslie WD, Fraser LA, Adachi JD, Morin S, Goltzman D, Lentle B, Jackson SA, Josse RG, Jamal SA. Comparison of fracture risk prediction among individuals with reduced and normal kidney function. Clin J Am Soc Nephrol 2015;10:646-53. [PMID: 25655423 DOI: 10.2215/CJN.06040614] [Cited by in Crossref: 106] [Cited by in F6Publishing: 107] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 679 |
Lanza D, Perna AF, Oliva A, Vanholder R, Pletinck A, Guastafierro S, Di Nunzio A, Vigorito C, Capasso G, Jankowski V, Jankowski J, Ingrosso D. Impact of the uremic milieu on the osteogenic potential of mesenchymal stem cells. PLoS One 2015;10:e0116468. [PMID: 25635832 DOI: 10.1371/journal.pone.0116468] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 680 |
Ortiz A. Translational nephrology: what translational research is and a bird's-eye view on translational research in nephrology. Clin Kidney J 2015;8:14-22. [PMID: 25713705 DOI: 10.1093/ckj/sfu142] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 681 |
Kim GH. Gaps between Global Guidelines and Local Practices in CKD-MBD. Electrolyte Blood Press 2014;12:35-40. [PMID: 25606042 DOI: 10.5049/EBP.2014.12.2.35] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 682 |
Shaman AM, Kowalski SR. Hyperphosphatemia Management in Patients with Chronic Kidney Disease. Saudi Pharm J 2016;24:494-505. [PMID: 27330380 DOI: 10.1016/j.jsps.2015.01.009] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 683 |
Sprague SM, Silva AL, Al-Saghir F, Damle R, Tabash SP, Petkovich M, Messner EJ, White JA, Melnick JZ, Bishop CW. Modified-release calcifediol effectively controls secondary hyperparathyroidism associated with vitamin D insufficiency in chronic kidney disease. Am J Nephrol 2014;40:535-45. [PMID: 25572630 DOI: 10.1159/000369939] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 684 |
Soomro IH, Goldfarb DS. Dysphoria induced in dialysis providers by secondary hyperparathyroidism. Clin J Am Soc Nephrol 2015;10:9-11. [PMID: 25516914 DOI: 10.2215/CJN.11551114] [Reference Citation Analysis]
|
| 685 |
Chiu DY, Green D, Abidin N, Sinha S, Kalra PA. Cardiac imaging in patients with chronic kidney disease. Nat Rev Nephrol 2015;11:207-20. [PMID: 25561081 DOI: 10.1038/nrneph.2014.243] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 686 |
Rees L, Shroff R. The demise of calcium-based phosphate binders-is this appropriate for children? Pediatr Nephrol 2015;30:2061-71. [PMID: 25543193 DOI: 10.1007/s00467-014-3017-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 687 |
Negri AL, Ureña Torres PA. Iron-based phosphate binders: do they offer advantages over currently available phosphate binders? Clin Kidney J 2015;8:161-7. [PMID: 25815172 DOI: 10.1093/ckj/sfu139] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 688 |
Yilmaz MI, Sonmez A, Saglam M, Cayci T, Kilic S, Unal HU, Karaman M, Cetinkaya H, Eyileten T, Gok M, Oguz Y, Vural A, Mallamaci F, Zoccali C. A longitudinal study of inflammation, CKD-mineral bone disorder, and carotid atherosclerosis after renal transplantation. Clin J Am Soc Nephrol 2015;10:471-9. [PMID: 25542907 DOI: 10.2215/CJN.07860814] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 689 |
Miller PD. Chronic kidney disease and the skeleton. Bone Res 2014;2:14044. [PMID: 26273531 DOI: 10.1038/boneres.2014.44] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 690 |
Ishani A, Liu J, Wetmore JB, Lowe KA, Do T, Bradbury BD, Block GA, Collins AJ. Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis. Clin J Am Soc Nephrol 2015;10:90-7. [PMID: 25516915 DOI: 10.2215/CJN.03520414] [Cited by in Crossref: 100] [Cited by in F6Publishing: 104] [Article Influence: 11.1] [Reference Citation Analysis]
|
| 691 |
Tentori F, Wang M, Bieber BA, Karaboyas A, Li Y, Jacobson SH, Andreucci VE, Fukagawa M, Frimat L, Mendelssohn DC, Port FK, Pisoni RL, Robinson BM. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol 2015;10:98-109. [PMID: 25516917 DOI: 10.2215/CJN.12941213] [Cited by in Crossref: 185] [Cited by in F6Publishing: 197] [Article Influence: 20.6] [Reference Citation Analysis]
|
| 692 |
Buiten MS, de Bie MK, Bouma-de Krijger A, van Dam B, Dekker FW, Jukema JW, Rabelink TJ, Rotmans JI. Soluble Klotho is not independently associated with cardiovascular disease in a population of dialysis patients. BMC Nephrol 2014;15:197. [PMID: 25495997 DOI: 10.1186/1471-2369-15-197] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 693 |
Nagatoya K, Nishimoto K, Shibahara N, Takahashi T, Kanehara H, Ueno N, Yasuda H, Okada S, Ueda H, Hirai K, Inoue T; Hokusetsu Renal Osteodystrophy Study Group. Effects of raloxifene on bone metabolism in postmenopausal women on chronic hemodialysis. Clin Exp Nephrol 2015;19:939-46. [PMID: 25504368 DOI: 10.1007/s10157-014-1065-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 694 |
Gonçalves FL, Elias RM, dos Reis LM, Graciolli FG, Zampieri FG, Oliveira RB, Jorgetti V, Moysés RM. Serum sclerostin is an independent predictor of mortality in hemodialysis patients. BMC Nephrol 2014;15:190. [PMID: 25465028 DOI: 10.1186/1471-2369-15-190] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 695 |
Esposito P, Rampino T, Gregorini M, Tinelli C, De Silvestri A, Malberti F, Coppo R, Dal Canton A; IAMM Group. Management of mineral metabolism in hemodialysis patients: discrepancy between interventions and perceived causes of failure. J Nephrol 2014;27:689-97. [PMID: 24804853 DOI: 10.1007/s40620-014-0100-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 696 |
Mathew AT, Hazzan A, Jhaveri KD, Block GA, Chidella S, Rosen L, Wagner J, Fishbane S. Increasing hip fractures in patients receiving hemodialysis and peritoneal dialysis. Am J Nephrol 2014;40:451-7. [PMID: 25427771 DOI: 10.1159/000369039] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 697 |
Rossi AP, Burris DD, Lucas FL, Crocker GA, Wasserman JC. Effects of a renal rehabilitation exercise program in patients with CKD: a randomized, controlled trial. Clin J Am Soc Nephrol 2014;9:2052-8. [PMID: 25414318 DOI: 10.2215/CJN.11791113] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 698 |
Block G, Isakova T. Tip-toeing toward the finish line. Nephrol Dial Transplant 2015;30:1-3. [PMID: 25414374 DOI: 10.1093/ndt/gfu360] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 699 |
Nagata Y, Inaba M, Imanishi Y, Okazaki H, Yamada S, Mori K, Shoji S, Koyama H, Okuno S. Increased undercarboxylated osteocalcin/intact osteocalcin ratio in patients undergoing hemodialysis. Osteoporos Int 2015;26:1053-61. [PMID: 25403902 DOI: 10.1007/s00198-014-2954-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 700 |
Alani H, Tamimi A, Tamimi N. Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs. World J Nephrol 2014; 3(4): 156-168 [PMID: 25374809 DOI: 10.5527/wjn.v3.i4.156] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 62] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 701 |
Rozentryt P, Nowak J, Niedziela J, Hudzik B, Doehner W, Jankowska EA, von Haehling S, Partyka R, Kawecka E, Myrda K, Rywik T, Szyguła B, Kokocińska D, Anker SD, Ponikowski P, Poloński L. Serum phosphorus level is related to degree of clinical response to up-titration of heart failure pharmacotherapy. International Journal of Cardiology 2014;177:248-54. [DOI: 10.1016/j.ijcard.2014.09.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 702 |
Ix JH, Anderson CA, Smits G, Persky MS, Block GA. Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease: a crossover study. Am J Clin Nutr 2014;100:1392-7. [PMID: 25332338 DOI: 10.3945/ajcn.114.085498] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 703 |
Barnieh L, Donaldson C, Manns B. Health care prioritization: a clinician's duty. Can J Kidney Health Dis 2014;1:27. [PMID: 25780616 DOI: 10.1186/s40697-014-0027-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 704 |
Wang S, Qin L, Wu T, Deng B, Sun Y, Hu D, Mohan C, Zhou XJ, Peng A. Elevated cardiac markers in chronic kidney disease as a consequence of hyperphosphatemia-induced cardiac myocyte injury. Med Sci Monit 2014;20:2043-53. [PMID: 25344353 DOI: 10.12659/MSM.890909] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 705 |
Fusaro M, Noale M, Tripepi G, Giannini S, D’Angelo A, Pica A, Calò LA, Miozzo D, Gallieni M. Long-term proton pump inhibitor use is associated with vascular calcification in chronic kidney disease: a cross-sectional study using propensity score analysis. Drug Saf. 2013;36:635-642. [PMID: 23670724 DOI: 10.1007/s40264-013-0062-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 706 |
Behets GJ, Spasovski G, Sterling LR, Goodman WG, Spiegel DM, De Broe ME, D'Haese PC. Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism. Kidney Int 2015;87:846-56. [PMID: 25337774 DOI: 10.1038/ki.2014.349] [Cited by in Crossref: 123] [Cited by in F6Publishing: 128] [Article Influence: 13.7] [Reference Citation Analysis]
|
| 707 |
Arcidiacono MV, Yang J, Fernandez E, Dusso A. Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice. Nephrol Dial Transplant 2015;30:434-40. [PMID: 25324357 DOI: 10.1093/ndt/gfu318] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 708 |
Shin S, Lee S. Niacin as a drug repositioning candidate for hyperphosphatemia management in dialysis patients. Ther Clin Risk Manag 2014;10:875-83. [PMID: 25342908 DOI: 10.2147/TCRM.S71559] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
